{"key":"de-ch","appUrl":"https://www.claraforschung.ch","cmsUrl":"https://cms.claraforschung.ch","culture":{"label":"de","culture":"de-ch","locale":"ch","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}},"page":{"status":200,"cacheVersion":"15-ce42f4ed-390c-4c21-b1c1-4210f54803c9","id":"ce42f4ed-390c-4c21-b1c1-4210f54803c9","contentType":"claraforschungHome","name":"Clara Forschung","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"metadata":{"createDate":"2024-02-16T14:50:18.27Z","updateDate":"2024-11-20T13:43:22.17Z","title":"Clara Forschung","description":null,"cultures":[{"label":"de","culture":"de-ch","locale":"ch","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}},{"label":"en","culture":"en-ch","locale":"ch","route":{"path":"/en","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}},{"label":"fr","culture":"fr-ch","locale":"ch","route":{"path":"/fr","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}}],"culture":{"label":"de","culture":"de-ch","locale":"ch","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}},"ogImage":null},"apiResponse":{"contentType":"claraforschungHome","name":"Clara Forschung","createDate":"2024-02-16T14:50:18.27Z","updateDate":"2024-11-20T13:43:22.17Z","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ce42f4ed-390c-4c21-b1c1-4210f54803c9","properties":{"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"a8218fde-9e09-4090-be7a-71259e470d15","properties":{"title":"Willkommen in der Clara Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}],"viewContext":{"isInsideContainer":false}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"2448abc9-6faa-434e-9e36-821f57f1710a","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Mit der Clara Forschung wurde eine Forschungseinrichtung aufgebaut, die allen gesetzlichen Ansprüchen einer modernen klinischen Forschungseinheit entspricht und sich durch eine hochqualitative, klinische Forschungstätigkeit auszeichnet.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"claraforschungComponentNewsFilter","id":"8173c7d0-5870-4ac8-ab53-e017ab0deb29","properties":{"jumpNavigationTitle":"News","title":"Aktuelles","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"News","tag":"#text"}]}],"blocks":[]}}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"componentRichtext","id":"e4591aed-2017-4881-8fb6-3b196d6a8731","properties":{"jumpNavigationTitle":"Kernforschungsgebiete","title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die Anforderungen an Forschungsinstitutionen sind in den letzten Jahren stets gestiegen. Um diesen erhöhten Anforderungen gerecht zu werden, wurde 2015 die Forschungsabteilung der St. Claraspital AG gegründet und schliesslich im April 2018 in eine Aktiengesellschaft (als Tochtergesellschaft der St. Clara AG, fortan «St. Clara Forschung AG»/«St. Clara Research Ltd») überführt, unter Mitbeteiligung der ","tag":"#text"},{"tag":"a","attributes":{"rel":"noopener","href":"http://lindenhofbern.ch/","target":"_blank"},"elements":[{"text":"Stiftung Lindenhof Bern","tag":"#text"}]},{"text":".","tag":"#text"}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Mit der St. Clara Forschung AG wurde eine Forschungseinrichtung aufgebaut, die allen gesetzlichen Ansprüchen einer modernen klinischen Forschungseinheit entspricht und sich durch eine hochqualitative, klinische Forschungstätigkeit auszeichnet. Zahlreiche internationale Kooperationen erlauben es, national und international kompetitive klinische und translationale Forschung auf einem hohen Niveau zu betreiben.","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":" ","tag":"#text"}]},{"tag":"h3","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"tag":"strong","attributes":{},"elements":[{"text":"Zweck der Clara Forschung","tag":"#text"}]}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Gemäss den Statuten der St. Clara Forschung AG ist der Zweck der Gesellschaft wie folgt definiert:","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"Art. 2: Die Gesellschaft bezweckt die akademische, nichtkommerzielle, weisungsungebundene, freie Forschung, welche die Verwertungs- und Publikationsfreiheit respektiert, auf dem Gebiet der Medizin und auf anderen Gebieten, die zur Medizin einen engen Bezug aufweisen. Die Tätigkeit der Gesellschaft ist gemeinnützig.","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]}]},{"tag":"h3","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"tag":"strong","attributes":{},"elements":[{"text":"Kernforschungsgebiete der Clara Forschung","tag":"#text"}]}]},{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"text":"Metabole und gastroenterologische Forschung","tag":"#text"}]},{"tag":"li","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"text":"Medizinische und medizinisch-onkologische Forschung","tag":"#text"}]},{"tag":"li","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"text":"Viszeralchirurgische Forschung","tag":"#text"}]}]}],"blocks":[]},"link":null}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"componentTeasers","id":"e3971029-0f8c-4c05-af71-3b147f1fcaf3","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"9189c92b-2db9-46e1-9e71-ccd199539d22","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Krebstherapie hat sich in den letzten Jahren enorm schnell entwickelt. Wirksamere aber auch schonendere Therapieformen können heute eingesetzt werden.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"6fb5422b-f674-4c3a-aaf7-c08f4de58d12","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die St. Clara Forschung erforscht schwerpunktmässig die Verbesserung in der Diagnostik und Behandlung von Krebserkrankungen des Bauches, des Blutsystems, der Brust, der Lunge, der Nieren, der Hoden und der Prostata.","tag":"#text"}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die allgemeine Forschung beschäftigt sich mit Forschungsprojekten ausserhalb der erwähnten Gebiete wie beispielsweise der Anästhesie, Notfallmedizin, Intensivmedizin, Palliativmedizin, Kardiologie, Pneumologie und Psychoonkologie.   ","tag":"#text"},{"tag":"span","attributes":{"style":"mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Lucida Sans Unicode'; mso-fareast-language: DE-CH;"},"elements":[{"tag":"br","attributes":{},"elements":[]}]}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentTeasers","id":"a9eb21f8-af75-4511-acaf-1354de102ea0","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"02b93292-12fd-4b10-9469-eaae67457117","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Um Behandlungskonzepte zu verbessern und neuartige Therapien zu entwickeln, ist Forschung unabdingbar. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"a629a076-ae6b-4d08-980f-af0ff3c76ca7","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Klinische Studien werden direkt am und mit dem Patienten durchgeführt. Diese kann sehr unterschiedlich sein. Beispielsweise, indem die Wirkung oder die Dosierung eines Medikaments getestet wird oder indem unterschiedliche Behandlungsmethoden für eine Indikation miteinander verglichen werden. Ziel der klinischen Forschung ist immer, Krankheiten besser zu verstehen und neue Therapieformen zu entwickeln oder bestehende zu verbessern. Zahlreiche Studien werden aktuell in der St. Clara Forschung AG durchgeführt:","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"6061c448-95d0-461b-8def-33e126368f75","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchdecke/Leiste","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":"Aktuelle Studien","items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"cd427adb-c784-4aa8-9e3b-4bf42e80faaa","properties":{"title":"Perioperative Outcome (Pain, Complications, Duration of Hops) in MIS for ventral hernie repair over 2 years. Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"c7db4eca-862e-4c73-80a3-323e0622ce20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"BASEC 2023-02357","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie werden zwei verschiedene Techniken zur Operation eines Bauchwandbruches (=Hernie) miteinander verglichen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/249587/studie/68943","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2d595df9-22c3-4173-b0e7-532ec8cb8b63","properties":{"title":"Robotic versus conventional minimal-invasive inguinal hernia repair – a prospective, randomized and blinded clinical trial (ROGER-RCT)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"14690720-f017-4921-8789-c89c5262dc2a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-01655","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"In dieser Studie soll untersucht werden, ob eine robotergestützte Leistenhernienreparatur die postoperativen Schmerzen reduzieren und die Genesung im Vergleich zum konventionellen laparoskopischen Ansatz verbessern kann.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"960fef41-ae29-4d76-90e6-aadaad60acc9","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchspeicheldrüse (Pankreas)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"13b037b7-b8ca-4c95-bce3-eb17be9c3106","properties":{"title":"Distal Pancreatectomy – A randomised controlled trial to compare minimal-invasive distal pancreatectomy to open resection (DISPACT-2 Trial)BASEC 2023-00705","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"d5d67ef3-6432-4c58-9718-937e0167d0f3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00705","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Teilentfernung der Bauchspeicheldrüse – Vergleich von Schlüssellochtechnikverfahren und offener Operation.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223849/studie/41792","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"e3257fd4-e10d-48b8-8c2d-a2736de17626","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Brust (Mamma)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"4e77c1bd-d1e6-47c2-8d10-2019a0e82886","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"487ea7fb-26fe-47f3-bbb1-ea4cd5d843a2","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"82d0d5be-fd4b-4ccc-91f1-f3d8c14c8646","properties":{"title":"A prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (EUBREAST 03 (R) AXSANA)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"508db622-8ccb-4749-bab2-f22414e9f9b7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-02830","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Studie an mehreren Kliniken, untersucht verschiedene OP-Methoden, um die Achselhöhlen bei Brustkrebspatientinnen mit befallenen Lymphknoten zu überprüfen. Diese Patientinnen erhalten vor der Operation eine Chemotherapie. Ziel der Studie ist es, die besten chirurgischen Verfahren zu vergleichen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/axsana/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"13125a74-5577-471f-a70c-7d07cb66adf2","properties":{"title":"Methods for Localization of Different types of breast lesions (EUBREAST 04 (R) MELODY)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"48ed91fa-7e6d-42fb-807c-a22d12d019dc","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00646","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"Eine Beobachtungsstudie ohne Eingriff, die an mehreren Standorten durchgeführt wird, um verschiedene bildgebende Verfahren zur genauen Erkennung von bösartigen Brusttumoren zu bewerten.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/melody/"},"elements":[{"text":"Mehr Infomationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"fba61881-b69e-4546-b129-66acf8e965f8","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"112cc61a-9fe4-4528-9742-5e58843926bb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ee5f2596-91ae-4e4b-90d7-e95d68f0d540","properties":{"title":"Intelligent Vacuum assisted biopsy Immediately before Surgery as an Intra- or pre-Operative surrogate for patient response to Neoadjuvant chemotherapy for breast cancer (VISION I) A multicenter prospective feasibility trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e3bf6ee7-83d3-40c1-84a0-3d69bf25e969","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00450","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Studie untersucht, ob eine intelligente, vakuumgestützte Biopsie direkt vor der Operation bei Brustkrebs genutzt werden kann, um schon vor oder während der Operation zu erkennen, wie gut die Patientinnen auf die vorherige Chemotherapie angesprochen haben.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/172850/studie/50248"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"502abcc8-2213-4d51-8495-2479b30b90cc","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Darm","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"b082020c-6fcb-4c92-af44-7af1c0f48a41","properties":{"title":"Cholecalciferol Comedication in patients with Chronic inflammatory bowel diseases (Crohn's disease or ulcerative Colitis) – the 5C-study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"99b902c7-464f-41b3-b98c-4e39d44b091a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00899","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Cholecalciferol-Co-Medikation bei Patient/innen mit chronisch entzündlichen Darmerkrankungen (Morbus Crohn oder Colitis ulcerosa)","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223851/studie/62115","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c14bba1c-04c7-440b-accc-45173f02bcec","properties":{"title":"Ergebnisqualität bei Darmkrebs: Identifikation von Unterschieden und Maßnahmen zur flächendeckenden Qualitätsentwicklung (EDIUM)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"67744ab5-42e6-4389-bea6-d88b4da53380","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-03069","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Vergleich und Messung der gesundheitsbezogenen Lebensqualität von Patientinnen und Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.edium-studie.de/studyInfo"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"0924559e-5ca3-434f-8a48-d0b8d9a20853","properties":{"title":"Snap Shot Audit Early Onset Colorectal Cancer (EOCC) - Are we doing enough or can we do more?","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"00b85655-bd27-4ef1-adc5-3b0c1506026f","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02297","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Snapshot Audit on Early onset Colorectal Cancer - are we doing enough, can we do more?","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223884/studie/64169"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c0ddbcc3-8eb3-47f6-ba49-8534dc70152f","properties":{"title":"Image-based ex-vivo  drug screening and genomics/transcriptomics for patients colorectal cancer stage II, III, IV (IBDS-CRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b5261ea6-4051-4ffc-8d08-4f502e744bf3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01441","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die klinische Bedeutung von Merkmalen der Tumorzellen bei Darmkrebs weiter zu erforschen. Dies geschieht über die Etablierung einer Plattform für die Analyse des genetischen Profils und der Wirkung von Krebsmedikamenten bei Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.ksbl.ch/kliniken/darmkrebszentrum-baselland/studien"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ce14c88f-3b6a-45ab-b413-390ad7d67565","properties":{"title":"Encorafenib and cetuximab in patients with metastatic, BRAFV600E-mutated, colorectal carcinoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland. (BERING CRC: BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3a9bfa33-9127-43d2-9f83-76ac821e3aa7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00647","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird die Wirksamkeit der Kombination bestehend aus Braftovi-Kapseln (Wirkstoff Encorafenib) und Erbitux bzw. einem gleichwertigen Arzneistoff (Biosimilar) (Wirkstoff Cetuximab) bei metastasierten Darmkrebs untersucht. Die in dieser Studie gewonnenen Daten sollen dazu beitragen, Erfahrungen mit diesen zugelassenen Medikamenten unter Routinebedingungen zu sammeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"f89bd827-a273-4246-a9e8-7bd6a6ae6fe1","properties":{"title":"Patient Reported Outcomes and Markers of Inflammation in Anal Cancer – a Longitudinal Observational Study (PROSAIC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b4c19a64-c048-459c-a9a6-5a6508ee9ee7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02161","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Beobachtungsstudie zur Lebensqualität beim neu diagnostizierten Analkarzinom","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2df1ee27-e288-40d6-9cf0-9a1a53aa2ee6","properties":{"title":"Biomarker identification to guide surgical intervention after neo-adjuvant chemoradiotherapy in rectal cancer (BSIRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"92d91535-85d1-4576-8109-d0aad3237b20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01199","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Identifikation von Biomarkern um das Ansprechen auf die Vorbehandlung beim Rektumkarzinom vorherzusagen","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"70895d41-749f-4143-a090-9597b0f1882c","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Eierstöcke","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2373ea90-1912-4bf7-9990-566862480908","properties":{"title":"MAintenance Therapie/ Erhaltungstherapie mit Aromatasehemmer für Patientinnen mit epithelialem Ovarialkarzinom: eine randomisierte doppelblinde Placebo-kontrollierte multizentrische Phase III Studie. (ENGOT-ov54/Swiss-GO-2/MATAO)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ba8d8b45-6fe0-4b78-9f4d-9e0f4b3e41bf","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00148","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Erhaltungstherapie mit einem Aromatase-Inhibitor bei epithelialem Ovarialkarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176034/studie/52935","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"efc2c2ad-b3c6-4f30-8e0f-cae4e441d4ce","properties":{"title":"SAKK_OvCaR: A retrospective and prospective registry of patients with ovarian cancer","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b11d6529-da0d-403d-9cd3-93593ee93bfe","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-01335","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Register Daten und Behandlung Ovarialcarcinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/ein-pro-und-retrospektives-register-von-patientinnen-mit-ovarialkarzinom"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"67cec99e-6f14-4c6d-8bcb-8e2094419ee4","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ernährung/Übergewicht","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"db4b4417-ff27-4d82-aaa5-c43d8c8f7f4f","properties":{"title":"Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM trial)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8560e58a-ef64-47a5-b2b8-71beef5f5e3d","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02392","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"SLIM Studie - Wirkung unterschiedlicher Schenkellängen beim Magenbypass","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176438/studie/52643","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"58fdf882-9191-4df1-9b72-4c9da32b6613","properties":{"title":"Understanding gut-brain interactions and the effect of a lowcarb dietary intervention in obese and depressive patients with and without glucose intolerance or diabetes: a pilot trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"6cbf87c1-ac9a-4786-95de-8a7934d2b6b5","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Bedeutung der Darm-Hirn-Achse und der Effekt einer kohlenhydratarmen Diät bei Übergewicht und Depression","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176258/studie/48748"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"7173dff6-7695-4eba-bf59-f71b0dd97462","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Hoden","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"d8bc2afb-28c1-4975-bf81-e2889b9aa83d","properties":{"title":"Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"19c8f679-740c-4862-97ae-9500f10b1b36","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKOS 13/083, PB_2016-00235","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Prospektive Datenerhebung bei Patienten mit Hodenkrebs","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.sag-tccs.com","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"debb5fb5-44cf-494a-ba78-c326374b15e7","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Lunge","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2ae1ea32-2b5a-423f-abd6-d3a197091d6f","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ff0bb2d7-9965-4af5-a105-228e548e46c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"26239e17-c1a5-4ae9-b94c-632d048c523c","properties":{"title":"SAKK_LuCa_2: Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"caaed598-39ef-444b-b37e-63b3778e0aae","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00398","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es handelt sich um eine Datenbank, in der Informationen über Patienten mit einer bestimmten Art von Lungenkrebs (metastasierter nicht-kleinzelliger Lungenkrebs, NSCLC) gesammelt werden. Ziel ist es, besser zu verstehen, wie sich diese Genveränderungen auf den Krankheitsverlauf und die Behandlungsergebnisse auswirken.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/register-und-studie-zum-egfr-mutierten-nsclc"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"11b78385-b1bd-4b97-a8c2-b63c3052f70c","properties":{"title":"SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) non-small cell lung cancer (NSCLC). A multicenter phase II trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"56fa4d89-2908-4864-9256-01425d662108","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02378,  EKOS 19/185","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der Studie SAKK 16/18 wird untersucht, ob eine zusätzliche präoperative Immuntherapie mit dem anti-PD-L1 Antikörper Durvalumab in Kombination mit Radiotherapie die Prognose lokal fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) verbessern kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176046/studie/49836"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"3a627627-6294-44d7-ba3e-8ef2b6a1b0f8","properties":{"title":"Procalcitonin and Lung UltraSonography based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: a pragmatic stepped-wedge cluster-randomized trial - The PLUS-IS-LESS study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"28dbdba9-d809-4ed7-ad3e-af1cb680b866","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00738","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Neue Instrumente zur Verbesserung der Behandlung von Patienten mit Verdacht auf Pneumonie","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/221174/studie/61941"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"c9a139db-2e90-45cb-be2c-b250ae5824d3","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Blut- und Lymphatisches System","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"943c4c40-c866-4fbf-9133-379d51f9e704","properties":{"title":"Multicentre Observational Study of MDS Patients in Switzerland – Swiss MDS Registry","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8ac1fcd9-2d85-4b0e-a54a-37c47617da11","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE: 339/2014; PB_2016-01917","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Daten- und Probensammlung zur Erkenntnis neuer biologischer Zusammenhänge bei myeloplastisches Syndrom, die auch eine Beschreibung des aktuellen Stands und der zukünftigen Entwicklungen in Diagnostik und Therapie erlauben. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.mds-switzerland.ch/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2a677604-1103-4bf9-a963-419377b23af5","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Magen- und Speiseröhre","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"279eb75b-392b-482b-9cac-f788b921c7f3","properties":{"title":" Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"26f6ecd6-ddb0-4f56-a2f5-4c4bc50bb87b","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"30134c7e-2494-4b1c-a92c-b4ebfd9866f0","properties":{"title":"CARDIA Trail: Surgery for Adenocarcinoma of the Gastroesophageal Junction (GEJ) Type II: Transthoracic Esophagectomy vs. Transhiatal Extended Gastrectomy","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3dc06a31-3fa9-45df-b723-d1fef99d649c","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00126","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der Vergleich von chirurgischen Therapien für das Adenokarzinom des gastroösophagealen Übergangs (GEJ): transthorakale Ösophagektomie versus transhiatal erweiterte Gastrektomie.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223905/studie/47421"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1572715f-6fbf-41b7-bd16-1c8eae96b55c","properties":{"title":"DANTE / FLOT8: A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"4369e292-e0b0-4459-8ff5-d2c4a9ded60e","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01150","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die DANTE/FLOT8- Studie untersucht, ob eine Kombination aus zwei Behandlungen bei Magenkrebs und Adenokarzinom an der Übergangsstelle zwischen Speiseröhre und Magen besser wirkt als eine der Behandlungen allein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/229432/studie/44090"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"082a400a-8a89-461e-9e22-abfd406c000f","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Niere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"7d27f24a-e2fc-4fa0-b976-6819ad724083","properties":{"title":"Metastatic Renal Cell Cancer: A Multicenter Prognostic and Predictive Factors Project in the Era of Modern Therapy (The International mRCC Database Consortium (IMDC))","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"a965ad71-3c5a-44b3-81e2-78d370372c33","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2018-01473","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Ein Projekt, das an mehreren Zentren durchgeführt wird, untersucht Faktoren, die den Krankheitsverlauf vorhersagen und den Behandlungserfolg in der modernen Therapie beeinflussen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.imdconline.com/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2e597fbc-b665-43c4-960d-5a4d9d6cea58","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Prostata","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"26b23bd5-fc02-4178-928c-8a0a831ec416","properties":{"title":"Blutentnahme zur Analyse zellfreier DNA bei Patienten mit fortgeschrittenen Krebsleiden (BEDNA-Studie)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"fcefe79b-f71c-4477-8124-f93b4a3c86c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKNZ 2014-329","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Analyse von im Blut frei zirkulierender Erbsubstanzen von Krebszellen bei Patienten mit fortgeschrittenem Krebsleiden. Die Etablierung dieser Technik könnte in Zukunft die Therapie und Überwachung von fortgeschrittenen Krebserkrankungen ermöglichen.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"b530f6c1-0a48-4984-b3df-2a30459a118b","properties":{"title":"Entwicklung von ex vivo Modellen des Prostatakarzinoms","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e880e044-0ee9-4eb5-834b-bb33aa5c8026","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKBB 37/13, PB_2018-00312","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Identifizierung spezifischer Mutationen könnte das grundlegende Verständnis der Entwicklung des Prostatakarzinoms, insbesondere des kastrationsresistenten Prostatakarzinoms verbessern und dazu beitragen, neue Marker und Strategien für dessen Behandlung zu entwickeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"aa52b80a-7f6c-4431-8e20-68c4ce5a64e4","properties":{"title":"Prostate Cancer Outcome - Compare and Reduce Variation in DKG-Prostatakrebszentren (PCO-CRV)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"270447e4-e676-4cfd-a593-6553c1da0db0","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2016-01172","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Internationaler Vergleich von Behandlung und Ergebnisqualität bei lokal begrenzten Prostatakarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.pco-study.com/findings"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"519b835c-1f29-4b7f-9727-9781af1b21c6","properties":{"title":"An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer (ProBio)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"df50fa44-8995-40fc-8e8d-958506d8d258","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-02495","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es geht darum, ob man durch das Untersuchen von Tumor-DNA bei Prostatakrebspatienten frühzeitig erkennen kann, welche Therapie besonders gut wirken wird. Damit könnten die Ärztinnen und Ärzte individuellere, wirksamere Behandlungen anbieten, die für die jeweilige Krebsart des Patienten besser passen als die üblichen Standardbehandlungen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/247767/studie/61659"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"bf3d75d5-bdd8-4f67-8920-fd2127639e61","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"abeff69c-6bd8-43bc-a918-356e8a8fb7c4","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"5775e216-94d1-410a-a8f1-fb11a9ec171a","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Andere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"c0ab1fe6-5224-4618-bfad-2de2dcbd45ea","properties":{"title":"Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"037e5793-4af4-4125-87cc-a3dfd59f4ddb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1498c7a2-37ed-4dc5-b949-53993d18ba4f","properties":{"title":"Informationssammlung zur effektiven Erforschung neuroendokrine Tumoren (SwissNET)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"471f352b-b77e-4b55-927b-2335b0617de1","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE 395/2014","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es werden Daten von Patienten/Innen mit NET aus der ganzen Schweiz erfasst. Basierend auf diesen Daten können Häufigkeit und Verlauf dieser seltenen Tumore in der Schweiz besser dokumentiert werden. Interessierte Spezialisten aus den verschiedenen Spezialgebieten sind in dem Trägerverein dieses Registers vereinigt, was zusätzlich zu einem regen Wissensaustausch führt.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.swissnet.net/de/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentHighlight","id":"6f1711e8-6711-4975-9ae6-7e0e6a43277e","properties":{"jumpNavigationTitle":"Probanden ge­su­cht","title":"Stu­di­en­teil­neh­mer/in­nen ge­su­cht für Low Carb Stu­die","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Mit dieser Studie wollen wir den Effekt einer «Low Carb»-Ernährung genauer untersuchen: Mittels einer App werden Sie geschult, stellen Ihre Ernährung langsam auf eine «Low Carb»-Ernährung um und halten diese mindestens 6 Monate ein. Während dieser Zeit werden verschiedene Untersuchungen vorgenommen wie: Blutuntersuchungen, Bestimmung der Körperzusammensetzung (Muskel-, Fettanteil), Messung des Leberfettanteils, Untersuchung des Gehirns, Untersuchung der Darmbakterien, Fragebögen zum Befinden.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"zur Low Carb Studie","target":"_blank","destinationId":"fadeffb7-929c-4df1-b934-0ea6f0f06655","destinationType":"claraforschungGeneric","route":{"path":"/de/aktuelle-studien/studienteilnehmerinnen-gesucht","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"01270bd3-fa72-451f-88a3-7d735d3d093a","name":"Medizinisches Angebot Onkologie Claraspital Teaser 2","mediaType":"Image","url":"/media/0ufdoals/medizinisches-angebot_onkologie_claraspital_teaser_2.jpg","extension":"jpg","width":960,"height":1200,"bytes":867878,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"0bdeac0c-3fbf-47fa-af19-62cdc7ec5376","properties":{"title":"Aktuelle Studien","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"3bd5e2ca-67e6-4ee8-b03f-16664dc2ed54","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"e34ba912-2111-4af3-8cec-6ae7f37a6105","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"65d3e01b-9422-4ce4-9f0e-31720b556d2c","properties":{"jumpNavigationTitle":null,"title":"Netzwerke metabole und gastroenterologische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. Unsere Forschungsprojekte werden durch öffentliche Geldgeber (Schweizerischen Nationalfonds (SNF)) und private Stiftungen (z.B. Botnar Foundation, Uniscientia) unterstützt. Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"b66dd421-8fd4-4e1c-8260-5b21ba287e45","properties":{"jumpNavigationTitle":null,"title":" Clarunis Netzwerk – Viszeralchirurgische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Das Netzwerk geht weit mehr als 50 Jahre auf das Departement Chirurgie der Universität Basel unter Professor Dr. med. Martin Allgöwer, Ordinarius für Chirurgie, zurück. Im Netzwerk sind Kliniken integriert, die einen engen Bezug zur Basler Chirurgenschule hatten und haben. Bei Neubesetzungen von Chefarztstellen mit Basler Schülern (z.B. Chur, Lugano, St. Claraspital etc.) hat sich ein erster Mitarbeitenden (MA)-Austausch in die Peripherie, aber auch umgekehrt ans Universitätszentrum eingestellt. Allgöwers Nachfolger, Prof. Dr. med. Felix Harder hat diese Interaktion mit den Kliniken weiter ausgebaut und intensiviert und hat neu die Videokonferenz (VC) als Fort- und Weiterbildungs-Plattform («Schlaue Stunde») etabliert.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Basierend auf diesen gut fundierten und institutionalisierten Pfeilern (VC und MA-Austausch) mit den affiliierten Kern-Kliniken ist mit Clarunis 2019 unter Prof. Dr. med. Markus von Flüe das Bewusstsein gewachsen, dass ein weiteres, gemeinsames Feld bearbeitet werden könnte, nämlich, dass dieser Verbund ein ausserordentlich grosses Potenzial für klinische Forschung birgt, das als weiteren Grundpfeiler des Netzwerkes in der erweiterten Nordwest-Schweiz bearbeitet und genutzt werden sollte.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine erste Netzwerk-Studie (EvaCol) wurde lanciert und unter der Leitung von PD Dr. med. Marco von Strauss durchgeführt und mit über 1100 eingeschlossenen Patienten der kolorektalen Chirurgie abgeschlossen. Unter dem neuen Ordinarius von Clarunis Prof. Dr. med. Beat Müller erfährt dieses Kern-Netzwerk eine noch grössere Dimension (graphische Darstellung des Clarunis Netzwerks) und gewinnt an Bedeutung für Clarunis und damit für die St. Clara Forschung. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"Clarunis Netzwerk","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Clarunis, Prof. Dr. med. Beat Müller","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Luzerner Kantonspital (LUKS), Prof. Dr. med. Martin Bolli","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Biel (SZB), Prof. Dr. med. Carsten Th. Viehl","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonsspital Aarau (KSA), Prof. Dr. med. Mark Hartel","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Lindenhofspital, Prof. Dr. med. Mathias Worni","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Oberwallis (SZO), Dr. med. Thomas Simon","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    St. Anna Klinik Luzern, Prof. Dr. med. Markus von Flüe","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Olten, Prof. Dr. med. Uli Dietz","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spital Limmattal Schlieren, Prof. Dr. med. Urs Zingg","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Basel-Land (KSBL) Liestal, Prof. Dr. med. Robert Rosenberg","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentImage","id":"e78a3514-102d-4b82-a4df-2d7e935b099c","properties":{"jumpNavigationTitle":null,"image":[{"focalPoint":null,"crops":[],"id":"53bec52d-9d74-48b2-8649-d8ee045b1440","name":"Claraforschung Netzwerk Contentimage","mediaType":"Image","url":"/media/fpcl2u1u/claraforschung_netzwerk_contentimage.jpg","extension":"jpg","width":1920,"height":1080,"bytes":399695,"properties":{}}],"altText":null,"caption":null,"fullWidth":false}},"settings":null},{"content":{"contentType":"componentTeasers","id":"2954661e-279b-4363-99d0-3636da9e854d","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"23208443-572d-4e5a-a7c4-c5ac90465831","name":"Medizinisches Angebot Forschung Claraspital Teaser","mediaType":"Image","url":"/media/iwccaizn/medizinisches-angebot_forschung_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":304241,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"efb5b3ca-05c1-4c37-829c-f18d80376e2f","properties":{"title":"Wissenschaftliche Netzwerke","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"9ad2f67a-7fc6-44aa-8d56-135373d1b29f","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG – Krebsforschung","createDate":"2024-10-18T09:59:39.393Z","updateDate":"2024-11-06T16:38:56.787Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag-krebsforschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ab57b132-cff4-44a4-b377-a2e37f6d82ed","properties":{"color":{"color":"eee4ef","label":"violet"},"label":"Kontakt ","title":"Krebs­for­schung/All­ge­mei­ne For­schung","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Wir freuen uns auf Ihre Kontaktaufnahme.","tag":"#text"}]}],"blocks":[]},"contactPhone":"+41 61 685 85 85","eMailAdress":"onko.forschung@claraspital.ch ","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}},{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Kontakt","title":"St. Clara Forschung AG","lead":null,"contactPhone":"+41 61 685 85 85","eMailAdress":"forschung@claraspital.ch","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"9cfadfb4-759c-4003-87bd-daac1e91e413","name":"Medizinisches Angebot Hernienzentrum Clarunis Teaser (1)","mediaType":"Image","url":"/media/wlppvhe2/medizinisches-angebot_hernienzentrum_clarunis_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":612763,"properties":{}}],"teaserTitle":"Krebsforschung/Allgemeine Forschung","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"04a08f65-8fc5-4df4-8a37-b73dd99aca44","properties":{"title":"Krebsforschung/Allgemeine Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/krebsforschungallgemeine-forschung"}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"a2dc7025-2720-43ff-825e-e8f2dd79e95e","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Stoffwechselerkrankungen wie Übergewicht, Diabetes und damit verbundene Erkrankungen wie Bluthochdruck, Blutfettstörungen und Leberverfettung nehmen weltweit zu und sehr viele Patient/innen sind davon betroffen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"703ddc00-11e3-4ef6-b881-5f5cd9b649c8","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Übergewicht ist eine multifaktorielle, chronische Erkrankung. Die Mechanismen, die der Entstehung von Übergewicht zugrunde liegen, sind noch immer nicht vollständig geklärt. Bei der Behandlung ist eine Kombination von therapeutischen Massnahmen erforderlich. Lebensstilanpassungen wie beispielsweise eine Ernährungsumstellung, gesteigerte körperliche Aktivität, zielgerichtete Medikamente und die Übergewichtschirurgie können einzeln oder in Kombination hilfreich sein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Hauptziele unseres Forschungsbereichs sind ein tieferes Verständnis für die Appetitregulation – einschliesslich der Interaktion zwischen dem Darm und dem Gehirn – zu erlangen, den Ursachen von Übergewicht und Magendarmerkrankungen auf den Grund zu gehen und schliesslich die Wirksamkeit verschiedener Behandlungsoptionen im Detail zu untersuchen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der gastroenterologischen Forschung stehen die chronisch entzündlichen Darmerkrankungen (CED) im Fokus. Bei dieser Erkrankung geht man von einer überschiessenden Aktivierung des Immunsystems der Darmschleimhaut aus. Dabei spielt eine gestörte Schleimhautbarriere eine wichtige Rolle wo eine lokale Entzündung z.B. durch eindringende Erreger ausgelöst werden kann. Wir interessieren uns daher für die Immunantwort von einer bestimmten Untergruppe von Immunzellen, die von aus der Darmmikroflora stammenden Antigene stimuliert werden. Die Analysen, die wir durchführen, können bei unterschiedlichen Mustern möglicherweise Rückschlüsse auf den individuellen klinischen Verlauf oder auf das Ansprechen einer Therapie bei einzelnen CED Patienten liefern. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Studienresultate werden regelmässig in anerkannten Fachzeitschriften publiziert sowie an nationalen und internationalen Kongressen vorgestellt. Wir halten eingeladene Fachvorträge und stehen in engem Kontakt mit den öffentlichen Medien, um Fachexperten wie auch die breite Öffentlichkeit über die Ursachen und Behandlungsoptionen von Übergewicht und Magendarmerkrankungen aufzuklären. Es ist uns hierbei ein besonderes Anliegen, das Stigma des schweren Übergewichts zu bekämpfen, indem wir neue Erkenntnisse über die biologischen Ursachen dieser Krankheit und therapeutischen Massnahmen vermitteln. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentHighlight","id":"cc2ae5a6-539b-4061-8691-b4e0c98cbebf","properties":{"jumpNavigationTitle":null,"title":"Studienbeispiele","text":{"tag":"#root","attributes":{},"elements":[{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie wird der Einfluss einer kohlenhydratreduzierten Kost auf das Gewicht, den Stoffwechsel und die psychische Gesundheit untersucht.","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie werden zwei Arten von Magenbypass-Operationen auf ihre Wirksamkeit hin untersucht. Diese grosse multizentrische Studie mit > 800 Studienteilnehmer/innen erlaubt es im Detail zu untersuchen wie diese Operationen sich auf den Stoffwechsel auswirken. ","tag":"#text"}]}]}],"blocks":[]},"link":null,"variation":{"color":"c7eae0","label":"green"}}},"settings":null},{"content":{"contentType":"componentTeasers","id":"93d4d935-e853-4ea1-a42b-f965529208e6","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"02b93292-12fd-4b10-9469-eaae67457117","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Um Behandlungskonzepte zu verbessern und neuartige Therapien zu entwickeln, ist Forschung unabdingbar. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"a629a076-ae6b-4d08-980f-af0ff3c76ca7","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Klinische Studien werden direkt am und mit dem Patienten durchgeführt. Diese kann sehr unterschiedlich sein. Beispielsweise, indem die Wirkung oder die Dosierung eines Medikaments getestet wird oder indem unterschiedliche Behandlungsmethoden für eine Indikation miteinander verglichen werden. Ziel der klinischen Forschung ist immer, Krankheiten besser zu verstehen und neue Therapieformen zu entwickeln oder bestehende zu verbessern. Zahlreiche Studien werden aktuell in der St. Clara Forschung AG durchgeführt:","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"6061c448-95d0-461b-8def-33e126368f75","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchdecke/Leiste","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":"Aktuelle Studien","items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"cd427adb-c784-4aa8-9e3b-4bf42e80faaa","properties":{"title":"Perioperative Outcome (Pain, Complications, Duration of Hops) in MIS for ventral hernie repair over 2 years. Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"c7db4eca-862e-4c73-80a3-323e0622ce20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"BASEC 2023-02357","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie werden zwei verschiedene Techniken zur Operation eines Bauchwandbruches (=Hernie) miteinander verglichen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/249587/studie/68943","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2d595df9-22c3-4173-b0e7-532ec8cb8b63","properties":{"title":"Robotic versus conventional minimal-invasive inguinal hernia repair – a prospective, randomized and blinded clinical trial (ROGER-RCT)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"14690720-f017-4921-8789-c89c5262dc2a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-01655","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"In dieser Studie soll untersucht werden, ob eine robotergestützte Leistenhernienreparatur die postoperativen Schmerzen reduzieren und die Genesung im Vergleich zum konventionellen laparoskopischen Ansatz verbessern kann.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"960fef41-ae29-4d76-90e6-aadaad60acc9","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchspeicheldrüse (Pankreas)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"13b037b7-b8ca-4c95-bce3-eb17be9c3106","properties":{"title":"Distal Pancreatectomy – A randomised controlled trial to compare minimal-invasive distal pancreatectomy to open resection (DISPACT-2 Trial)BASEC 2023-00705","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"d5d67ef3-6432-4c58-9718-937e0167d0f3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00705","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Teilentfernung der Bauchspeicheldrüse – Vergleich von Schlüssellochtechnikverfahren und offener Operation.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223849/studie/41792","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"e3257fd4-e10d-48b8-8c2d-a2736de17626","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Brust (Mamma)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"4e77c1bd-d1e6-47c2-8d10-2019a0e82886","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"487ea7fb-26fe-47f3-bbb1-ea4cd5d843a2","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"82d0d5be-fd4b-4ccc-91f1-f3d8c14c8646","properties":{"title":"A prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (EUBREAST 03 (R) AXSANA)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"508db622-8ccb-4749-bab2-f22414e9f9b7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-02830","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Studie an mehreren Kliniken, untersucht verschiedene OP-Methoden, um die Achselhöhlen bei Brustkrebspatientinnen mit befallenen Lymphknoten zu überprüfen. Diese Patientinnen erhalten vor der Operation eine Chemotherapie. Ziel der Studie ist es, die besten chirurgischen Verfahren zu vergleichen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/axsana/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"13125a74-5577-471f-a70c-7d07cb66adf2","properties":{"title":"Methods for Localization of Different types of breast lesions (EUBREAST 04 (R) MELODY)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"48ed91fa-7e6d-42fb-807c-a22d12d019dc","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00646","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"Eine Beobachtungsstudie ohne Eingriff, die an mehreren Standorten durchgeführt wird, um verschiedene bildgebende Verfahren zur genauen Erkennung von bösartigen Brusttumoren zu bewerten.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/melody/"},"elements":[{"text":"Mehr Infomationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"fba61881-b69e-4546-b129-66acf8e965f8","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"112cc61a-9fe4-4528-9742-5e58843926bb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ee5f2596-91ae-4e4b-90d7-e95d68f0d540","properties":{"title":"Intelligent Vacuum assisted biopsy Immediately before Surgery as an Intra- or pre-Operative surrogate for patient response to Neoadjuvant chemotherapy for breast cancer (VISION I) A multicenter prospective feasibility trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e3bf6ee7-83d3-40c1-84a0-3d69bf25e969","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00450","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Studie untersucht, ob eine intelligente, vakuumgestützte Biopsie direkt vor der Operation bei Brustkrebs genutzt werden kann, um schon vor oder während der Operation zu erkennen, wie gut die Patientinnen auf die vorherige Chemotherapie angesprochen haben.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/172850/studie/50248"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"502abcc8-2213-4d51-8495-2479b30b90cc","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Darm","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"b082020c-6fcb-4c92-af44-7af1c0f48a41","properties":{"title":"Cholecalciferol Comedication in patients with Chronic inflammatory bowel diseases (Crohn's disease or ulcerative Colitis) – the 5C-study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"99b902c7-464f-41b3-b98c-4e39d44b091a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00899","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Cholecalciferol-Co-Medikation bei Patient/innen mit chronisch entzündlichen Darmerkrankungen (Morbus Crohn oder Colitis ulcerosa)","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223851/studie/62115","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c14bba1c-04c7-440b-accc-45173f02bcec","properties":{"title":"Ergebnisqualität bei Darmkrebs: Identifikation von Unterschieden und Maßnahmen zur flächendeckenden Qualitätsentwicklung (EDIUM)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"67744ab5-42e6-4389-bea6-d88b4da53380","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-03069","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Vergleich und Messung der gesundheitsbezogenen Lebensqualität von Patientinnen und Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.edium-studie.de/studyInfo"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"0924559e-5ca3-434f-8a48-d0b8d9a20853","properties":{"title":"Snap Shot Audit Early Onset Colorectal Cancer (EOCC) - Are we doing enough or can we do more?","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"00b85655-bd27-4ef1-adc5-3b0c1506026f","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02297","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Snapshot Audit on Early onset Colorectal Cancer - are we doing enough, can we do more?","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223884/studie/64169"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c0ddbcc3-8eb3-47f6-ba49-8534dc70152f","properties":{"title":"Image-based ex-vivo  drug screening and genomics/transcriptomics for patients colorectal cancer stage II, III, IV (IBDS-CRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b5261ea6-4051-4ffc-8d08-4f502e744bf3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01441","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die klinische Bedeutung von Merkmalen der Tumorzellen bei Darmkrebs weiter zu erforschen. Dies geschieht über die Etablierung einer Plattform für die Analyse des genetischen Profils und der Wirkung von Krebsmedikamenten bei Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.ksbl.ch/kliniken/darmkrebszentrum-baselland/studien"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ce14c88f-3b6a-45ab-b413-390ad7d67565","properties":{"title":"Encorafenib and cetuximab in patients with metastatic, BRAFV600E-mutated, colorectal carcinoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland. (BERING CRC: BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3a9bfa33-9127-43d2-9f83-76ac821e3aa7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00647","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird die Wirksamkeit der Kombination bestehend aus Braftovi-Kapseln (Wirkstoff Encorafenib) und Erbitux bzw. einem gleichwertigen Arzneistoff (Biosimilar) (Wirkstoff Cetuximab) bei metastasierten Darmkrebs untersucht. Die in dieser Studie gewonnenen Daten sollen dazu beitragen, Erfahrungen mit diesen zugelassenen Medikamenten unter Routinebedingungen zu sammeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"f89bd827-a273-4246-a9e8-7bd6a6ae6fe1","properties":{"title":"Patient Reported Outcomes and Markers of Inflammation in Anal Cancer – a Longitudinal Observational Study (PROSAIC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b4c19a64-c048-459c-a9a6-5a6508ee9ee7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02161","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Beobachtungsstudie zur Lebensqualität beim neu diagnostizierten Analkarzinom","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2df1ee27-e288-40d6-9cf0-9a1a53aa2ee6","properties":{"title":"Biomarker identification to guide surgical intervention after neo-adjuvant chemoradiotherapy in rectal cancer (BSIRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"92d91535-85d1-4576-8109-d0aad3237b20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01199","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Identifikation von Biomarkern um das Ansprechen auf die Vorbehandlung beim Rektumkarzinom vorherzusagen","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"70895d41-749f-4143-a090-9597b0f1882c","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Eierstöcke","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2373ea90-1912-4bf7-9990-566862480908","properties":{"title":"MAintenance Therapie/ Erhaltungstherapie mit Aromatasehemmer für Patientinnen mit epithelialem Ovarialkarzinom: eine randomisierte doppelblinde Placebo-kontrollierte multizentrische Phase III Studie. (ENGOT-ov54/Swiss-GO-2/MATAO)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ba8d8b45-6fe0-4b78-9f4d-9e0f4b3e41bf","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00148","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Erhaltungstherapie mit einem Aromatase-Inhibitor bei epithelialem Ovarialkarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176034/studie/52935","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"efc2c2ad-b3c6-4f30-8e0f-cae4e441d4ce","properties":{"title":"SAKK_OvCaR: A retrospective and prospective registry of patients with ovarian cancer","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b11d6529-da0d-403d-9cd3-93593ee93bfe","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-01335","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Register Daten und Behandlung Ovarialcarcinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/ein-pro-und-retrospektives-register-von-patientinnen-mit-ovarialkarzinom"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"67cec99e-6f14-4c6d-8bcb-8e2094419ee4","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ernährung/Übergewicht","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"db4b4417-ff27-4d82-aaa5-c43d8c8f7f4f","properties":{"title":"Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM trial)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8560e58a-ef64-47a5-b2b8-71beef5f5e3d","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02392","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"SLIM Studie - Wirkung unterschiedlicher Schenkellängen beim Magenbypass","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176438/studie/52643","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"58fdf882-9191-4df1-9b72-4c9da32b6613","properties":{"title":"Understanding gut-brain interactions and the effect of a lowcarb dietary intervention in obese and depressive patients with and without glucose intolerance or diabetes: a pilot trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"6cbf87c1-ac9a-4786-95de-8a7934d2b6b5","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Bedeutung der Darm-Hirn-Achse und der Effekt einer kohlenhydratarmen Diät bei Übergewicht und Depression","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176258/studie/48748"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"7173dff6-7695-4eba-bf59-f71b0dd97462","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Hoden","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"d8bc2afb-28c1-4975-bf81-e2889b9aa83d","properties":{"title":"Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"19c8f679-740c-4862-97ae-9500f10b1b36","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKOS 13/083, PB_2016-00235","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Prospektive Datenerhebung bei Patienten mit Hodenkrebs","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.sag-tccs.com","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"debb5fb5-44cf-494a-ba78-c326374b15e7","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Lunge","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2ae1ea32-2b5a-423f-abd6-d3a197091d6f","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ff0bb2d7-9965-4af5-a105-228e548e46c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"26239e17-c1a5-4ae9-b94c-632d048c523c","properties":{"title":"SAKK_LuCa_2: Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"caaed598-39ef-444b-b37e-63b3778e0aae","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00398","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es handelt sich um eine Datenbank, in der Informationen über Patienten mit einer bestimmten Art von Lungenkrebs (metastasierter nicht-kleinzelliger Lungenkrebs, NSCLC) gesammelt werden. Ziel ist es, besser zu verstehen, wie sich diese Genveränderungen auf den Krankheitsverlauf und die Behandlungsergebnisse auswirken.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/register-und-studie-zum-egfr-mutierten-nsclc"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"11b78385-b1bd-4b97-a8c2-b63c3052f70c","properties":{"title":"SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) non-small cell lung cancer (NSCLC). A multicenter phase II trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"56fa4d89-2908-4864-9256-01425d662108","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02378,  EKOS 19/185","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der Studie SAKK 16/18 wird untersucht, ob eine zusätzliche präoperative Immuntherapie mit dem anti-PD-L1 Antikörper Durvalumab in Kombination mit Radiotherapie die Prognose lokal fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) verbessern kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176046/studie/49836"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"3a627627-6294-44d7-ba3e-8ef2b6a1b0f8","properties":{"title":"Procalcitonin and Lung UltraSonography based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: a pragmatic stepped-wedge cluster-randomized trial - The PLUS-IS-LESS study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"28dbdba9-d809-4ed7-ad3e-af1cb680b866","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00738","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Neue Instrumente zur Verbesserung der Behandlung von Patienten mit Verdacht auf Pneumonie","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/221174/studie/61941"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"c9a139db-2e90-45cb-be2c-b250ae5824d3","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Blut- und Lymphatisches System","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"943c4c40-c866-4fbf-9133-379d51f9e704","properties":{"title":"Multicentre Observational Study of MDS Patients in Switzerland – Swiss MDS Registry","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8ac1fcd9-2d85-4b0e-a54a-37c47617da11","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE: 339/2014; PB_2016-01917","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Daten- und Probensammlung zur Erkenntnis neuer biologischer Zusammenhänge bei myeloplastisches Syndrom, die auch eine Beschreibung des aktuellen Stands und der zukünftigen Entwicklungen in Diagnostik und Therapie erlauben. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.mds-switzerland.ch/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2a677604-1103-4bf9-a963-419377b23af5","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Magen- und Speiseröhre","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"279eb75b-392b-482b-9cac-f788b921c7f3","properties":{"title":" Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"26f6ecd6-ddb0-4f56-a2f5-4c4bc50bb87b","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"30134c7e-2494-4b1c-a92c-b4ebfd9866f0","properties":{"title":"CARDIA Trail: Surgery for Adenocarcinoma of the Gastroesophageal Junction (GEJ) Type II: Transthoracic Esophagectomy vs. Transhiatal Extended Gastrectomy","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3dc06a31-3fa9-45df-b723-d1fef99d649c","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00126","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der Vergleich von chirurgischen Therapien für das Adenokarzinom des gastroösophagealen Übergangs (GEJ): transthorakale Ösophagektomie versus transhiatal erweiterte Gastrektomie.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223905/studie/47421"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1572715f-6fbf-41b7-bd16-1c8eae96b55c","properties":{"title":"DANTE / FLOT8: A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"4369e292-e0b0-4459-8ff5-d2c4a9ded60e","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01150","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die DANTE/FLOT8- Studie untersucht, ob eine Kombination aus zwei Behandlungen bei Magenkrebs und Adenokarzinom an der Übergangsstelle zwischen Speiseröhre und Magen besser wirkt als eine der Behandlungen allein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/229432/studie/44090"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"082a400a-8a89-461e-9e22-abfd406c000f","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Niere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"7d27f24a-e2fc-4fa0-b976-6819ad724083","properties":{"title":"Metastatic Renal Cell Cancer: A Multicenter Prognostic and Predictive Factors Project in the Era of Modern Therapy (The International mRCC Database Consortium (IMDC))","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"a965ad71-3c5a-44b3-81e2-78d370372c33","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2018-01473","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Ein Projekt, das an mehreren Zentren durchgeführt wird, untersucht Faktoren, die den Krankheitsverlauf vorhersagen und den Behandlungserfolg in der modernen Therapie beeinflussen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.imdconline.com/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2e597fbc-b665-43c4-960d-5a4d9d6cea58","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Prostata","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"26b23bd5-fc02-4178-928c-8a0a831ec416","properties":{"title":"Blutentnahme zur Analyse zellfreier DNA bei Patienten mit fortgeschrittenen Krebsleiden (BEDNA-Studie)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"fcefe79b-f71c-4477-8124-f93b4a3c86c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKNZ 2014-329","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Analyse von im Blut frei zirkulierender Erbsubstanzen von Krebszellen bei Patienten mit fortgeschrittenem Krebsleiden. Die Etablierung dieser Technik könnte in Zukunft die Therapie und Überwachung von fortgeschrittenen Krebserkrankungen ermöglichen.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"b530f6c1-0a48-4984-b3df-2a30459a118b","properties":{"title":"Entwicklung von ex vivo Modellen des Prostatakarzinoms","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e880e044-0ee9-4eb5-834b-bb33aa5c8026","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKBB 37/13, PB_2018-00312","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Identifizierung spezifischer Mutationen könnte das grundlegende Verständnis der Entwicklung des Prostatakarzinoms, insbesondere des kastrationsresistenten Prostatakarzinoms verbessern und dazu beitragen, neue Marker und Strategien für dessen Behandlung zu entwickeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"aa52b80a-7f6c-4431-8e20-68c4ce5a64e4","properties":{"title":"Prostate Cancer Outcome - Compare and Reduce Variation in DKG-Prostatakrebszentren (PCO-CRV)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"270447e4-e676-4cfd-a593-6553c1da0db0","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2016-01172","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Internationaler Vergleich von Behandlung und Ergebnisqualität bei lokal begrenzten Prostatakarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.pco-study.com/findings"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"519b835c-1f29-4b7f-9727-9781af1b21c6","properties":{"title":"An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer (ProBio)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"df50fa44-8995-40fc-8e8d-958506d8d258","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-02495","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es geht darum, ob man durch das Untersuchen von Tumor-DNA bei Prostatakrebspatienten frühzeitig erkennen kann, welche Therapie besonders gut wirken wird. Damit könnten die Ärztinnen und Ärzte individuellere, wirksamere Behandlungen anbieten, die für die jeweilige Krebsart des Patienten besser passen als die üblichen Standardbehandlungen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/247767/studie/61659"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"bf3d75d5-bdd8-4f67-8920-fd2127639e61","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"abeff69c-6bd8-43bc-a918-356e8a8fb7c4","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"5775e216-94d1-410a-a8f1-fb11a9ec171a","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Andere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"c0ab1fe6-5224-4618-bfad-2de2dcbd45ea","properties":{"title":"Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"037e5793-4af4-4125-87cc-a3dfd59f4ddb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1498c7a2-37ed-4dc5-b949-53993d18ba4f","properties":{"title":"Informationssammlung zur effektiven Erforschung neuroendokrine Tumoren (SwissNET)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"471f352b-b77e-4b55-927b-2335b0617de1","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE 395/2014","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es werden Daten von Patienten/Innen mit NET aus der ganzen Schweiz erfasst. Basierend auf diesen Daten können Häufigkeit und Verlauf dieser seltenen Tumore in der Schweiz besser dokumentiert werden. Interessierte Spezialisten aus den verschiedenen Spezialgebieten sind in dem Trägerverein dieses Registers vereinigt, was zusätzlich zu einem regen Wissensaustausch führt.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.swissnet.net/de/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentHighlight","id":"6f1711e8-6711-4975-9ae6-7e0e6a43277e","properties":{"jumpNavigationTitle":"Probanden ge­su­cht","title":"Stu­di­en­teil­neh­mer/in­nen ge­su­cht für Low Carb Stu­die","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Mit dieser Studie wollen wir den Effekt einer «Low Carb»-Ernährung genauer untersuchen: Mittels einer App werden Sie geschult, stellen Ihre Ernährung langsam auf eine «Low Carb»-Ernährung um und halten diese mindestens 6 Monate ein. Während dieser Zeit werden verschiedene Untersuchungen vorgenommen wie: Blutuntersuchungen, Bestimmung der Körperzusammensetzung (Muskel-, Fettanteil), Messung des Leberfettanteils, Untersuchung des Gehirns, Untersuchung der Darmbakterien, Fragebögen zum Befinden.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"zur Low Carb Studie","target":"_blank","destinationId":"fadeffb7-929c-4df1-b934-0ea6f0f06655","destinationType":"claraforschungGeneric","route":{"path":"/de/aktuelle-studien/studienteilnehmerinnen-gesucht","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"01270bd3-fa72-451f-88a3-7d735d3d093a","name":"Medizinisches Angebot Onkologie Claraspital Teaser 2","mediaType":"Image","url":"/media/0ufdoals/medizinisches-angebot_onkologie_claraspital_teaser_2.jpg","extension":"jpg","width":960,"height":1200,"bytes":867878,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"0bdeac0c-3fbf-47fa-af19-62cdc7ec5376","properties":{"title":"Aktuelle Studien","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"3bd5e2ca-67e6-4ee8-b03f-16664dc2ed54","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"e34ba912-2111-4af3-8cec-6ae7f37a6105","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"65d3e01b-9422-4ce4-9f0e-31720b556d2c","properties":{"jumpNavigationTitle":null,"title":"Netzwerke metabole und gastroenterologische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. Unsere Forschungsprojekte werden durch öffentliche Geldgeber (Schweizerischen Nationalfonds (SNF)) und private Stiftungen (z.B. Botnar Foundation, Uniscientia) unterstützt. Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"b66dd421-8fd4-4e1c-8260-5b21ba287e45","properties":{"jumpNavigationTitle":null,"title":" Clarunis Netzwerk – Viszeralchirurgische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Das Netzwerk geht weit mehr als 50 Jahre auf das Departement Chirurgie der Universität Basel unter Professor Dr. med. Martin Allgöwer, Ordinarius für Chirurgie, zurück. Im Netzwerk sind Kliniken integriert, die einen engen Bezug zur Basler Chirurgenschule hatten und haben. Bei Neubesetzungen von Chefarztstellen mit Basler Schülern (z.B. Chur, Lugano, St. Claraspital etc.) hat sich ein erster Mitarbeitenden (MA)-Austausch in die Peripherie, aber auch umgekehrt ans Universitätszentrum eingestellt. Allgöwers Nachfolger, Prof. Dr. med. Felix Harder hat diese Interaktion mit den Kliniken weiter ausgebaut und intensiviert und hat neu die Videokonferenz (VC) als Fort- und Weiterbildungs-Plattform («Schlaue Stunde») etabliert.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Basierend auf diesen gut fundierten und institutionalisierten Pfeilern (VC und MA-Austausch) mit den affiliierten Kern-Kliniken ist mit Clarunis 2019 unter Prof. Dr. med. Markus von Flüe das Bewusstsein gewachsen, dass ein weiteres, gemeinsames Feld bearbeitet werden könnte, nämlich, dass dieser Verbund ein ausserordentlich grosses Potenzial für klinische Forschung birgt, das als weiteren Grundpfeiler des Netzwerkes in der erweiterten Nordwest-Schweiz bearbeitet und genutzt werden sollte.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine erste Netzwerk-Studie (EvaCol) wurde lanciert und unter der Leitung von PD Dr. med. Marco von Strauss durchgeführt und mit über 1100 eingeschlossenen Patienten der kolorektalen Chirurgie abgeschlossen. Unter dem neuen Ordinarius von Clarunis Prof. Dr. med. Beat Müller erfährt dieses Kern-Netzwerk eine noch grössere Dimension (graphische Darstellung des Clarunis Netzwerks) und gewinnt an Bedeutung für Clarunis und damit für die St. Clara Forschung. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"Clarunis Netzwerk","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Clarunis, Prof. Dr. med. Beat Müller","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Luzerner Kantonspital (LUKS), Prof. Dr. med. Martin Bolli","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Biel (SZB), Prof. Dr. med. Carsten Th. Viehl","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonsspital Aarau (KSA), Prof. Dr. med. Mark Hartel","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Lindenhofspital, Prof. Dr. med. Mathias Worni","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Oberwallis (SZO), Dr. med. Thomas Simon","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    St. Anna Klinik Luzern, Prof. Dr. med. Markus von Flüe","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Olten, Prof. Dr. med. Uli Dietz","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spital Limmattal Schlieren, Prof. Dr. med. Urs Zingg","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Basel-Land (KSBL) Liestal, Prof. Dr. med. Robert Rosenberg","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentImage","id":"e78a3514-102d-4b82-a4df-2d7e935b099c","properties":{"jumpNavigationTitle":null,"image":[{"focalPoint":null,"crops":[],"id":"53bec52d-9d74-48b2-8649-d8ee045b1440","name":"Claraforschung Netzwerk Contentimage","mediaType":"Image","url":"/media/fpcl2u1u/claraforschung_netzwerk_contentimage.jpg","extension":"jpg","width":1920,"height":1080,"bytes":399695,"properties":{}}],"altText":null,"caption":null,"fullWidth":false}},"settings":null},{"content":{"contentType":"componentTeasers","id":"2954661e-279b-4363-99d0-3636da9e854d","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"23208443-572d-4e5a-a7c4-c5ac90465831","name":"Medizinisches Angebot Forschung Claraspital Teaser","mediaType":"Image","url":"/media/iwccaizn/medizinisches-angebot_forschung_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":304241,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"efb5b3ca-05c1-4c37-829c-f18d80376e2f","properties":{"title":"Wissenschaftliche Netzwerke","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"fc110ac2-6df1-424b-b003-4b6f3c4bf6fb","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Kontakt","title":"St. Clara Forschung AG","lead":null,"contactPhone":"+41 61 685 85 85","eMailAdress":"forschung@claraspital.ch","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"d2d37e0c-9af7-4748-a5c3-6e1a6fd12f79","name":"Medizinisches Angebot Bariatrie Claraspital Teaser","mediaType":"Image","url":"/media/bj5nhuxx/medizinisches-angebot_bariatrie_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":556718,"properties":{}}],"teaserTitle":"Metabole und gastroenterologische Forschung","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"6755e1e2-2911-4006-8695-c4fbfd8ea988","properties":{"title":"Metabole und gastroenterologische Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung"}},{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"02b93292-12fd-4b10-9469-eaae67457117","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Um Behandlungskonzepte zu verbessern und neuartige Therapien zu entwickeln, ist Forschung unabdingbar. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"a629a076-ae6b-4d08-980f-af0ff3c76ca7","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Klinische Studien werden direkt am und mit dem Patienten durchgeführt. Diese kann sehr unterschiedlich sein. Beispielsweise, indem die Wirkung oder die Dosierung eines Medikaments getestet wird oder indem unterschiedliche Behandlungsmethoden für eine Indikation miteinander verglichen werden. Ziel der klinischen Forschung ist immer, Krankheiten besser zu verstehen und neue Therapieformen zu entwickeln oder bestehende zu verbessern. Zahlreiche Studien werden aktuell in der St. Clara Forschung AG durchgeführt:","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"6061c448-95d0-461b-8def-33e126368f75","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchdecke/Leiste","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":"Aktuelle Studien","items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"cd427adb-c784-4aa8-9e3b-4bf42e80faaa","properties":{"title":"Perioperative Outcome (Pain, Complications, Duration of Hops) in MIS for ventral hernie repair over 2 years. Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"c7db4eca-862e-4c73-80a3-323e0622ce20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"BASEC 2023-02357","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie werden zwei verschiedene Techniken zur Operation eines Bauchwandbruches (=Hernie) miteinander verglichen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/249587/studie/68943","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2d595df9-22c3-4173-b0e7-532ec8cb8b63","properties":{"title":"Robotic versus conventional minimal-invasive inguinal hernia repair – a prospective, randomized and blinded clinical trial (ROGER-RCT)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"14690720-f017-4921-8789-c89c5262dc2a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-01655","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"In dieser Studie soll untersucht werden, ob eine robotergestützte Leistenhernienreparatur die postoperativen Schmerzen reduzieren und die Genesung im Vergleich zum konventionellen laparoskopischen Ansatz verbessern kann.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"960fef41-ae29-4d76-90e6-aadaad60acc9","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchspeicheldrüse (Pankreas)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"13b037b7-b8ca-4c95-bce3-eb17be9c3106","properties":{"title":"Distal Pancreatectomy – A randomised controlled trial to compare minimal-invasive distal pancreatectomy to open resection (DISPACT-2 Trial)BASEC 2023-00705","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"d5d67ef3-6432-4c58-9718-937e0167d0f3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00705","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Teilentfernung der Bauchspeicheldrüse – Vergleich von Schlüssellochtechnikverfahren und offener Operation.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223849/studie/41792","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"e3257fd4-e10d-48b8-8c2d-a2736de17626","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Brust (Mamma)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"4e77c1bd-d1e6-47c2-8d10-2019a0e82886","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"487ea7fb-26fe-47f3-bbb1-ea4cd5d843a2","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"82d0d5be-fd4b-4ccc-91f1-f3d8c14c8646","properties":{"title":"A prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (EUBREAST 03 (R) AXSANA)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"508db622-8ccb-4749-bab2-f22414e9f9b7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-02830","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Studie an mehreren Kliniken, untersucht verschiedene OP-Methoden, um die Achselhöhlen bei Brustkrebspatientinnen mit befallenen Lymphknoten zu überprüfen. Diese Patientinnen erhalten vor der Operation eine Chemotherapie. Ziel der Studie ist es, die besten chirurgischen Verfahren zu vergleichen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/axsana/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"13125a74-5577-471f-a70c-7d07cb66adf2","properties":{"title":"Methods for Localization of Different types of breast lesions (EUBREAST 04 (R) MELODY)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"48ed91fa-7e6d-42fb-807c-a22d12d019dc","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00646","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"Eine Beobachtungsstudie ohne Eingriff, die an mehreren Standorten durchgeführt wird, um verschiedene bildgebende Verfahren zur genauen Erkennung von bösartigen Brusttumoren zu bewerten.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/melody/"},"elements":[{"text":"Mehr Infomationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"fba61881-b69e-4546-b129-66acf8e965f8","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"112cc61a-9fe4-4528-9742-5e58843926bb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ee5f2596-91ae-4e4b-90d7-e95d68f0d540","properties":{"title":"Intelligent Vacuum assisted biopsy Immediately before Surgery as an Intra- or pre-Operative surrogate for patient response to Neoadjuvant chemotherapy for breast cancer (VISION I) A multicenter prospective feasibility trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e3bf6ee7-83d3-40c1-84a0-3d69bf25e969","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00450","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Studie untersucht, ob eine intelligente, vakuumgestützte Biopsie direkt vor der Operation bei Brustkrebs genutzt werden kann, um schon vor oder während der Operation zu erkennen, wie gut die Patientinnen auf die vorherige Chemotherapie angesprochen haben.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/172850/studie/50248"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"502abcc8-2213-4d51-8495-2479b30b90cc","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Darm","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"b082020c-6fcb-4c92-af44-7af1c0f48a41","properties":{"title":"Cholecalciferol Comedication in patients with Chronic inflammatory bowel diseases (Crohn's disease or ulcerative Colitis) – the 5C-study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"99b902c7-464f-41b3-b98c-4e39d44b091a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00899","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Cholecalciferol-Co-Medikation bei Patient/innen mit chronisch entzündlichen Darmerkrankungen (Morbus Crohn oder Colitis ulcerosa)","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223851/studie/62115","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c14bba1c-04c7-440b-accc-45173f02bcec","properties":{"title":"Ergebnisqualität bei Darmkrebs: Identifikation von Unterschieden und Maßnahmen zur flächendeckenden Qualitätsentwicklung (EDIUM)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"67744ab5-42e6-4389-bea6-d88b4da53380","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-03069","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Vergleich und Messung der gesundheitsbezogenen Lebensqualität von Patientinnen und Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.edium-studie.de/studyInfo"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"0924559e-5ca3-434f-8a48-d0b8d9a20853","properties":{"title":"Snap Shot Audit Early Onset Colorectal Cancer (EOCC) - Are we doing enough or can we do more?","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"00b85655-bd27-4ef1-adc5-3b0c1506026f","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02297","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Snapshot Audit on Early onset Colorectal Cancer - are we doing enough, can we do more?","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223884/studie/64169"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c0ddbcc3-8eb3-47f6-ba49-8534dc70152f","properties":{"title":"Image-based ex-vivo  drug screening and genomics/transcriptomics for patients colorectal cancer stage II, III, IV (IBDS-CRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b5261ea6-4051-4ffc-8d08-4f502e744bf3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01441","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die klinische Bedeutung von Merkmalen der Tumorzellen bei Darmkrebs weiter zu erforschen. Dies geschieht über die Etablierung einer Plattform für die Analyse des genetischen Profils und der Wirkung von Krebsmedikamenten bei Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.ksbl.ch/kliniken/darmkrebszentrum-baselland/studien"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ce14c88f-3b6a-45ab-b413-390ad7d67565","properties":{"title":"Encorafenib and cetuximab in patients with metastatic, BRAFV600E-mutated, colorectal carcinoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland. (BERING CRC: BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3a9bfa33-9127-43d2-9f83-76ac821e3aa7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00647","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird die Wirksamkeit der Kombination bestehend aus Braftovi-Kapseln (Wirkstoff Encorafenib) und Erbitux bzw. einem gleichwertigen Arzneistoff (Biosimilar) (Wirkstoff Cetuximab) bei metastasierten Darmkrebs untersucht. Die in dieser Studie gewonnenen Daten sollen dazu beitragen, Erfahrungen mit diesen zugelassenen Medikamenten unter Routinebedingungen zu sammeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"f89bd827-a273-4246-a9e8-7bd6a6ae6fe1","properties":{"title":"Patient Reported Outcomes and Markers of Inflammation in Anal Cancer – a Longitudinal Observational Study (PROSAIC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b4c19a64-c048-459c-a9a6-5a6508ee9ee7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02161","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Beobachtungsstudie zur Lebensqualität beim neu diagnostizierten Analkarzinom","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2df1ee27-e288-40d6-9cf0-9a1a53aa2ee6","properties":{"title":"Biomarker identification to guide surgical intervention after neo-adjuvant chemoradiotherapy in rectal cancer (BSIRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"92d91535-85d1-4576-8109-d0aad3237b20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01199","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Identifikation von Biomarkern um das Ansprechen auf die Vorbehandlung beim Rektumkarzinom vorherzusagen","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"70895d41-749f-4143-a090-9597b0f1882c","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Eierstöcke","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2373ea90-1912-4bf7-9990-566862480908","properties":{"title":"MAintenance Therapie/ Erhaltungstherapie mit Aromatasehemmer für Patientinnen mit epithelialem Ovarialkarzinom: eine randomisierte doppelblinde Placebo-kontrollierte multizentrische Phase III Studie. (ENGOT-ov54/Swiss-GO-2/MATAO)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ba8d8b45-6fe0-4b78-9f4d-9e0f4b3e41bf","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00148","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Erhaltungstherapie mit einem Aromatase-Inhibitor bei epithelialem Ovarialkarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176034/studie/52935","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"efc2c2ad-b3c6-4f30-8e0f-cae4e441d4ce","properties":{"title":"SAKK_OvCaR: A retrospective and prospective registry of patients with ovarian cancer","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b11d6529-da0d-403d-9cd3-93593ee93bfe","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-01335","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Register Daten und Behandlung Ovarialcarcinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/ein-pro-und-retrospektives-register-von-patientinnen-mit-ovarialkarzinom"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"67cec99e-6f14-4c6d-8bcb-8e2094419ee4","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ernährung/Übergewicht","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"db4b4417-ff27-4d82-aaa5-c43d8c8f7f4f","properties":{"title":"Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM trial)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8560e58a-ef64-47a5-b2b8-71beef5f5e3d","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02392","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"SLIM Studie - Wirkung unterschiedlicher Schenkellängen beim Magenbypass","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176438/studie/52643","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"58fdf882-9191-4df1-9b72-4c9da32b6613","properties":{"title":"Understanding gut-brain interactions and the effect of a lowcarb dietary intervention in obese and depressive patients with and without glucose intolerance or diabetes: a pilot trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"6cbf87c1-ac9a-4786-95de-8a7934d2b6b5","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Bedeutung der Darm-Hirn-Achse und der Effekt einer kohlenhydratarmen Diät bei Übergewicht und Depression","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176258/studie/48748"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"7173dff6-7695-4eba-bf59-f71b0dd97462","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Hoden","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"d8bc2afb-28c1-4975-bf81-e2889b9aa83d","properties":{"title":"Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"19c8f679-740c-4862-97ae-9500f10b1b36","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKOS 13/083, PB_2016-00235","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Prospektive Datenerhebung bei Patienten mit Hodenkrebs","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.sag-tccs.com","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"debb5fb5-44cf-494a-ba78-c326374b15e7","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Lunge","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2ae1ea32-2b5a-423f-abd6-d3a197091d6f","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ff0bb2d7-9965-4af5-a105-228e548e46c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"26239e17-c1a5-4ae9-b94c-632d048c523c","properties":{"title":"SAKK_LuCa_2: Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"caaed598-39ef-444b-b37e-63b3778e0aae","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00398","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es handelt sich um eine Datenbank, in der Informationen über Patienten mit einer bestimmten Art von Lungenkrebs (metastasierter nicht-kleinzelliger Lungenkrebs, NSCLC) gesammelt werden. Ziel ist es, besser zu verstehen, wie sich diese Genveränderungen auf den Krankheitsverlauf und die Behandlungsergebnisse auswirken.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/register-und-studie-zum-egfr-mutierten-nsclc"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"11b78385-b1bd-4b97-a8c2-b63c3052f70c","properties":{"title":"SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) non-small cell lung cancer (NSCLC). A multicenter phase II trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"56fa4d89-2908-4864-9256-01425d662108","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02378,  EKOS 19/185","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der Studie SAKK 16/18 wird untersucht, ob eine zusätzliche präoperative Immuntherapie mit dem anti-PD-L1 Antikörper Durvalumab in Kombination mit Radiotherapie die Prognose lokal fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) verbessern kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176046/studie/49836"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"3a627627-6294-44d7-ba3e-8ef2b6a1b0f8","properties":{"title":"Procalcitonin and Lung UltraSonography based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: a pragmatic stepped-wedge cluster-randomized trial - The PLUS-IS-LESS study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"28dbdba9-d809-4ed7-ad3e-af1cb680b866","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00738","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Neue Instrumente zur Verbesserung der Behandlung von Patienten mit Verdacht auf Pneumonie","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/221174/studie/61941"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"c9a139db-2e90-45cb-be2c-b250ae5824d3","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Blut- und Lymphatisches System","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"943c4c40-c866-4fbf-9133-379d51f9e704","properties":{"title":"Multicentre Observational Study of MDS Patients in Switzerland – Swiss MDS Registry","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8ac1fcd9-2d85-4b0e-a54a-37c47617da11","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE: 339/2014; PB_2016-01917","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Daten- und Probensammlung zur Erkenntnis neuer biologischer Zusammenhänge bei myeloplastisches Syndrom, die auch eine Beschreibung des aktuellen Stands und der zukünftigen Entwicklungen in Diagnostik und Therapie erlauben. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.mds-switzerland.ch/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2a677604-1103-4bf9-a963-419377b23af5","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Magen- und Speiseröhre","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"279eb75b-392b-482b-9cac-f788b921c7f3","properties":{"title":" Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"26f6ecd6-ddb0-4f56-a2f5-4c4bc50bb87b","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"30134c7e-2494-4b1c-a92c-b4ebfd9866f0","properties":{"title":"CARDIA Trail: Surgery for Adenocarcinoma of the Gastroesophageal Junction (GEJ) Type II: Transthoracic Esophagectomy vs. Transhiatal Extended Gastrectomy","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3dc06a31-3fa9-45df-b723-d1fef99d649c","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00126","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der Vergleich von chirurgischen Therapien für das Adenokarzinom des gastroösophagealen Übergangs (GEJ): transthorakale Ösophagektomie versus transhiatal erweiterte Gastrektomie.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223905/studie/47421"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1572715f-6fbf-41b7-bd16-1c8eae96b55c","properties":{"title":"DANTE / FLOT8: A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"4369e292-e0b0-4459-8ff5-d2c4a9ded60e","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01150","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die DANTE/FLOT8- Studie untersucht, ob eine Kombination aus zwei Behandlungen bei Magenkrebs und Adenokarzinom an der Übergangsstelle zwischen Speiseröhre und Magen besser wirkt als eine der Behandlungen allein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/229432/studie/44090"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"082a400a-8a89-461e-9e22-abfd406c000f","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Niere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"7d27f24a-e2fc-4fa0-b976-6819ad724083","properties":{"title":"Metastatic Renal Cell Cancer: A Multicenter Prognostic and Predictive Factors Project in the Era of Modern Therapy (The International mRCC Database Consortium (IMDC))","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"a965ad71-3c5a-44b3-81e2-78d370372c33","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2018-01473","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Ein Projekt, das an mehreren Zentren durchgeführt wird, untersucht Faktoren, die den Krankheitsverlauf vorhersagen und den Behandlungserfolg in der modernen Therapie beeinflussen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.imdconline.com/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2e597fbc-b665-43c4-960d-5a4d9d6cea58","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Prostata","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"26b23bd5-fc02-4178-928c-8a0a831ec416","properties":{"title":"Blutentnahme zur Analyse zellfreier DNA bei Patienten mit fortgeschrittenen Krebsleiden (BEDNA-Studie)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"fcefe79b-f71c-4477-8124-f93b4a3c86c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKNZ 2014-329","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Analyse von im Blut frei zirkulierender Erbsubstanzen von Krebszellen bei Patienten mit fortgeschrittenem Krebsleiden. Die Etablierung dieser Technik könnte in Zukunft die Therapie und Überwachung von fortgeschrittenen Krebserkrankungen ermöglichen.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"b530f6c1-0a48-4984-b3df-2a30459a118b","properties":{"title":"Entwicklung von ex vivo Modellen des Prostatakarzinoms","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e880e044-0ee9-4eb5-834b-bb33aa5c8026","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKBB 37/13, PB_2018-00312","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Identifizierung spezifischer Mutationen könnte das grundlegende Verständnis der Entwicklung des Prostatakarzinoms, insbesondere des kastrationsresistenten Prostatakarzinoms verbessern und dazu beitragen, neue Marker und Strategien für dessen Behandlung zu entwickeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"aa52b80a-7f6c-4431-8e20-68c4ce5a64e4","properties":{"title":"Prostate Cancer Outcome - Compare and Reduce Variation in DKG-Prostatakrebszentren (PCO-CRV)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"270447e4-e676-4cfd-a593-6553c1da0db0","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2016-01172","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Internationaler Vergleich von Behandlung und Ergebnisqualität bei lokal begrenzten Prostatakarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.pco-study.com/findings"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"519b835c-1f29-4b7f-9727-9781af1b21c6","properties":{"title":"An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer (ProBio)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"df50fa44-8995-40fc-8e8d-958506d8d258","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-02495","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es geht darum, ob man durch das Untersuchen von Tumor-DNA bei Prostatakrebspatienten frühzeitig erkennen kann, welche Therapie besonders gut wirken wird. Damit könnten die Ärztinnen und Ärzte individuellere, wirksamere Behandlungen anbieten, die für die jeweilige Krebsart des Patienten besser passen als die üblichen Standardbehandlungen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/247767/studie/61659"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"bf3d75d5-bdd8-4f67-8920-fd2127639e61","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"abeff69c-6bd8-43bc-a918-356e8a8fb7c4","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"5775e216-94d1-410a-a8f1-fb11a9ec171a","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Andere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"c0ab1fe6-5224-4618-bfad-2de2dcbd45ea","properties":{"title":"Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"037e5793-4af4-4125-87cc-a3dfd59f4ddb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1498c7a2-37ed-4dc5-b949-53993d18ba4f","properties":{"title":"Informationssammlung zur effektiven Erforschung neuroendokrine Tumoren (SwissNET)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"471f352b-b77e-4b55-927b-2335b0617de1","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE 395/2014","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es werden Daten von Patienten/Innen mit NET aus der ganzen Schweiz erfasst. Basierend auf diesen Daten können Häufigkeit und Verlauf dieser seltenen Tumore in der Schweiz besser dokumentiert werden. Interessierte Spezialisten aus den verschiedenen Spezialgebieten sind in dem Trägerverein dieses Registers vereinigt, was zusätzlich zu einem regen Wissensaustausch führt.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.swissnet.net/de/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentHighlight","id":"6f1711e8-6711-4975-9ae6-7e0e6a43277e","properties":{"jumpNavigationTitle":"Probanden ge­su­cht","title":"Stu­di­en­teil­neh­mer/in­nen ge­su­cht für Low Carb Stu­die","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Mit dieser Studie wollen wir den Effekt einer «Low Carb»-Ernährung genauer untersuchen: Mittels einer App werden Sie geschult, stellen Ihre Ernährung langsam auf eine «Low Carb»-Ernährung um und halten diese mindestens 6 Monate ein. Während dieser Zeit werden verschiedene Untersuchungen vorgenommen wie: Blutuntersuchungen, Bestimmung der Körperzusammensetzung (Muskel-, Fettanteil), Messung des Leberfettanteils, Untersuchung des Gehirns, Untersuchung der Darmbakterien, Fragebögen zum Befinden.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"zur Low Carb Studie","target":"_blank","destinationId":"fadeffb7-929c-4df1-b934-0ea6f0f06655","destinationType":"claraforschungGeneric","route":{"path":"/de/aktuelle-studien/studienteilnehmerinnen-gesucht","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"01270bd3-fa72-451f-88a3-7d735d3d093a","name":"Medizinisches Angebot Onkologie Claraspital Teaser 2","mediaType":"Image","url":"/media/0ufdoals/medizinisches-angebot_onkologie_claraspital_teaser_2.jpg","extension":"jpg","width":960,"height":1200,"bytes":867878,"properties":{}}],"teaserTitle":"Aktuelle Studien","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"0bdeac0c-3fbf-47fa-af19-62cdc7ec5376","properties":{"title":"Aktuelle Studien","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/aktuelle-studien"}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"3bd5e2ca-67e6-4ee8-b03f-16664dc2ed54","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"e34ba912-2111-4af3-8cec-6ae7f37a6105","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"65d3e01b-9422-4ce4-9f0e-31720b556d2c","properties":{"jumpNavigationTitle":null,"title":"Netzwerke metabole und gastroenterologische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. Unsere Forschungsprojekte werden durch öffentliche Geldgeber (Schweizerischen Nationalfonds (SNF)) und private Stiftungen (z.B. Botnar Foundation, Uniscientia) unterstützt. Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"b66dd421-8fd4-4e1c-8260-5b21ba287e45","properties":{"jumpNavigationTitle":null,"title":" Clarunis Netzwerk – Viszeralchirurgische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Das Netzwerk geht weit mehr als 50 Jahre auf das Departement Chirurgie der Universität Basel unter Professor Dr. med. Martin Allgöwer, Ordinarius für Chirurgie, zurück. Im Netzwerk sind Kliniken integriert, die einen engen Bezug zur Basler Chirurgenschule hatten und haben. Bei Neubesetzungen von Chefarztstellen mit Basler Schülern (z.B. Chur, Lugano, St. Claraspital etc.) hat sich ein erster Mitarbeitenden (MA)-Austausch in die Peripherie, aber auch umgekehrt ans Universitätszentrum eingestellt. Allgöwers Nachfolger, Prof. Dr. med. Felix Harder hat diese Interaktion mit den Kliniken weiter ausgebaut und intensiviert und hat neu die Videokonferenz (VC) als Fort- und Weiterbildungs-Plattform («Schlaue Stunde») etabliert.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Basierend auf diesen gut fundierten und institutionalisierten Pfeilern (VC und MA-Austausch) mit den affiliierten Kern-Kliniken ist mit Clarunis 2019 unter Prof. Dr. med. Markus von Flüe das Bewusstsein gewachsen, dass ein weiteres, gemeinsames Feld bearbeitet werden könnte, nämlich, dass dieser Verbund ein ausserordentlich grosses Potenzial für klinische Forschung birgt, das als weiteren Grundpfeiler des Netzwerkes in der erweiterten Nordwest-Schweiz bearbeitet und genutzt werden sollte.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine erste Netzwerk-Studie (EvaCol) wurde lanciert und unter der Leitung von PD Dr. med. Marco von Strauss durchgeführt und mit über 1100 eingeschlossenen Patienten der kolorektalen Chirurgie abgeschlossen. Unter dem neuen Ordinarius von Clarunis Prof. Dr. med. Beat Müller erfährt dieses Kern-Netzwerk eine noch grössere Dimension (graphische Darstellung des Clarunis Netzwerks) und gewinnt an Bedeutung für Clarunis und damit für die St. Clara Forschung. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"Clarunis Netzwerk","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Clarunis, Prof. Dr. med. Beat Müller","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Luzerner Kantonspital (LUKS), Prof. Dr. med. Martin Bolli","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Biel (SZB), Prof. Dr. med. Carsten Th. Viehl","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonsspital Aarau (KSA), Prof. Dr. med. Mark Hartel","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Lindenhofspital, Prof. Dr. med. Mathias Worni","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Oberwallis (SZO), Dr. med. Thomas Simon","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    St. Anna Klinik Luzern, Prof. Dr. med. Markus von Flüe","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Olten, Prof. Dr. med. Uli Dietz","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spital Limmattal Schlieren, Prof. Dr. med. Urs Zingg","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Basel-Land (KSBL) Liestal, Prof. Dr. med. Robert Rosenberg","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentImage","id":"e78a3514-102d-4b82-a4df-2d7e935b099c","properties":{"jumpNavigationTitle":null,"image":[{"focalPoint":null,"crops":[],"id":"53bec52d-9d74-48b2-8649-d8ee045b1440","name":"Claraforschung Netzwerk Contentimage","mediaType":"Image","url":"/media/fpcl2u1u/claraforschung_netzwerk_contentimage.jpg","extension":"jpg","width":1920,"height":1080,"bytes":399695,"properties":{}}],"altText":null,"caption":null,"fullWidth":false}},"settings":null},{"content":{"contentType":"componentTeasers","id":"2954661e-279b-4363-99d0-3636da9e854d","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"9189c92b-2db9-46e1-9e71-ccd199539d22","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Krebstherapie hat sich in den letzten Jahren enorm schnell entwickelt. Wirksamere aber auch schonendere Therapieformen können heute eingesetzt werden.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"6fb5422b-f674-4c3a-aaf7-c08f4de58d12","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die St. Clara Forschung erforscht schwerpunktmässig die Verbesserung in der Diagnostik und Behandlung von Krebserkrankungen des Bauches, des Blutsystems, der Brust, der Lunge, der Nieren, der Hoden und der Prostata.","tag":"#text"}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die allgemeine Forschung beschäftigt sich mit Forschungsprojekten ausserhalb der erwähnten Gebiete wie beispielsweise der Anästhesie, Notfallmedizin, Intensivmedizin, Palliativmedizin, Kardiologie, Pneumologie und Psychoonkologie.   ","tag":"#text"},{"tag":"span","attributes":{"style":"mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Lucida Sans Unicode'; mso-fareast-language: DE-CH;"},"elements":[{"tag":"br","attributes":{},"elements":[]}]}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentTeasers","id":"a9eb21f8-af75-4511-acaf-1354de102ea0","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"9ad2f67a-7fc6-44aa-8d56-135373d1b29f","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG – Krebsforschung","createDate":"2024-10-18T09:59:39.393Z","updateDate":"2024-11-06T16:38:56.787Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag-krebsforschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ab57b132-cff4-44a4-b377-a2e37f6d82ed","properties":{}},{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"9cfadfb4-759c-4003-87bd-daac1e91e413","name":"Medizinisches Angebot Hernienzentrum Clarunis Teaser (1)","mediaType":"Image","url":"/media/wlppvhe2/medizinisches-angebot_hernienzentrum_clarunis_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":612763,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"04a08f65-8fc5-4df4-8a37-b73dd99aca44","properties":{"title":"Krebsforschung/Allgemeine Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"a2dc7025-2720-43ff-825e-e8f2dd79e95e","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Stoffwechselerkrankungen wie Übergewicht, Diabetes und damit verbundene Erkrankungen wie Bluthochdruck, Blutfettstörungen und Leberverfettung nehmen weltweit zu und sehr viele Patient/innen sind davon betroffen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"703ddc00-11e3-4ef6-b881-5f5cd9b649c8","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Übergewicht ist eine multifaktorielle, chronische Erkrankung. Die Mechanismen, die der Entstehung von Übergewicht zugrunde liegen, sind noch immer nicht vollständig geklärt. Bei der Behandlung ist eine Kombination von therapeutischen Massnahmen erforderlich. Lebensstilanpassungen wie beispielsweise eine Ernährungsumstellung, gesteigerte körperliche Aktivität, zielgerichtete Medikamente und die Übergewichtschirurgie können einzeln oder in Kombination hilfreich sein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Hauptziele unseres Forschungsbereichs sind ein tieferes Verständnis für die Appetitregulation – einschliesslich der Interaktion zwischen dem Darm und dem Gehirn – zu erlangen, den Ursachen von Übergewicht und Magendarmerkrankungen auf den Grund zu gehen und schliesslich die Wirksamkeit verschiedener Behandlungsoptionen im Detail zu untersuchen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der gastroenterologischen Forschung stehen die chronisch entzündlichen Darmerkrankungen (CED) im Fokus. Bei dieser Erkrankung geht man von einer überschiessenden Aktivierung des Immunsystems der Darmschleimhaut aus. Dabei spielt eine gestörte Schleimhautbarriere eine wichtige Rolle wo eine lokale Entzündung z.B. durch eindringende Erreger ausgelöst werden kann. Wir interessieren uns daher für die Immunantwort von einer bestimmten Untergruppe von Immunzellen, die von aus der Darmmikroflora stammenden Antigene stimuliert werden. Die Analysen, die wir durchführen, können bei unterschiedlichen Mustern möglicherweise Rückschlüsse auf den individuellen klinischen Verlauf oder auf das Ansprechen einer Therapie bei einzelnen CED Patienten liefern. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Studienresultate werden regelmässig in anerkannten Fachzeitschriften publiziert sowie an nationalen und internationalen Kongressen vorgestellt. Wir halten eingeladene Fachvorträge und stehen in engem Kontakt mit den öffentlichen Medien, um Fachexperten wie auch die breite Öffentlichkeit über die Ursachen und Behandlungsoptionen von Übergewicht und Magendarmerkrankungen aufzuklären. Es ist uns hierbei ein besonderes Anliegen, das Stigma des schweren Übergewichts zu bekämpfen, indem wir neue Erkenntnisse über die biologischen Ursachen dieser Krankheit und therapeutischen Massnahmen vermitteln. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentHighlight","id":"cc2ae5a6-539b-4061-8691-b4e0c98cbebf","properties":{"jumpNavigationTitle":null,"title":"Studienbeispiele","text":{"tag":"#root","attributes":{},"elements":[{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie wird der Einfluss einer kohlenhydratreduzierten Kost auf das Gewicht, den Stoffwechsel und die psychische Gesundheit untersucht.","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie werden zwei Arten von Magenbypass-Operationen auf ihre Wirksamkeit hin untersucht. Diese grosse multizentrische Studie mit > 800 Studienteilnehmer/innen erlaubt es im Detail zu untersuchen wie diese Operationen sich auf den Stoffwechsel auswirken. ","tag":"#text"}]}]}],"blocks":[]},"link":null,"variation":{"color":"c7eae0","label":"green"}}},"settings":null},{"content":{"contentType":"componentTeasers","id":"93d4d935-e853-4ea1-a42b-f965529208e6","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"fc110ac2-6df1-424b-b003-4b6f3c4bf6fb","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"d2d37e0c-9af7-4748-a5c3-6e1a6fd12f79","name":"Medizinisches Angebot Bariatrie Claraspital Teaser","mediaType":"Image","url":"/media/bj5nhuxx/medizinisches-angebot_bariatrie_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":556718,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"6755e1e2-2911-4006-8695-c4fbfd8ea988","properties":{"title":"Metabole und gastroenterologische Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"23208443-572d-4e5a-a7c4-c5ac90465831","name":"Medizinisches Angebot Forschung Claraspital Teaser","mediaType":"Image","url":"/media/iwccaizn/medizinisches-angebot_forschung_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":304241,"properties":{}}],"teaserTitle":"Wissenschaftliche Netzwerke","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"efb5b3ca-05c1-4c37-829c-f18d80376e2f","properties":{"title":"Wissenschaftliche Netzwerke","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/wissenschaftliche-netzwerke"}},{"contentType":"claraforschungGeneric","name":"Dr. Peter Eichenberger Grant","createDate":"2024-11-06T12:09:47.487Z","updateDate":"2024-11-14T09:56:10.557Z","route":{"path":"/de/klinische-forschung/dr-peter-eichenberger-grant","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"88f79ec0-708c-4670-871d-210faa0199bf","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"25e720f8-9f5a-4f39-952c-81232cadba9f","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Peter Eichenberger war der langjährige Spitaldirektor des St. Claraspitals. Dank seiner visionären Idee und dem Engagement des Teams der St. Clara Forschung konnte sich die Institution in kurzer Zeit national und international profilieren.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"0df9391a-676a-4b69-9280-e8e086480665","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Pro Jahr stehen CHF 60'000 zur Forschungsförderung zur Verfügung. Es sollen unterstützungswürdige Forschungsprojekte mit Bezug zum Claraspital finanziell unterstützt werden. Der Förderbetrag kann vom/von der Beitragsempfänger/in im Rahmen einer akademischen Karriere als kompetitiv eingeworbene Drittmittel angerechnet werden. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Beitragsberechtigt sind Angestellte des Claraspitals, von Clarunis, der Lindenhofgruppe und der St. Clara Forschung.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eingereicht werden müssen (siehe Reglement):","tag":"#text"}]},{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{},"elements":[{"text":"Begleitschreiben","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"Forschungsplan/Synopsis","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"Budget- und Zeitplan","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"CV und wichtigste Publikationen","tag":"#text"}]}]},{"tag":"p","attributes":{},"elements":[{"text":"Einreichung per Email bis 20. Januar 2025 um 23.59 Uhr an ","tag":"#text"},{"tag":"a","attributes":{"href":"mailto:forschung@claraspital.ch"},"elements":[{"text":"forschung@claraspital.ch","tag":"#text"}]},{"text":"  ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"Für Fragen steht Prof. Dr. med. Markus Zuber gerne zur Verfügung.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentDownloads","id":"7f198f1b-2a99-4aff-ae80-b53f0e75a4bf","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"items":[{"contentType":"claraforschungGlobalDownload","name":"Antragsvorlage Dr. Pe­ter Ei­chen­ber­ger Grant 2025","createDate":"2024-11-06T17:08:40.36Z","updateDate":"2024-11-06T17:18:29.393Z","route":{"path":"/global/downloads/antragsvorlage-dr-pe-ter-ei-chen-ber-ger-grant-2025","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f1bd1f84-caf7-44ea-8a69-6a4c8888de02","properties":{"title":"Antragsvorlage Dr. Pe­ter Ei­chen­ber­ger Grant 2025","description":null,"download":[{"focalPoint":null,"crops":[],"id":"bd26273f-0b91-4009-bf43-843ad3068190","name":"Grant Template Budget Zeitplan","mediaType":"umbracoMediaArticle","url":"/media/cetdnpmr/grant_template_budget_zeitplan.docx","extension":"docx","width":null,"height":null,"bytes":821707,"properties":{}}]}},{"contentType":"claraforschungGlobalDownload","name":"Reglement Dr. Pe­ter Ei­chen­ber­ger Grant","createDate":"2024-11-06T17:20:33.483Z","updateDate":"2024-11-06T17:20:33.483Z","route":{"path":"/global/downloads/reglement-dr-pe-ter-ei-chen-ber-ger-grant","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ae9d83ef-aaed-4c6c-809e-91eb3cd5100d","properties":{"title":"Reglement Dr. Pe­ter Ei­chen­ber­ger Grant","description":null,"download":[{"focalPoint":null,"crops":[],"id":"76f7b04d-0619-41ea-9133-b89e215c9dc3","name":"Reglement Dr Peter Eichenberger Forschungsfoerderung","mediaType":"umbracoMediaArticle","url":"/media/moypo3qz/reglement_dr_peter_eichenberger_forschungsfoerderung.pdf","extension":"pdf","width":null,"height":null,"bytes":128093,"properties":{}}]}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"2fbec068-e2c0-4fbd-a494-8b2875637718","properties":{"jumpNavigationTitle":null,"title":"Noch Fragen?","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ihr Ansprechpartner","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"ad2f629c-05e1-4263-ab11-06bdc314a720","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Zuber_Markus","createDate":"2024-09-25T17:30:42.08Z","updateDate":"2024-09-26T10:47:20.88Z","route":{"path":"/de/mitarbeitende/zuber_markus","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"26776349-2a2e-4554-aa33-17d3700ebc8e","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"22158db0-3d1d-4a34-a321-152d2615ce56","name":"Forschung Grant Claraspital Teaser","mediaType":"Image","url":"/media/w0gbkiq3/forschung_grant_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":258799,"properties":{}}],"teaserTitle":"Dr. Peter Eichenberger Grant","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"2007720b-3d00-412f-a3c9-80568eae8867","properties":{"title":"Dr. Peter Eichenberger Grant","lead":"Der  Grant ist  dem ehemaligen und langjährigen Direktor des Claraspitals, Dr. rer. pol. Peter Eichenberger (1966-2024) gewidmet und wird jährlich vom Koordinationsgremium der St. Clara Forschung AG vergeben.","image":[{"focalPoint":null,"crops":[],"id":"c4504126-8917-4315-a8a4-2d682549bdad","name":"Claraforschung Grant Hero","mediaType":"Image","url":"/media/ebafbrax/claraforschung_grant_hero.jpg","extension":"jpg","width":1920,"height":1080,"bytes":439021,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/dr-peter-eichenberger-grant"}},{"contentType":"claraforschungGeneric","name":"Team","createDate":"2024-09-17T10:35:55.977Z","updateDate":"2024-11-05T10:16:59.127Z","route":{"path":"/de/team","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"4d0f538c-4e6d-4f1e-b28e-36e69b6ef2f6","properties":{"contentComponents":{"items":[{"content":{"contentType":"claraforschungComponentEmployeeList","id":"ce92e29f-07a5-4696-a0e7-ed937eb3d412","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"In der Geschäftsleitung","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"254ec8be-1faf-48e2-b68e-cda0b9ff7d3f","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Zuber_Markus","createDate":"2024-09-25T17:30:42.08Z","updateDate":"2024-09-26T10:47:20.88Z","route":{"path":"/de/mitarbeitende/zuber_markus","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"26776349-2a2e-4554-aa33-17d3700ebc8e","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Leitung","createDate":"2024-10-01T10:06:02.273Z","updateDate":"2024-11-06T16:38:58.63Z","route":{"path":"/global/position/leitung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"69ae1db3-b85c-4f67-9036-954ae3d68820","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"6feb2640-8959-47d4-8cd3-5715a5eb7051","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Templeton Arnoud","createDate":"2024-09-25T14:28:55.307Z","updateDate":"2024-09-26T10:23:24.577Z","route":{"path":"/de/mitarbeitende/templeton-arnoud","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"460a7bde-474d-4eaf-b18a-f410385fd143","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Stv. Leitung","createDate":"2024-10-01T10:06:49.027Z","updateDate":"2024-11-06T16:38:59.113Z","route":{"path":"/global/position/stv-leitung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c5e31cb0-f856-40f8-a881-ac383393d158","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"a29db87e-de01-4641-a1c4-6505699e3ef5","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Meyer-Gerspach Anne Christin","createDate":"2024-09-25T09:36:10.713Z","updateDate":"2024-10-01T12:58:52.11Z","route":{"path":"/de/mitarbeitende/meyer-gerspach-anne-christin","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f1a90997-340e-4302-b575-33a1793f59c8","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"a121f6c7-ede5-41ef-969c-9c67f80b1ed1","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Woelnerhanssen Bettina","createDate":"2024-09-25T17:07:29.957Z","updateDate":"2024-10-24T10:24:27.907Z","route":{"path":"/de/mitarbeitende/woelnerhanssen-bettina","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"0837f013-c9cb-4f8f-b1d6-3f333ac198b3","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"f1f96e44-a911-4078-9cc7-658e69d4fd17","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"von Strauss Marco","createDate":"2024-09-25T16:30:01.517Z","updateDate":"2024-09-26T10:23:31.877Z","route":{"path":"/de/mitarbeitende/von-strauss-marco","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"3f757c45-5f65-43c0-917c-bdda064e7d57","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"4df0b6af-7e92-445e-b4b9-b6964db68cc6","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Studienkoordination und Sekretariat","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"72f25aa5-354a-49c0-b144-4c32795d2488","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Allmendinger Birgit","createDate":"2024-09-17T10:43:48.577Z","updateDate":"2024-09-17T10:44:46.19Z","route":{"path":"/global/mitarbeitende-ohne-seite/allmendinger-birgit","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c2553e67-b2a5-46f7-8709-ee1970119541","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"7b3d9f23-7c99-4e7b-ab61-db12441c8ce3","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Diana Bakker de Jong","createDate":"2024-09-17T10:45:10.133Z","updateDate":"2024-09-17T10:45:44.42Z","route":{"path":"/global/mitarbeitende-ohne-seite/diana-bakker-de-jong","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e9161bda-166e-4764-92f7-d61f0d3352f1","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"dd34dde2-8b74-4205-95cc-261511ffad4d","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Distler Jana","createDate":"2024-09-17T10:46:06.293Z","updateDate":"2024-09-17T10:46:40.613Z","route":{"path":"/global/mitarbeitende-ohne-seite/distler-jana","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c89943ef-c3bf-491f-b291-4050910969a6","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"278b0399-2842-493b-b4aa-8001e146bce8","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Kammer Barbara","createDate":"2024-09-17T10:47:59.553Z","updateDate":"2024-09-17T10:48:41.757Z","route":{"path":"/global/mitarbeitende-ohne-seite/kammer-barbara","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"da16e846-2e92-45f0-87ed-47a639a2d7fb","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"a3eb90f7-2c72-43c0-a5f7-b8e648e0e725","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Pflimlin-Fritschy Véronique","createDate":"2024-09-17T10:49:08.393Z","updateDate":"2024-09-17T10:49:51.227Z","route":{"path":"/global/mitarbeitende-ohne-seite/pflimlin-fritschy-veronique","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"2916d5c2-81b3-49ac-b67d-c0e44b29a53d","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"5ac20dca-3bbc-4bff-86a1-fe0c2716a4ca","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Punsola Catherine","createDate":"2024-09-17T10:50:14.82Z","updateDate":"2024-09-17T10:50:58.293Z","route":{"path":"/global/mitarbeitende-ohne-seite/punsola-catherine","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"32bddcb7-a57e-4364-afec-f96f335ae5b8","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"e4589715-f8bd-4520-b789-ff67ce58167b","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Ruscher Uta","createDate":"2024-09-17T10:52:06.99Z","updateDate":"2024-09-17T10:53:10.147Z","route":{"path":"/global/mitarbeitende-ohne-seite/ruscher-uta","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"899c187e-dc20-49a8-b62f-62c03a34018b","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"6f5dc835-41b7-4b2e-bccb-a26ab6803fe4","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Nathell Benkert Therese","createDate":"2024-09-17T10:56:43.433Z","updateDate":"2024-09-17T11:02:55.383Z","route":{"path":"/global/mitarbeitende-ohne-seite/nathell-benkert-therese","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"a4a25820-1b51-4484-825e-b828b12c782c","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"b475a808-0eef-40e3-8df1-a6839843a12f","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"(Post-)Doktorand/innen","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"35b4e3aa-4dae-4a21-bd41-482a0115b7dc","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Altstädt Anita","createDate":"2024-09-17T11:07:13.57Z","updateDate":"2024-09-17T11:08:31.897Z","route":{"path":"/global/mitarbeitende-ohne-seite/altstaedt-anita","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"1dcbfe2d-b64f-4c99-a144-86843290d110","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"ac9117e6-44ee-41be-bddf-915fb36b98dc","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Flad Emilie","createDate":"2024-09-17T11:03:21.87Z","updateDate":"2024-09-17T11:04:40.893Z","route":{"path":"/global/mitarbeitende-ohne-seite/flad-emilie","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c55116cd-5304-441c-b564-15f80cd676c1","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"2cb689c9-436f-49e2-9d21-7632e5b4f30d","name":"Claraspital Partnerschaften Teaser","mediaType":"Image","url":"/media/z4elmldp/claraspital_partnerschaften_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":435552,"properties":{}}],"teaserTitle":"Team","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"e9d302de-f0dd-4522-90c5-bc5b58fd9125","properties":{"title":"Team","lead":null,"image":[{"focalPoint":{"left":0.5288220551378446,"top":0.5133667502088555},"crops":[],"id":"569f4c4c-e84b-4422-896b-c8ed64e01f75","name":"Home Claraforschung2","mediaType":"Image","url":"/media/jjgj4vsl/home_claraforschung2.jpg","extension":"jpg","width":1920,"height":1080,"bytes":1340275,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/team"}},{"contentType":"claraforschungGeneric","name":"Medien & Publikationen","createDate":"2024-08-27T09:03:48.353Z","updateDate":"2024-11-05T11:29:12.847Z","route":{"path":"/de/medien-publikationen","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"87805e88-c17b-477e-a319-5bbe7bd5dbd9","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentRichtext","id":"8c04a69e-9d5d-4ab1-a0aa-0b9b62df5a79","properties":{"jumpNavigationTitle":null,"title":"Breite Reichweite und öffentliche Wahrnehmung ","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die Clara Forschung legt grossen Wert auf den öffentlichen Dialog über ihre Arbeit und die Ergebnisse der Wissenschaft. Neben erfolgreichen Veröffentlichungen in Fachzeitschriften nehmen die Forschenden aktiv an nationalen und internationalen Kongressen sowie Fachveranstaltungen teil. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentTeasersAuto","id":"4f1fb319-ec13-4a7b-8b8d-194b7499a814","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"Information":null}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"f731bd2c-422e-4806-9f6d-e3f44bed596d","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Kontakt","title":"St. Clara Forschung AG","lead":null,"contactPhone":"+41 61 685 85 85","eMailAdress":"forschung@claraspital.ch","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}},{"contentType":"claraforschungGlobalContactAddress","name":"Klinische Forschung unterstützen","createDate":"2024-09-18T09:33:34.53Z","updateDate":"2024-11-18T07:54:30.76Z","route":{"path":"/global/contact-addresses/klinische-forschung-unterstuetzen","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ee921ab0-8e98-4632-bf44-609be7d37fff","properties":{"color":{"color":"eee4ef","label":"violet"},"label":"Klinische Forschung unterstützen","title":"Klinische Forschung unterstützen","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Spendenkonto Basler Kantonalbank, Basel   ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"CH10 0077 0252 7146 7200 1","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":" ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Bitte Zahlungszweck erwähnen:","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"• Krebsforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung Chirurgie","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Übergewichts-, Diabetes- und Stoffwechselforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung allgemein","tag":"#text"}]}],"blocks":[]},"contactPhone":null,"eMailAdress":null,"contactAddress":null,"contactLinks":null}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"892fad92-4da2-4792-bcd5-ec9ee6f6ca05","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"In der St. Clara Forschung","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"6537d5a3-e8ab-4546-ae8f-cbb07a3a9192","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Zuber_Markus","createDate":"2024-09-25T17:30:42.08Z","updateDate":"2024-09-26T10:47:20.88Z","route":{"path":"/de/mitarbeitende/zuber_markus","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"26776349-2a2e-4554-aa33-17d3700ebc8e","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Leitung St. Clara Forschung AG","createDate":"2024-09-25T17:19:29.953Z","updateDate":"2024-11-06T16:38:58.13Z","route":{"path":"/global/position/leitung-st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"9e02025a-7027-41f2-8a3f-297571c02943","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"dc86d883-102a-46f9-a80c-3ca461cc0810","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Templeton Arnoud","createDate":"2024-09-25T14:28:55.307Z","updateDate":"2024-09-26T10:23:24.577Z","route":{"path":"/de/mitarbeitende/templeton-arnoud","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"460a7bde-474d-4eaf-b18a-f410385fd143","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Stv. Leitung St. Clara Forschung AG","createDate":"2024-10-01T10:04:52.593Z","updateDate":"2024-11-06T16:38:58.307Z","route":{"path":"/global/position/stv-leitung-st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f34ec0a6-9d15-40cc-a932-c0339c560da9","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"7fc11125-214d-4a08-95ce-e0f0b8a15173","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Woelnerhanssen Bettina","createDate":"2024-09-25T17:07:29.957Z","updateDate":"2024-10-24T10:24:27.907Z","route":{"path":"/de/mitarbeitende/woelnerhanssen-bettina","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"0837f013-c9cb-4f8f-b1d6-3f333ac198b3","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"53ad345e-bcf6-4947-b7f1-9d86dd708549","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Meyer-Gerspach Anne Christin","createDate":"2024-09-25T09:36:10.713Z","updateDate":"2024-10-01T12:58:52.11Z","route":{"path":"/de/mitarbeitende/meyer-gerspach-anne-christin","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f1a90997-340e-4302-b575-33a1793f59c8","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"aa908c42-beac-427c-a7f4-f7898fe9c57f","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"von Strauss Marco","createDate":"2024-09-25T16:30:01.517Z","updateDate":"2024-09-26T10:23:31.877Z","route":{"path":"/de/mitarbeitende/von-strauss-marco","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"3f757c45-5f65-43c0-917c-bdda064e7d57","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"5b24e095-f0dd-4ba0-a9f7-1b8bdf23fe18","name":"Claraspital Publikationen Teaser","mediaType":"Image","url":"/media/spqciw43/claraspital_publikationen_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":585662,"properties":{}}],"teaserTitle":"Medien & Publikationen","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"89f3c99c-f224-4cb1-bb24-90270f21aa06","properties":{"title":"Medien & Publikationen","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/medien-publikationen"}},{"contentType":"claraforschungGeneric","name":"Spender/in werden","createDate":"2024-08-27T10:21:10.47Z","updateDate":"2024-11-05T11:29:42.043Z","route":{"path":"/de/spenderin-werden","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b5299480-9779-4c8f-8845-1a0cf2e0c836","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHighlight","id":"14cfd0e1-cbbb-4db9-a361-2f884fc3fd40","properties":{"jumpNavigationTitle":null,"title":"Klinische Forschung","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Der medizinische Fortschritt hat die Lebensqualität und die Heilungschancen der Patient/innen wesentlich verbessert. Doch wollen wir nicht stillstehen, sondern weiter forschen. Denn die klinische Forschung hilft uns, die Behandlung künftiger Patient/innen weiter zu verbessern.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Dank grosszügigen Spenden ist es möglich, aktiv an klinischen Forschungsprogrammen teilzunehmen oder zu initiieren. Gleichzeitig können wir so die wissenschaftliche Weiterbildung und Weiterentwicklung unserer Mitarbeitenden fördern. ","tag":"#text"}]}],"blocks":[]},"link":null,"variation":{"color":"c7eae0","label":"green"}}},"settings":null},{"content":{"contentType":"componentDownloads","id":"e7b18a68-5f5a-493b-be29-ff8ccc2c5a3f","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"items":[{"contentType":"globalDownload","name":"Flyer Spenden","createDate":"2024-09-05T10:49:24.247Z","updateDate":"2024-09-18T08:04:13.327Z","route":{"path":"/global/downloads/flyer-spenden","startItem":{"id":"0fc8e525-6845-48e3-8880-bbef2831f719","path":"claraspital"}},"id":"847fa18e-084d-4445-8e1f-131d0246a4a3","properties":{"title":"Flyer Spenden","description":null,"download":[{"focalPoint":null,"crops":[],"id":"04430548-dbc9-404e-9f84-02152550b849","name":"Flyer Spenden","mediaType":"umbracoMediaArticle","url":"/media/mycfgbgj/gzd-flyer-spenden-lowres_geschwaerzt.pdf","extension":"pdf","width":null,"height":null,"bytes":2689956,"properties":{}}]}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"41d80564-71b2-4165-b084-4e1729fc59a7","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"Klinische Forschung unterstützen","createDate":"2024-09-18T09:33:34.53Z","updateDate":"2024-11-18T07:54:30.76Z","route":{"path":"/global/contact-addresses/klinische-forschung-unterstuetzen","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ee921ab0-8e98-4632-bf44-609be7d37fff","properties":{"color":{"color":"eee4ef","label":"violet"},"label":"Klinische Forschung unterstützen","title":"Klinische Forschung unterstützen","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Spendenkonto Basler Kantonalbank, Basel   ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"CH10 0077 0252 7146 7200 1","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":" ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Bitte Zahlungszweck erwähnen:","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"• Krebsforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung Chirurgie","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Übergewichts-, Diabetes- und Stoffwechselforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung allgemein","tag":"#text"}]}],"blocks":[]},"contactPhone":null,"eMailAdress":null,"contactAddress":null,"contactLinks":null}},{"contentType":"claraforschungGlobalContactAddress","name":"Spenden Patientenfonds","createDate":"2024-09-23T13:04:45.143Z","updateDate":"2024-11-06T16:38:55.747Z","route":{"path":"/global/contact-addresses/spenden-patientenfonds","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"1f55c287-04fe-4cfd-81f4-51f033fbfb54","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Spenden Patientenfonds","title":"Spenden Patientenfonds","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Spendenkonto Basler Kantonalbank, Basel   ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"CH54 0077 0016 0501 2088 4","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":" ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Bitte Zahlungszweck erwähnen:","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"• Fonds für Patient/innen","tag":"#text"}]}],"blocks":[]},"contactPhone":null,"eMailAdress":null,"contactAddress":null,"contactLinks":null}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"45a3b0b5-b81d-4059-a388-1a3ecbeb8bce","name":"Medizinisches Angebot Kunsttherapie Claraspital Teaser","mediaType":"Image","url":"/media/woykgri3/medizinisches-angebot_kunsttherapie_claraspital_teaser.jpg","extension":"jpg","width":960,"height":1200,"bytes":731169,"properties":{}}],"teaserTitle":"Spender/in werden","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"7902a1dd-034d-47bc-88f4-de3bbee5e7c6","properties":{"title":"Spender/in werden","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/spenderin-werden"}}]}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"componentHighlight","id":"9fb21a2e-f3c8-47fe-b816-58fd00d65cbb","properties":{"jumpNavigationTitle":"Dr. Peter Eichenberger Grant","title":"Dr. Peter Eichenberger Grant am Claraspital Basel","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Pro Jahr stehen CHF 60'000 zur Forschungsförderung zur Verfügung. Es sollen unterstützungswürdige Forschungsprojekte mit Bezug zum Claraspital finanziell unterstützt werden. Der Förderbetrag kann vom/von der Beitragsempfänger/in im Rahmen einer akademischen Karriere als kompetitiv eingeworbene Drittmittel angerechnet werden. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Beitragsberechtigt sind Angestellte des Claraspitals, von Clarunis, der Lindenhofgruppe und der St. Clara Forschung.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der  Grant ist  dem ehemaligen und langjährigen Direktor des Claraspitals, Dr. rer. pol. Peter Eichenberger (1966-2024) gewidmet und wird jährlich vom Koordinationsgremium der St. Clara Forschung AG vergeben. Peter Eichenberger war der langjährige Spitaldirektor des St. Claraspitals. Dank seiner visionären Idee und dem Engagement des Teams der St. Clara Forschung konnte sich die Institution in kurzer Zeit national und international profilieren.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"Dr. Peter Eichenberger Grant","target":null,"destinationId":"88f79ec0-708c-4670-871d-210faa0199bf","destinationType":"claraforschungGeneric","route":{"path":"/de/klinische-forschung/dr-peter-eichenberger-grant","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null,"viewContext":{"isInsideContainer":false}}]}},"cultures":{"de-ch":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"en-ch":{"path":"/en","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"fr-ch":{"path":"/fr","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}}},"properties":{"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"a8218fde-9e09-4090-be7a-71259e470d15","properties":{"title":"Willkommen in der Clara Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}],"viewContext":{"isInsideContainer":false}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"2448abc9-6faa-434e-9e36-821f57f1710a","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Mit der Clara Forschung wurde eine Forschungseinrichtung aufgebaut, die allen gesetzlichen Ansprüchen einer modernen klinischen Forschungseinheit entspricht und sich durch eine hochqualitative, klinische Forschungstätigkeit auszeichnet.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"claraforschungComponentNewsFilter","id":"8173c7d0-5870-4ac8-ab53-e017ab0deb29","properties":{"jumpNavigationTitle":"News","title":"Aktuelles","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"News","tag":"#text"}]}],"blocks":[]}}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"componentRichtext","id":"e4591aed-2017-4881-8fb6-3b196d6a8731","properties":{"jumpNavigationTitle":"Kernforschungsgebiete","title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die Anforderungen an Forschungsinstitutionen sind in den letzten Jahren stets gestiegen. Um diesen erhöhten Anforderungen gerecht zu werden, wurde 2015 die Forschungsabteilung der St. Claraspital AG gegründet und schliesslich im April 2018 in eine Aktiengesellschaft (als Tochtergesellschaft der St. Clara AG, fortan «St. Clara Forschung AG»/«St. Clara Research Ltd») überführt, unter Mitbeteiligung der ","tag":"#text"},{"tag":"a","attributes":{"rel":"noopener","href":"http://lindenhofbern.ch/","target":"_blank"},"elements":[{"text":"Stiftung Lindenhof Bern","tag":"#text"}]},{"text":".","tag":"#text"}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Mit der St. Clara Forschung AG wurde eine Forschungseinrichtung aufgebaut, die allen gesetzlichen Ansprüchen einer modernen klinischen Forschungseinheit entspricht und sich durch eine hochqualitative, klinische Forschungstätigkeit auszeichnet. Zahlreiche internationale Kooperationen erlauben es, national und international kompetitive klinische und translationale Forschung auf einem hohen Niveau zu betreiben.","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":" ","tag":"#text"}]},{"tag":"h3","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"tag":"strong","attributes":{},"elements":[{"text":"Zweck der Clara Forschung","tag":"#text"}]}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Gemäss den Statuten der St. Clara Forschung AG ist der Zweck der Gesellschaft wie folgt definiert:","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"Art. 2: Die Gesellschaft bezweckt die akademische, nichtkommerzielle, weisungsungebundene, freie Forschung, welche die Verwertungs- und Publikationsfreiheit respektiert, auf dem Gebiet der Medizin und auf anderen Gebieten, die zur Medizin einen engen Bezug aufweisen. Die Tätigkeit der Gesellschaft ist gemeinnützig.","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]}]},{"tag":"h3","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"tag":"strong","attributes":{},"elements":[{"text":"Kernforschungsgebiete der Clara Forschung","tag":"#text"}]}]},{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"text":"Metabole und gastroenterologische Forschung","tag":"#text"}]},{"tag":"li","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"text":"Medizinische und medizinisch-onkologische Forschung","tag":"#text"}]},{"tag":"li","attributes":{"class":"MsoNormal","style":"line-height: normal;"},"elements":[{"text":"Viszeralchirurgische Forschung","tag":"#text"}]}]}],"blocks":[]},"link":null}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"componentTeasers","id":"e3971029-0f8c-4c05-af71-3b147f1fcaf3","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"9189c92b-2db9-46e1-9e71-ccd199539d22","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Krebstherapie hat sich in den letzten Jahren enorm schnell entwickelt. Wirksamere aber auch schonendere Therapieformen können heute eingesetzt werden.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"6fb5422b-f674-4c3a-aaf7-c08f4de58d12","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die St. Clara Forschung erforscht schwerpunktmässig die Verbesserung in der Diagnostik und Behandlung von Krebserkrankungen des Bauches, des Blutsystems, der Brust, der Lunge, der Nieren, der Hoden und der Prostata.","tag":"#text"}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die allgemeine Forschung beschäftigt sich mit Forschungsprojekten ausserhalb der erwähnten Gebiete wie beispielsweise der Anästhesie, Notfallmedizin, Intensivmedizin, Palliativmedizin, Kardiologie, Pneumologie und Psychoonkologie.   ","tag":"#text"},{"tag":"span","attributes":{"style":"mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Lucida Sans Unicode'; mso-fareast-language: DE-CH;"},"elements":[{"tag":"br","attributes":{},"elements":[]}]}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentTeasers","id":"a9eb21f8-af75-4511-acaf-1354de102ea0","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"02b93292-12fd-4b10-9469-eaae67457117","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Um Behandlungskonzepte zu verbessern und neuartige Therapien zu entwickeln, ist Forschung unabdingbar. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"a629a076-ae6b-4d08-980f-af0ff3c76ca7","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Klinische Studien werden direkt am und mit dem Patienten durchgeführt. Diese kann sehr unterschiedlich sein. Beispielsweise, indem die Wirkung oder die Dosierung eines Medikaments getestet wird oder indem unterschiedliche Behandlungsmethoden für eine Indikation miteinander verglichen werden. Ziel der klinischen Forschung ist immer, Krankheiten besser zu verstehen und neue Therapieformen zu entwickeln oder bestehende zu verbessern. Zahlreiche Studien werden aktuell in der St. Clara Forschung AG durchgeführt:","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"6061c448-95d0-461b-8def-33e126368f75","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchdecke/Leiste","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":"Aktuelle Studien","items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"cd427adb-c784-4aa8-9e3b-4bf42e80faaa","properties":{"title":"Perioperative Outcome (Pain, Complications, Duration of Hops) in MIS for ventral hernie repair over 2 years. Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"c7db4eca-862e-4c73-80a3-323e0622ce20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"BASEC 2023-02357","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie werden zwei verschiedene Techniken zur Operation eines Bauchwandbruches (=Hernie) miteinander verglichen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/249587/studie/68943","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2d595df9-22c3-4173-b0e7-532ec8cb8b63","properties":{"title":"Robotic versus conventional minimal-invasive inguinal hernia repair – a prospective, randomized and blinded clinical trial (ROGER-RCT)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"14690720-f017-4921-8789-c89c5262dc2a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-01655","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"In dieser Studie soll untersucht werden, ob eine robotergestützte Leistenhernienreparatur die postoperativen Schmerzen reduzieren und die Genesung im Vergleich zum konventionellen laparoskopischen Ansatz verbessern kann.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"960fef41-ae29-4d76-90e6-aadaad60acc9","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchspeicheldrüse (Pankreas)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"13b037b7-b8ca-4c95-bce3-eb17be9c3106","properties":{"title":"Distal Pancreatectomy – A randomised controlled trial to compare minimal-invasive distal pancreatectomy to open resection (DISPACT-2 Trial)BASEC 2023-00705","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"d5d67ef3-6432-4c58-9718-937e0167d0f3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00705","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Teilentfernung der Bauchspeicheldrüse – Vergleich von Schlüssellochtechnikverfahren und offener Operation.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223849/studie/41792","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"e3257fd4-e10d-48b8-8c2d-a2736de17626","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Brust (Mamma)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"4e77c1bd-d1e6-47c2-8d10-2019a0e82886","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"487ea7fb-26fe-47f3-bbb1-ea4cd5d843a2","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"82d0d5be-fd4b-4ccc-91f1-f3d8c14c8646","properties":{"title":"A prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (EUBREAST 03 (R) AXSANA)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"508db622-8ccb-4749-bab2-f22414e9f9b7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-02830","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Studie an mehreren Kliniken, untersucht verschiedene OP-Methoden, um die Achselhöhlen bei Brustkrebspatientinnen mit befallenen Lymphknoten zu überprüfen. Diese Patientinnen erhalten vor der Operation eine Chemotherapie. Ziel der Studie ist es, die besten chirurgischen Verfahren zu vergleichen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/axsana/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"13125a74-5577-471f-a70c-7d07cb66adf2","properties":{"title":"Methods for Localization of Different types of breast lesions (EUBREAST 04 (R) MELODY)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"48ed91fa-7e6d-42fb-807c-a22d12d019dc","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00646","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"Eine Beobachtungsstudie ohne Eingriff, die an mehreren Standorten durchgeführt wird, um verschiedene bildgebende Verfahren zur genauen Erkennung von bösartigen Brusttumoren zu bewerten.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/melody/"},"elements":[{"text":"Mehr Infomationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"fba61881-b69e-4546-b129-66acf8e965f8","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"112cc61a-9fe4-4528-9742-5e58843926bb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ee5f2596-91ae-4e4b-90d7-e95d68f0d540","properties":{"title":"Intelligent Vacuum assisted biopsy Immediately before Surgery as an Intra- or pre-Operative surrogate for patient response to Neoadjuvant chemotherapy for breast cancer (VISION I) A multicenter prospective feasibility trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e3bf6ee7-83d3-40c1-84a0-3d69bf25e969","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00450","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Studie untersucht, ob eine intelligente, vakuumgestützte Biopsie direkt vor der Operation bei Brustkrebs genutzt werden kann, um schon vor oder während der Operation zu erkennen, wie gut die Patientinnen auf die vorherige Chemotherapie angesprochen haben.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/172850/studie/50248"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"502abcc8-2213-4d51-8495-2479b30b90cc","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Darm","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"b082020c-6fcb-4c92-af44-7af1c0f48a41","properties":{"title":"Cholecalciferol Comedication in patients with Chronic inflammatory bowel diseases (Crohn's disease or ulcerative Colitis) – the 5C-study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"99b902c7-464f-41b3-b98c-4e39d44b091a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00899","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Cholecalciferol-Co-Medikation bei Patient/innen mit chronisch entzündlichen Darmerkrankungen (Morbus Crohn oder Colitis ulcerosa)","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223851/studie/62115","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c14bba1c-04c7-440b-accc-45173f02bcec","properties":{"title":"Ergebnisqualität bei Darmkrebs: Identifikation von Unterschieden und Maßnahmen zur flächendeckenden Qualitätsentwicklung (EDIUM)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"67744ab5-42e6-4389-bea6-d88b4da53380","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-03069","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Vergleich und Messung der gesundheitsbezogenen Lebensqualität von Patientinnen und Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.edium-studie.de/studyInfo"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"0924559e-5ca3-434f-8a48-d0b8d9a20853","properties":{"title":"Snap Shot Audit Early Onset Colorectal Cancer (EOCC) - Are we doing enough or can we do more?","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"00b85655-bd27-4ef1-adc5-3b0c1506026f","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02297","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Snapshot Audit on Early onset Colorectal Cancer - are we doing enough, can we do more?","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223884/studie/64169"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c0ddbcc3-8eb3-47f6-ba49-8534dc70152f","properties":{"title":"Image-based ex-vivo  drug screening and genomics/transcriptomics for patients colorectal cancer stage II, III, IV (IBDS-CRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b5261ea6-4051-4ffc-8d08-4f502e744bf3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01441","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die klinische Bedeutung von Merkmalen der Tumorzellen bei Darmkrebs weiter zu erforschen. Dies geschieht über die Etablierung einer Plattform für die Analyse des genetischen Profils und der Wirkung von Krebsmedikamenten bei Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.ksbl.ch/kliniken/darmkrebszentrum-baselland/studien"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ce14c88f-3b6a-45ab-b413-390ad7d67565","properties":{"title":"Encorafenib and cetuximab in patients with metastatic, BRAFV600E-mutated, colorectal carcinoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland. (BERING CRC: BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3a9bfa33-9127-43d2-9f83-76ac821e3aa7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00647","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird die Wirksamkeit der Kombination bestehend aus Braftovi-Kapseln (Wirkstoff Encorafenib) und Erbitux bzw. einem gleichwertigen Arzneistoff (Biosimilar) (Wirkstoff Cetuximab) bei metastasierten Darmkrebs untersucht. Die in dieser Studie gewonnenen Daten sollen dazu beitragen, Erfahrungen mit diesen zugelassenen Medikamenten unter Routinebedingungen zu sammeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"f89bd827-a273-4246-a9e8-7bd6a6ae6fe1","properties":{"title":"Patient Reported Outcomes and Markers of Inflammation in Anal Cancer – a Longitudinal Observational Study (PROSAIC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b4c19a64-c048-459c-a9a6-5a6508ee9ee7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02161","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Beobachtungsstudie zur Lebensqualität beim neu diagnostizierten Analkarzinom","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2df1ee27-e288-40d6-9cf0-9a1a53aa2ee6","properties":{"title":"Biomarker identification to guide surgical intervention after neo-adjuvant chemoradiotherapy in rectal cancer (BSIRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"92d91535-85d1-4576-8109-d0aad3237b20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01199","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Identifikation von Biomarkern um das Ansprechen auf die Vorbehandlung beim Rektumkarzinom vorherzusagen","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"70895d41-749f-4143-a090-9597b0f1882c","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Eierstöcke","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2373ea90-1912-4bf7-9990-566862480908","properties":{"title":"MAintenance Therapie/ Erhaltungstherapie mit Aromatasehemmer für Patientinnen mit epithelialem Ovarialkarzinom: eine randomisierte doppelblinde Placebo-kontrollierte multizentrische Phase III Studie. (ENGOT-ov54/Swiss-GO-2/MATAO)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ba8d8b45-6fe0-4b78-9f4d-9e0f4b3e41bf","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00148","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Erhaltungstherapie mit einem Aromatase-Inhibitor bei epithelialem Ovarialkarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176034/studie/52935","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"efc2c2ad-b3c6-4f30-8e0f-cae4e441d4ce","properties":{"title":"SAKK_OvCaR: A retrospective and prospective registry of patients with ovarian cancer","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b11d6529-da0d-403d-9cd3-93593ee93bfe","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-01335","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Register Daten und Behandlung Ovarialcarcinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/ein-pro-und-retrospektives-register-von-patientinnen-mit-ovarialkarzinom"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"67cec99e-6f14-4c6d-8bcb-8e2094419ee4","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ernährung/Übergewicht","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"db4b4417-ff27-4d82-aaa5-c43d8c8f7f4f","properties":{"title":"Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM trial)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8560e58a-ef64-47a5-b2b8-71beef5f5e3d","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02392","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"SLIM Studie - Wirkung unterschiedlicher Schenkellängen beim Magenbypass","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176438/studie/52643","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"58fdf882-9191-4df1-9b72-4c9da32b6613","properties":{"title":"Understanding gut-brain interactions and the effect of a lowcarb dietary intervention in obese and depressive patients with and without glucose intolerance or diabetes: a pilot trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"6cbf87c1-ac9a-4786-95de-8a7934d2b6b5","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Bedeutung der Darm-Hirn-Achse und der Effekt einer kohlenhydratarmen Diät bei Übergewicht und Depression","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176258/studie/48748"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"7173dff6-7695-4eba-bf59-f71b0dd97462","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Hoden","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"d8bc2afb-28c1-4975-bf81-e2889b9aa83d","properties":{"title":"Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"19c8f679-740c-4862-97ae-9500f10b1b36","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKOS 13/083, PB_2016-00235","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Prospektive Datenerhebung bei Patienten mit Hodenkrebs","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.sag-tccs.com","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"debb5fb5-44cf-494a-ba78-c326374b15e7","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Lunge","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2ae1ea32-2b5a-423f-abd6-d3a197091d6f","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ff0bb2d7-9965-4af5-a105-228e548e46c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"26239e17-c1a5-4ae9-b94c-632d048c523c","properties":{"title":"SAKK_LuCa_2: Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"caaed598-39ef-444b-b37e-63b3778e0aae","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00398","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es handelt sich um eine Datenbank, in der Informationen über Patienten mit einer bestimmten Art von Lungenkrebs (metastasierter nicht-kleinzelliger Lungenkrebs, NSCLC) gesammelt werden. Ziel ist es, besser zu verstehen, wie sich diese Genveränderungen auf den Krankheitsverlauf und die Behandlungsergebnisse auswirken.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/register-und-studie-zum-egfr-mutierten-nsclc"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"11b78385-b1bd-4b97-a8c2-b63c3052f70c","properties":{"title":"SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) non-small cell lung cancer (NSCLC). A multicenter phase II trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"56fa4d89-2908-4864-9256-01425d662108","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02378,  EKOS 19/185","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der Studie SAKK 16/18 wird untersucht, ob eine zusätzliche präoperative Immuntherapie mit dem anti-PD-L1 Antikörper Durvalumab in Kombination mit Radiotherapie die Prognose lokal fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) verbessern kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176046/studie/49836"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"3a627627-6294-44d7-ba3e-8ef2b6a1b0f8","properties":{"title":"Procalcitonin and Lung UltraSonography based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: a pragmatic stepped-wedge cluster-randomized trial - The PLUS-IS-LESS study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"28dbdba9-d809-4ed7-ad3e-af1cb680b866","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00738","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Neue Instrumente zur Verbesserung der Behandlung von Patienten mit Verdacht auf Pneumonie","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/221174/studie/61941"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"c9a139db-2e90-45cb-be2c-b250ae5824d3","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Blut- und Lymphatisches System","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"943c4c40-c866-4fbf-9133-379d51f9e704","properties":{"title":"Multicentre Observational Study of MDS Patients in Switzerland – Swiss MDS Registry","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8ac1fcd9-2d85-4b0e-a54a-37c47617da11","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE: 339/2014; PB_2016-01917","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Daten- und Probensammlung zur Erkenntnis neuer biologischer Zusammenhänge bei myeloplastisches Syndrom, die auch eine Beschreibung des aktuellen Stands und der zukünftigen Entwicklungen in Diagnostik und Therapie erlauben. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.mds-switzerland.ch/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2a677604-1103-4bf9-a963-419377b23af5","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Magen- und Speiseröhre","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"279eb75b-392b-482b-9cac-f788b921c7f3","properties":{"title":" Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"26f6ecd6-ddb0-4f56-a2f5-4c4bc50bb87b","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"30134c7e-2494-4b1c-a92c-b4ebfd9866f0","properties":{"title":"CARDIA Trail: Surgery for Adenocarcinoma of the Gastroesophageal Junction (GEJ) Type II: Transthoracic Esophagectomy vs. Transhiatal Extended Gastrectomy","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3dc06a31-3fa9-45df-b723-d1fef99d649c","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00126","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der Vergleich von chirurgischen Therapien für das Adenokarzinom des gastroösophagealen Übergangs (GEJ): transthorakale Ösophagektomie versus transhiatal erweiterte Gastrektomie.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223905/studie/47421"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1572715f-6fbf-41b7-bd16-1c8eae96b55c","properties":{"title":"DANTE / FLOT8: A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"4369e292-e0b0-4459-8ff5-d2c4a9ded60e","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01150","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die DANTE/FLOT8- Studie untersucht, ob eine Kombination aus zwei Behandlungen bei Magenkrebs und Adenokarzinom an der Übergangsstelle zwischen Speiseröhre und Magen besser wirkt als eine der Behandlungen allein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/229432/studie/44090"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"082a400a-8a89-461e-9e22-abfd406c000f","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Niere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"7d27f24a-e2fc-4fa0-b976-6819ad724083","properties":{"title":"Metastatic Renal Cell Cancer: A Multicenter Prognostic and Predictive Factors Project in the Era of Modern Therapy (The International mRCC Database Consortium (IMDC))","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"a965ad71-3c5a-44b3-81e2-78d370372c33","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2018-01473","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Ein Projekt, das an mehreren Zentren durchgeführt wird, untersucht Faktoren, die den Krankheitsverlauf vorhersagen und den Behandlungserfolg in der modernen Therapie beeinflussen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.imdconline.com/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2e597fbc-b665-43c4-960d-5a4d9d6cea58","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Prostata","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"26b23bd5-fc02-4178-928c-8a0a831ec416","properties":{"title":"Blutentnahme zur Analyse zellfreier DNA bei Patienten mit fortgeschrittenen Krebsleiden (BEDNA-Studie)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"fcefe79b-f71c-4477-8124-f93b4a3c86c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKNZ 2014-329","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Analyse von im Blut frei zirkulierender Erbsubstanzen von Krebszellen bei Patienten mit fortgeschrittenem Krebsleiden. Die Etablierung dieser Technik könnte in Zukunft die Therapie und Überwachung von fortgeschrittenen Krebserkrankungen ermöglichen.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"b530f6c1-0a48-4984-b3df-2a30459a118b","properties":{"title":"Entwicklung von ex vivo Modellen des Prostatakarzinoms","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e880e044-0ee9-4eb5-834b-bb33aa5c8026","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKBB 37/13, PB_2018-00312","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Identifizierung spezifischer Mutationen könnte das grundlegende Verständnis der Entwicklung des Prostatakarzinoms, insbesondere des kastrationsresistenten Prostatakarzinoms verbessern und dazu beitragen, neue Marker und Strategien für dessen Behandlung zu entwickeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"aa52b80a-7f6c-4431-8e20-68c4ce5a64e4","properties":{"title":"Prostate Cancer Outcome - Compare and Reduce Variation in DKG-Prostatakrebszentren (PCO-CRV)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"270447e4-e676-4cfd-a593-6553c1da0db0","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2016-01172","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Internationaler Vergleich von Behandlung und Ergebnisqualität bei lokal begrenzten Prostatakarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.pco-study.com/findings"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"519b835c-1f29-4b7f-9727-9781af1b21c6","properties":{"title":"An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer (ProBio)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"df50fa44-8995-40fc-8e8d-958506d8d258","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-02495","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es geht darum, ob man durch das Untersuchen von Tumor-DNA bei Prostatakrebspatienten frühzeitig erkennen kann, welche Therapie besonders gut wirken wird. Damit könnten die Ärztinnen und Ärzte individuellere, wirksamere Behandlungen anbieten, die für die jeweilige Krebsart des Patienten besser passen als die üblichen Standardbehandlungen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/247767/studie/61659"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"bf3d75d5-bdd8-4f67-8920-fd2127639e61","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"abeff69c-6bd8-43bc-a918-356e8a8fb7c4","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"5775e216-94d1-410a-a8f1-fb11a9ec171a","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Andere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"c0ab1fe6-5224-4618-bfad-2de2dcbd45ea","properties":{"title":"Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"037e5793-4af4-4125-87cc-a3dfd59f4ddb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1498c7a2-37ed-4dc5-b949-53993d18ba4f","properties":{"title":"Informationssammlung zur effektiven Erforschung neuroendokrine Tumoren (SwissNET)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"471f352b-b77e-4b55-927b-2335b0617de1","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE 395/2014","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es werden Daten von Patienten/Innen mit NET aus der ganzen Schweiz erfasst. Basierend auf diesen Daten können Häufigkeit und Verlauf dieser seltenen Tumore in der Schweiz besser dokumentiert werden. Interessierte Spezialisten aus den verschiedenen Spezialgebieten sind in dem Trägerverein dieses Registers vereinigt, was zusätzlich zu einem regen Wissensaustausch führt.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.swissnet.net/de/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentHighlight","id":"6f1711e8-6711-4975-9ae6-7e0e6a43277e","properties":{"jumpNavigationTitle":"Probanden ge­su­cht","title":"Stu­di­en­teil­neh­mer/in­nen ge­su­cht für Low Carb Stu­die","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Mit dieser Studie wollen wir den Effekt einer «Low Carb»-Ernährung genauer untersuchen: Mittels einer App werden Sie geschult, stellen Ihre Ernährung langsam auf eine «Low Carb»-Ernährung um und halten diese mindestens 6 Monate ein. Während dieser Zeit werden verschiedene Untersuchungen vorgenommen wie: Blutuntersuchungen, Bestimmung der Körperzusammensetzung (Muskel-, Fettanteil), Messung des Leberfettanteils, Untersuchung des Gehirns, Untersuchung der Darmbakterien, Fragebögen zum Befinden.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"zur Low Carb Studie","target":"_blank","destinationId":"fadeffb7-929c-4df1-b934-0ea6f0f06655","destinationType":"claraforschungGeneric","route":{"path":"/de/aktuelle-studien/studienteilnehmerinnen-gesucht","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"01270bd3-fa72-451f-88a3-7d735d3d093a","name":"Medizinisches Angebot Onkologie Claraspital Teaser 2","mediaType":"Image","url":"/media/0ufdoals/medizinisches-angebot_onkologie_claraspital_teaser_2.jpg","extension":"jpg","width":960,"height":1200,"bytes":867878,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"0bdeac0c-3fbf-47fa-af19-62cdc7ec5376","properties":{"title":"Aktuelle Studien","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"3bd5e2ca-67e6-4ee8-b03f-16664dc2ed54","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"e34ba912-2111-4af3-8cec-6ae7f37a6105","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"65d3e01b-9422-4ce4-9f0e-31720b556d2c","properties":{"jumpNavigationTitle":null,"title":"Netzwerke metabole und gastroenterologische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. Unsere Forschungsprojekte werden durch öffentliche Geldgeber (Schweizerischen Nationalfonds (SNF)) und private Stiftungen (z.B. Botnar Foundation, Uniscientia) unterstützt. Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"b66dd421-8fd4-4e1c-8260-5b21ba287e45","properties":{"jumpNavigationTitle":null,"title":" Clarunis Netzwerk – Viszeralchirurgische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Das Netzwerk geht weit mehr als 50 Jahre auf das Departement Chirurgie der Universität Basel unter Professor Dr. med. Martin Allgöwer, Ordinarius für Chirurgie, zurück. Im Netzwerk sind Kliniken integriert, die einen engen Bezug zur Basler Chirurgenschule hatten und haben. Bei Neubesetzungen von Chefarztstellen mit Basler Schülern (z.B. Chur, Lugano, St. Claraspital etc.) hat sich ein erster Mitarbeitenden (MA)-Austausch in die Peripherie, aber auch umgekehrt ans Universitätszentrum eingestellt. Allgöwers Nachfolger, Prof. Dr. med. Felix Harder hat diese Interaktion mit den Kliniken weiter ausgebaut und intensiviert und hat neu die Videokonferenz (VC) als Fort- und Weiterbildungs-Plattform («Schlaue Stunde») etabliert.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Basierend auf diesen gut fundierten und institutionalisierten Pfeilern (VC und MA-Austausch) mit den affiliierten Kern-Kliniken ist mit Clarunis 2019 unter Prof. Dr. med. Markus von Flüe das Bewusstsein gewachsen, dass ein weiteres, gemeinsames Feld bearbeitet werden könnte, nämlich, dass dieser Verbund ein ausserordentlich grosses Potenzial für klinische Forschung birgt, das als weiteren Grundpfeiler des Netzwerkes in der erweiterten Nordwest-Schweiz bearbeitet und genutzt werden sollte.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine erste Netzwerk-Studie (EvaCol) wurde lanciert und unter der Leitung von PD Dr. med. Marco von Strauss durchgeführt und mit über 1100 eingeschlossenen Patienten der kolorektalen Chirurgie abgeschlossen. Unter dem neuen Ordinarius von Clarunis Prof. Dr. med. Beat Müller erfährt dieses Kern-Netzwerk eine noch grössere Dimension (graphische Darstellung des Clarunis Netzwerks) und gewinnt an Bedeutung für Clarunis und damit für die St. Clara Forschung. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"Clarunis Netzwerk","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Clarunis, Prof. Dr. med. Beat Müller","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Luzerner Kantonspital (LUKS), Prof. Dr. med. Martin Bolli","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Biel (SZB), Prof. Dr. med. Carsten Th. Viehl","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonsspital Aarau (KSA), Prof. Dr. med. Mark Hartel","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Lindenhofspital, Prof. Dr. med. Mathias Worni","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Oberwallis (SZO), Dr. med. Thomas Simon","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    St. Anna Klinik Luzern, Prof. Dr. med. Markus von Flüe","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Olten, Prof. Dr. med. Uli Dietz","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spital Limmattal Schlieren, Prof. Dr. med. Urs Zingg","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Basel-Land (KSBL) Liestal, Prof. Dr. med. Robert Rosenberg","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentImage","id":"e78a3514-102d-4b82-a4df-2d7e935b099c","properties":{"jumpNavigationTitle":null,"image":[{"focalPoint":null,"crops":[],"id":"53bec52d-9d74-48b2-8649-d8ee045b1440","name":"Claraforschung Netzwerk Contentimage","mediaType":"Image","url":"/media/fpcl2u1u/claraforschung_netzwerk_contentimage.jpg","extension":"jpg","width":1920,"height":1080,"bytes":399695,"properties":{}}],"altText":null,"caption":null,"fullWidth":false}},"settings":null},{"content":{"contentType":"componentTeasers","id":"2954661e-279b-4363-99d0-3636da9e854d","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"23208443-572d-4e5a-a7c4-c5ac90465831","name":"Medizinisches Angebot Forschung Claraspital Teaser","mediaType":"Image","url":"/media/iwccaizn/medizinisches-angebot_forschung_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":304241,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"efb5b3ca-05c1-4c37-829c-f18d80376e2f","properties":{"title":"Wissenschaftliche Netzwerke","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"9ad2f67a-7fc6-44aa-8d56-135373d1b29f","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG – Krebsforschung","createDate":"2024-10-18T09:59:39.393Z","updateDate":"2024-11-06T16:38:56.787Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag-krebsforschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ab57b132-cff4-44a4-b377-a2e37f6d82ed","properties":{"color":{"color":"eee4ef","label":"violet"},"label":"Kontakt ","title":"Krebs­for­schung/All­ge­mei­ne For­schung","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Wir freuen uns auf Ihre Kontaktaufnahme.","tag":"#text"}]}],"blocks":[]},"contactPhone":"+41 61 685 85 85","eMailAdress":"onko.forschung@claraspital.ch ","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}},{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Kontakt","title":"St. Clara Forschung AG","lead":null,"contactPhone":"+41 61 685 85 85","eMailAdress":"forschung@claraspital.ch","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"9cfadfb4-759c-4003-87bd-daac1e91e413","name":"Medizinisches Angebot Hernienzentrum Clarunis Teaser (1)","mediaType":"Image","url":"/media/wlppvhe2/medizinisches-angebot_hernienzentrum_clarunis_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":612763,"properties":{}}],"teaserTitle":"Krebsforschung/Allgemeine Forschung","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"04a08f65-8fc5-4df4-8a37-b73dd99aca44","properties":{"title":"Krebsforschung/Allgemeine Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/krebsforschungallgemeine-forschung"}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"a2dc7025-2720-43ff-825e-e8f2dd79e95e","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Stoffwechselerkrankungen wie Übergewicht, Diabetes und damit verbundene Erkrankungen wie Bluthochdruck, Blutfettstörungen und Leberverfettung nehmen weltweit zu und sehr viele Patient/innen sind davon betroffen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"703ddc00-11e3-4ef6-b881-5f5cd9b649c8","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Übergewicht ist eine multifaktorielle, chronische Erkrankung. Die Mechanismen, die der Entstehung von Übergewicht zugrunde liegen, sind noch immer nicht vollständig geklärt. Bei der Behandlung ist eine Kombination von therapeutischen Massnahmen erforderlich. Lebensstilanpassungen wie beispielsweise eine Ernährungsumstellung, gesteigerte körperliche Aktivität, zielgerichtete Medikamente und die Übergewichtschirurgie können einzeln oder in Kombination hilfreich sein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Hauptziele unseres Forschungsbereichs sind ein tieferes Verständnis für die Appetitregulation – einschliesslich der Interaktion zwischen dem Darm und dem Gehirn – zu erlangen, den Ursachen von Übergewicht und Magendarmerkrankungen auf den Grund zu gehen und schliesslich die Wirksamkeit verschiedener Behandlungsoptionen im Detail zu untersuchen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der gastroenterologischen Forschung stehen die chronisch entzündlichen Darmerkrankungen (CED) im Fokus. Bei dieser Erkrankung geht man von einer überschiessenden Aktivierung des Immunsystems der Darmschleimhaut aus. Dabei spielt eine gestörte Schleimhautbarriere eine wichtige Rolle wo eine lokale Entzündung z.B. durch eindringende Erreger ausgelöst werden kann. Wir interessieren uns daher für die Immunantwort von einer bestimmten Untergruppe von Immunzellen, die von aus der Darmmikroflora stammenden Antigene stimuliert werden. Die Analysen, die wir durchführen, können bei unterschiedlichen Mustern möglicherweise Rückschlüsse auf den individuellen klinischen Verlauf oder auf das Ansprechen einer Therapie bei einzelnen CED Patienten liefern. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Studienresultate werden regelmässig in anerkannten Fachzeitschriften publiziert sowie an nationalen und internationalen Kongressen vorgestellt. Wir halten eingeladene Fachvorträge und stehen in engem Kontakt mit den öffentlichen Medien, um Fachexperten wie auch die breite Öffentlichkeit über die Ursachen und Behandlungsoptionen von Übergewicht und Magendarmerkrankungen aufzuklären. Es ist uns hierbei ein besonderes Anliegen, das Stigma des schweren Übergewichts zu bekämpfen, indem wir neue Erkenntnisse über die biologischen Ursachen dieser Krankheit und therapeutischen Massnahmen vermitteln. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentHighlight","id":"cc2ae5a6-539b-4061-8691-b4e0c98cbebf","properties":{"jumpNavigationTitle":null,"title":"Studienbeispiele","text":{"tag":"#root","attributes":{},"elements":[{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie wird der Einfluss einer kohlenhydratreduzierten Kost auf das Gewicht, den Stoffwechsel und die psychische Gesundheit untersucht.","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie werden zwei Arten von Magenbypass-Operationen auf ihre Wirksamkeit hin untersucht. Diese grosse multizentrische Studie mit > 800 Studienteilnehmer/innen erlaubt es im Detail zu untersuchen wie diese Operationen sich auf den Stoffwechsel auswirken. ","tag":"#text"}]}]}],"blocks":[]},"link":null,"variation":{"color":"c7eae0","label":"green"}}},"settings":null},{"content":{"contentType":"componentTeasers","id":"93d4d935-e853-4ea1-a42b-f965529208e6","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"02b93292-12fd-4b10-9469-eaae67457117","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Um Behandlungskonzepte zu verbessern und neuartige Therapien zu entwickeln, ist Forschung unabdingbar. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"a629a076-ae6b-4d08-980f-af0ff3c76ca7","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Klinische Studien werden direkt am und mit dem Patienten durchgeführt. Diese kann sehr unterschiedlich sein. Beispielsweise, indem die Wirkung oder die Dosierung eines Medikaments getestet wird oder indem unterschiedliche Behandlungsmethoden für eine Indikation miteinander verglichen werden. Ziel der klinischen Forschung ist immer, Krankheiten besser zu verstehen und neue Therapieformen zu entwickeln oder bestehende zu verbessern. Zahlreiche Studien werden aktuell in der St. Clara Forschung AG durchgeführt:","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"6061c448-95d0-461b-8def-33e126368f75","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchdecke/Leiste","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":"Aktuelle Studien","items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"cd427adb-c784-4aa8-9e3b-4bf42e80faaa","properties":{"title":"Perioperative Outcome (Pain, Complications, Duration of Hops) in MIS for ventral hernie repair over 2 years. Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"c7db4eca-862e-4c73-80a3-323e0622ce20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"BASEC 2023-02357","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie werden zwei verschiedene Techniken zur Operation eines Bauchwandbruches (=Hernie) miteinander verglichen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/249587/studie/68943","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2d595df9-22c3-4173-b0e7-532ec8cb8b63","properties":{"title":"Robotic versus conventional minimal-invasive inguinal hernia repair – a prospective, randomized and blinded clinical trial (ROGER-RCT)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"14690720-f017-4921-8789-c89c5262dc2a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-01655","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"In dieser Studie soll untersucht werden, ob eine robotergestützte Leistenhernienreparatur die postoperativen Schmerzen reduzieren und die Genesung im Vergleich zum konventionellen laparoskopischen Ansatz verbessern kann.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"960fef41-ae29-4d76-90e6-aadaad60acc9","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchspeicheldrüse (Pankreas)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"13b037b7-b8ca-4c95-bce3-eb17be9c3106","properties":{"title":"Distal Pancreatectomy – A randomised controlled trial to compare minimal-invasive distal pancreatectomy to open resection (DISPACT-2 Trial)BASEC 2023-00705","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"d5d67ef3-6432-4c58-9718-937e0167d0f3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00705","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Teilentfernung der Bauchspeicheldrüse – Vergleich von Schlüssellochtechnikverfahren und offener Operation.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223849/studie/41792","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"e3257fd4-e10d-48b8-8c2d-a2736de17626","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Brust (Mamma)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"4e77c1bd-d1e6-47c2-8d10-2019a0e82886","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"487ea7fb-26fe-47f3-bbb1-ea4cd5d843a2","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"82d0d5be-fd4b-4ccc-91f1-f3d8c14c8646","properties":{"title":"A prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (EUBREAST 03 (R) AXSANA)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"508db622-8ccb-4749-bab2-f22414e9f9b7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-02830","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Studie an mehreren Kliniken, untersucht verschiedene OP-Methoden, um die Achselhöhlen bei Brustkrebspatientinnen mit befallenen Lymphknoten zu überprüfen. Diese Patientinnen erhalten vor der Operation eine Chemotherapie. Ziel der Studie ist es, die besten chirurgischen Verfahren zu vergleichen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/axsana/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"13125a74-5577-471f-a70c-7d07cb66adf2","properties":{"title":"Methods for Localization of Different types of breast lesions (EUBREAST 04 (R) MELODY)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"48ed91fa-7e6d-42fb-807c-a22d12d019dc","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00646","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"Eine Beobachtungsstudie ohne Eingriff, die an mehreren Standorten durchgeführt wird, um verschiedene bildgebende Verfahren zur genauen Erkennung von bösartigen Brusttumoren zu bewerten.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/melody/"},"elements":[{"text":"Mehr Infomationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"fba61881-b69e-4546-b129-66acf8e965f8","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"112cc61a-9fe4-4528-9742-5e58843926bb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ee5f2596-91ae-4e4b-90d7-e95d68f0d540","properties":{"title":"Intelligent Vacuum assisted biopsy Immediately before Surgery as an Intra- or pre-Operative surrogate for patient response to Neoadjuvant chemotherapy for breast cancer (VISION I) A multicenter prospective feasibility trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e3bf6ee7-83d3-40c1-84a0-3d69bf25e969","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00450","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Studie untersucht, ob eine intelligente, vakuumgestützte Biopsie direkt vor der Operation bei Brustkrebs genutzt werden kann, um schon vor oder während der Operation zu erkennen, wie gut die Patientinnen auf die vorherige Chemotherapie angesprochen haben.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/172850/studie/50248"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"502abcc8-2213-4d51-8495-2479b30b90cc","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Darm","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"b082020c-6fcb-4c92-af44-7af1c0f48a41","properties":{"title":"Cholecalciferol Comedication in patients with Chronic inflammatory bowel diseases (Crohn's disease or ulcerative Colitis) – the 5C-study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"99b902c7-464f-41b3-b98c-4e39d44b091a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00899","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Cholecalciferol-Co-Medikation bei Patient/innen mit chronisch entzündlichen Darmerkrankungen (Morbus Crohn oder Colitis ulcerosa)","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223851/studie/62115","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c14bba1c-04c7-440b-accc-45173f02bcec","properties":{"title":"Ergebnisqualität bei Darmkrebs: Identifikation von Unterschieden und Maßnahmen zur flächendeckenden Qualitätsentwicklung (EDIUM)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"67744ab5-42e6-4389-bea6-d88b4da53380","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-03069","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Vergleich und Messung der gesundheitsbezogenen Lebensqualität von Patientinnen und Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.edium-studie.de/studyInfo"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"0924559e-5ca3-434f-8a48-d0b8d9a20853","properties":{"title":"Snap Shot Audit Early Onset Colorectal Cancer (EOCC) - Are we doing enough or can we do more?","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"00b85655-bd27-4ef1-adc5-3b0c1506026f","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02297","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Snapshot Audit on Early onset Colorectal Cancer - are we doing enough, can we do more?","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223884/studie/64169"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c0ddbcc3-8eb3-47f6-ba49-8534dc70152f","properties":{"title":"Image-based ex-vivo  drug screening and genomics/transcriptomics for patients colorectal cancer stage II, III, IV (IBDS-CRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b5261ea6-4051-4ffc-8d08-4f502e744bf3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01441","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die klinische Bedeutung von Merkmalen der Tumorzellen bei Darmkrebs weiter zu erforschen. Dies geschieht über die Etablierung einer Plattform für die Analyse des genetischen Profils und der Wirkung von Krebsmedikamenten bei Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.ksbl.ch/kliniken/darmkrebszentrum-baselland/studien"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ce14c88f-3b6a-45ab-b413-390ad7d67565","properties":{"title":"Encorafenib and cetuximab in patients with metastatic, BRAFV600E-mutated, colorectal carcinoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland. (BERING CRC: BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3a9bfa33-9127-43d2-9f83-76ac821e3aa7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00647","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird die Wirksamkeit der Kombination bestehend aus Braftovi-Kapseln (Wirkstoff Encorafenib) und Erbitux bzw. einem gleichwertigen Arzneistoff (Biosimilar) (Wirkstoff Cetuximab) bei metastasierten Darmkrebs untersucht. Die in dieser Studie gewonnenen Daten sollen dazu beitragen, Erfahrungen mit diesen zugelassenen Medikamenten unter Routinebedingungen zu sammeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"f89bd827-a273-4246-a9e8-7bd6a6ae6fe1","properties":{"title":"Patient Reported Outcomes and Markers of Inflammation in Anal Cancer – a Longitudinal Observational Study (PROSAIC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b4c19a64-c048-459c-a9a6-5a6508ee9ee7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02161","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Beobachtungsstudie zur Lebensqualität beim neu diagnostizierten Analkarzinom","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2df1ee27-e288-40d6-9cf0-9a1a53aa2ee6","properties":{"title":"Biomarker identification to guide surgical intervention after neo-adjuvant chemoradiotherapy in rectal cancer (BSIRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"92d91535-85d1-4576-8109-d0aad3237b20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01199","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Identifikation von Biomarkern um das Ansprechen auf die Vorbehandlung beim Rektumkarzinom vorherzusagen","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"70895d41-749f-4143-a090-9597b0f1882c","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Eierstöcke","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2373ea90-1912-4bf7-9990-566862480908","properties":{"title":"MAintenance Therapie/ Erhaltungstherapie mit Aromatasehemmer für Patientinnen mit epithelialem Ovarialkarzinom: eine randomisierte doppelblinde Placebo-kontrollierte multizentrische Phase III Studie. (ENGOT-ov54/Swiss-GO-2/MATAO)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ba8d8b45-6fe0-4b78-9f4d-9e0f4b3e41bf","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00148","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Erhaltungstherapie mit einem Aromatase-Inhibitor bei epithelialem Ovarialkarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176034/studie/52935","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"efc2c2ad-b3c6-4f30-8e0f-cae4e441d4ce","properties":{"title":"SAKK_OvCaR: A retrospective and prospective registry of patients with ovarian cancer","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b11d6529-da0d-403d-9cd3-93593ee93bfe","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-01335","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Register Daten und Behandlung Ovarialcarcinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/ein-pro-und-retrospektives-register-von-patientinnen-mit-ovarialkarzinom"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"67cec99e-6f14-4c6d-8bcb-8e2094419ee4","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ernährung/Übergewicht","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"db4b4417-ff27-4d82-aaa5-c43d8c8f7f4f","properties":{"title":"Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM trial)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8560e58a-ef64-47a5-b2b8-71beef5f5e3d","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02392","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"SLIM Studie - Wirkung unterschiedlicher Schenkellängen beim Magenbypass","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176438/studie/52643","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"58fdf882-9191-4df1-9b72-4c9da32b6613","properties":{"title":"Understanding gut-brain interactions and the effect of a lowcarb dietary intervention in obese and depressive patients with and without glucose intolerance or diabetes: a pilot trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"6cbf87c1-ac9a-4786-95de-8a7934d2b6b5","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Bedeutung der Darm-Hirn-Achse und der Effekt einer kohlenhydratarmen Diät bei Übergewicht und Depression","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176258/studie/48748"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"7173dff6-7695-4eba-bf59-f71b0dd97462","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Hoden","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"d8bc2afb-28c1-4975-bf81-e2889b9aa83d","properties":{"title":"Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"19c8f679-740c-4862-97ae-9500f10b1b36","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKOS 13/083, PB_2016-00235","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Prospektive Datenerhebung bei Patienten mit Hodenkrebs","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.sag-tccs.com","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"debb5fb5-44cf-494a-ba78-c326374b15e7","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Lunge","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2ae1ea32-2b5a-423f-abd6-d3a197091d6f","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ff0bb2d7-9965-4af5-a105-228e548e46c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"26239e17-c1a5-4ae9-b94c-632d048c523c","properties":{"title":"SAKK_LuCa_2: Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"caaed598-39ef-444b-b37e-63b3778e0aae","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00398","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es handelt sich um eine Datenbank, in der Informationen über Patienten mit einer bestimmten Art von Lungenkrebs (metastasierter nicht-kleinzelliger Lungenkrebs, NSCLC) gesammelt werden. Ziel ist es, besser zu verstehen, wie sich diese Genveränderungen auf den Krankheitsverlauf und die Behandlungsergebnisse auswirken.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/register-und-studie-zum-egfr-mutierten-nsclc"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"11b78385-b1bd-4b97-a8c2-b63c3052f70c","properties":{"title":"SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) non-small cell lung cancer (NSCLC). A multicenter phase II trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"56fa4d89-2908-4864-9256-01425d662108","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02378,  EKOS 19/185","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der Studie SAKK 16/18 wird untersucht, ob eine zusätzliche präoperative Immuntherapie mit dem anti-PD-L1 Antikörper Durvalumab in Kombination mit Radiotherapie die Prognose lokal fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) verbessern kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176046/studie/49836"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"3a627627-6294-44d7-ba3e-8ef2b6a1b0f8","properties":{"title":"Procalcitonin and Lung UltraSonography based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: a pragmatic stepped-wedge cluster-randomized trial - The PLUS-IS-LESS study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"28dbdba9-d809-4ed7-ad3e-af1cb680b866","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00738","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Neue Instrumente zur Verbesserung der Behandlung von Patienten mit Verdacht auf Pneumonie","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/221174/studie/61941"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"c9a139db-2e90-45cb-be2c-b250ae5824d3","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Blut- und Lymphatisches System","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"943c4c40-c866-4fbf-9133-379d51f9e704","properties":{"title":"Multicentre Observational Study of MDS Patients in Switzerland – Swiss MDS Registry","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8ac1fcd9-2d85-4b0e-a54a-37c47617da11","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE: 339/2014; PB_2016-01917","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Daten- und Probensammlung zur Erkenntnis neuer biologischer Zusammenhänge bei myeloplastisches Syndrom, die auch eine Beschreibung des aktuellen Stands und der zukünftigen Entwicklungen in Diagnostik und Therapie erlauben. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.mds-switzerland.ch/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2a677604-1103-4bf9-a963-419377b23af5","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Magen- und Speiseröhre","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"279eb75b-392b-482b-9cac-f788b921c7f3","properties":{"title":" Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"26f6ecd6-ddb0-4f56-a2f5-4c4bc50bb87b","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"30134c7e-2494-4b1c-a92c-b4ebfd9866f0","properties":{"title":"CARDIA Trail: Surgery for Adenocarcinoma of the Gastroesophageal Junction (GEJ) Type II: Transthoracic Esophagectomy vs. Transhiatal Extended Gastrectomy","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3dc06a31-3fa9-45df-b723-d1fef99d649c","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00126","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der Vergleich von chirurgischen Therapien für das Adenokarzinom des gastroösophagealen Übergangs (GEJ): transthorakale Ösophagektomie versus transhiatal erweiterte Gastrektomie.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223905/studie/47421"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1572715f-6fbf-41b7-bd16-1c8eae96b55c","properties":{"title":"DANTE / FLOT8: A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"4369e292-e0b0-4459-8ff5-d2c4a9ded60e","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01150","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die DANTE/FLOT8- Studie untersucht, ob eine Kombination aus zwei Behandlungen bei Magenkrebs und Adenokarzinom an der Übergangsstelle zwischen Speiseröhre und Magen besser wirkt als eine der Behandlungen allein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/229432/studie/44090"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"082a400a-8a89-461e-9e22-abfd406c000f","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Niere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"7d27f24a-e2fc-4fa0-b976-6819ad724083","properties":{"title":"Metastatic Renal Cell Cancer: A Multicenter Prognostic and Predictive Factors Project in the Era of Modern Therapy (The International mRCC Database Consortium (IMDC))","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"a965ad71-3c5a-44b3-81e2-78d370372c33","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2018-01473","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Ein Projekt, das an mehreren Zentren durchgeführt wird, untersucht Faktoren, die den Krankheitsverlauf vorhersagen und den Behandlungserfolg in der modernen Therapie beeinflussen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.imdconline.com/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2e597fbc-b665-43c4-960d-5a4d9d6cea58","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Prostata","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"26b23bd5-fc02-4178-928c-8a0a831ec416","properties":{"title":"Blutentnahme zur Analyse zellfreier DNA bei Patienten mit fortgeschrittenen Krebsleiden (BEDNA-Studie)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"fcefe79b-f71c-4477-8124-f93b4a3c86c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKNZ 2014-329","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Analyse von im Blut frei zirkulierender Erbsubstanzen von Krebszellen bei Patienten mit fortgeschrittenem Krebsleiden. Die Etablierung dieser Technik könnte in Zukunft die Therapie und Überwachung von fortgeschrittenen Krebserkrankungen ermöglichen.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"b530f6c1-0a48-4984-b3df-2a30459a118b","properties":{"title":"Entwicklung von ex vivo Modellen des Prostatakarzinoms","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e880e044-0ee9-4eb5-834b-bb33aa5c8026","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKBB 37/13, PB_2018-00312","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Identifizierung spezifischer Mutationen könnte das grundlegende Verständnis der Entwicklung des Prostatakarzinoms, insbesondere des kastrationsresistenten Prostatakarzinoms verbessern und dazu beitragen, neue Marker und Strategien für dessen Behandlung zu entwickeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"aa52b80a-7f6c-4431-8e20-68c4ce5a64e4","properties":{"title":"Prostate Cancer Outcome - Compare and Reduce Variation in DKG-Prostatakrebszentren (PCO-CRV)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"270447e4-e676-4cfd-a593-6553c1da0db0","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2016-01172","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Internationaler Vergleich von Behandlung und Ergebnisqualität bei lokal begrenzten Prostatakarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.pco-study.com/findings"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"519b835c-1f29-4b7f-9727-9781af1b21c6","properties":{"title":"An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer (ProBio)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"df50fa44-8995-40fc-8e8d-958506d8d258","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-02495","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es geht darum, ob man durch das Untersuchen von Tumor-DNA bei Prostatakrebspatienten frühzeitig erkennen kann, welche Therapie besonders gut wirken wird. Damit könnten die Ärztinnen und Ärzte individuellere, wirksamere Behandlungen anbieten, die für die jeweilige Krebsart des Patienten besser passen als die üblichen Standardbehandlungen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/247767/studie/61659"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"bf3d75d5-bdd8-4f67-8920-fd2127639e61","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"abeff69c-6bd8-43bc-a918-356e8a8fb7c4","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"5775e216-94d1-410a-a8f1-fb11a9ec171a","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Andere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"c0ab1fe6-5224-4618-bfad-2de2dcbd45ea","properties":{"title":"Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"037e5793-4af4-4125-87cc-a3dfd59f4ddb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1498c7a2-37ed-4dc5-b949-53993d18ba4f","properties":{"title":"Informationssammlung zur effektiven Erforschung neuroendokrine Tumoren (SwissNET)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"471f352b-b77e-4b55-927b-2335b0617de1","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE 395/2014","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es werden Daten von Patienten/Innen mit NET aus der ganzen Schweiz erfasst. Basierend auf diesen Daten können Häufigkeit und Verlauf dieser seltenen Tumore in der Schweiz besser dokumentiert werden. Interessierte Spezialisten aus den verschiedenen Spezialgebieten sind in dem Trägerverein dieses Registers vereinigt, was zusätzlich zu einem regen Wissensaustausch führt.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.swissnet.net/de/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentHighlight","id":"6f1711e8-6711-4975-9ae6-7e0e6a43277e","properties":{"jumpNavigationTitle":"Probanden ge­su­cht","title":"Stu­di­en­teil­neh­mer/in­nen ge­su­cht für Low Carb Stu­die","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Mit dieser Studie wollen wir den Effekt einer «Low Carb»-Ernährung genauer untersuchen: Mittels einer App werden Sie geschult, stellen Ihre Ernährung langsam auf eine «Low Carb»-Ernährung um und halten diese mindestens 6 Monate ein. Während dieser Zeit werden verschiedene Untersuchungen vorgenommen wie: Blutuntersuchungen, Bestimmung der Körperzusammensetzung (Muskel-, Fettanteil), Messung des Leberfettanteils, Untersuchung des Gehirns, Untersuchung der Darmbakterien, Fragebögen zum Befinden.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"zur Low Carb Studie","target":"_blank","destinationId":"fadeffb7-929c-4df1-b934-0ea6f0f06655","destinationType":"claraforschungGeneric","route":{"path":"/de/aktuelle-studien/studienteilnehmerinnen-gesucht","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"01270bd3-fa72-451f-88a3-7d735d3d093a","name":"Medizinisches Angebot Onkologie Claraspital Teaser 2","mediaType":"Image","url":"/media/0ufdoals/medizinisches-angebot_onkologie_claraspital_teaser_2.jpg","extension":"jpg","width":960,"height":1200,"bytes":867878,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"0bdeac0c-3fbf-47fa-af19-62cdc7ec5376","properties":{"title":"Aktuelle Studien","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"3bd5e2ca-67e6-4ee8-b03f-16664dc2ed54","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"e34ba912-2111-4af3-8cec-6ae7f37a6105","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"65d3e01b-9422-4ce4-9f0e-31720b556d2c","properties":{"jumpNavigationTitle":null,"title":"Netzwerke metabole und gastroenterologische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. Unsere Forschungsprojekte werden durch öffentliche Geldgeber (Schweizerischen Nationalfonds (SNF)) und private Stiftungen (z.B. Botnar Foundation, Uniscientia) unterstützt. Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"b66dd421-8fd4-4e1c-8260-5b21ba287e45","properties":{"jumpNavigationTitle":null,"title":" Clarunis Netzwerk – Viszeralchirurgische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Das Netzwerk geht weit mehr als 50 Jahre auf das Departement Chirurgie der Universität Basel unter Professor Dr. med. Martin Allgöwer, Ordinarius für Chirurgie, zurück. Im Netzwerk sind Kliniken integriert, die einen engen Bezug zur Basler Chirurgenschule hatten und haben. Bei Neubesetzungen von Chefarztstellen mit Basler Schülern (z.B. Chur, Lugano, St. Claraspital etc.) hat sich ein erster Mitarbeitenden (MA)-Austausch in die Peripherie, aber auch umgekehrt ans Universitätszentrum eingestellt. Allgöwers Nachfolger, Prof. Dr. med. Felix Harder hat diese Interaktion mit den Kliniken weiter ausgebaut und intensiviert und hat neu die Videokonferenz (VC) als Fort- und Weiterbildungs-Plattform («Schlaue Stunde») etabliert.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Basierend auf diesen gut fundierten und institutionalisierten Pfeilern (VC und MA-Austausch) mit den affiliierten Kern-Kliniken ist mit Clarunis 2019 unter Prof. Dr. med. Markus von Flüe das Bewusstsein gewachsen, dass ein weiteres, gemeinsames Feld bearbeitet werden könnte, nämlich, dass dieser Verbund ein ausserordentlich grosses Potenzial für klinische Forschung birgt, das als weiteren Grundpfeiler des Netzwerkes in der erweiterten Nordwest-Schweiz bearbeitet und genutzt werden sollte.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine erste Netzwerk-Studie (EvaCol) wurde lanciert und unter der Leitung von PD Dr. med. Marco von Strauss durchgeführt und mit über 1100 eingeschlossenen Patienten der kolorektalen Chirurgie abgeschlossen. Unter dem neuen Ordinarius von Clarunis Prof. Dr. med. Beat Müller erfährt dieses Kern-Netzwerk eine noch grössere Dimension (graphische Darstellung des Clarunis Netzwerks) und gewinnt an Bedeutung für Clarunis und damit für die St. Clara Forschung. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"Clarunis Netzwerk","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Clarunis, Prof. Dr. med. Beat Müller","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Luzerner Kantonspital (LUKS), Prof. Dr. med. Martin Bolli","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Biel (SZB), Prof. Dr. med. Carsten Th. Viehl","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonsspital Aarau (KSA), Prof. Dr. med. Mark Hartel","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Lindenhofspital, Prof. Dr. med. Mathias Worni","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Oberwallis (SZO), Dr. med. Thomas Simon","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    St. Anna Klinik Luzern, Prof. Dr. med. Markus von Flüe","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Olten, Prof. Dr. med. Uli Dietz","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spital Limmattal Schlieren, Prof. Dr. med. Urs Zingg","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Basel-Land (KSBL) Liestal, Prof. Dr. med. Robert Rosenberg","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentImage","id":"e78a3514-102d-4b82-a4df-2d7e935b099c","properties":{"jumpNavigationTitle":null,"image":[{"focalPoint":null,"crops":[],"id":"53bec52d-9d74-48b2-8649-d8ee045b1440","name":"Claraforschung Netzwerk Contentimage","mediaType":"Image","url":"/media/fpcl2u1u/claraforschung_netzwerk_contentimage.jpg","extension":"jpg","width":1920,"height":1080,"bytes":399695,"properties":{}}],"altText":null,"caption":null,"fullWidth":false}},"settings":null},{"content":{"contentType":"componentTeasers","id":"2954661e-279b-4363-99d0-3636da9e854d","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"23208443-572d-4e5a-a7c4-c5ac90465831","name":"Medizinisches Angebot Forschung Claraspital Teaser","mediaType":"Image","url":"/media/iwccaizn/medizinisches-angebot_forschung_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":304241,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"efb5b3ca-05c1-4c37-829c-f18d80376e2f","properties":{"title":"Wissenschaftliche Netzwerke","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"fc110ac2-6df1-424b-b003-4b6f3c4bf6fb","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Kontakt","title":"St. Clara Forschung AG","lead":null,"contactPhone":"+41 61 685 85 85","eMailAdress":"forschung@claraspital.ch","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"d2d37e0c-9af7-4748-a5c3-6e1a6fd12f79","name":"Medizinisches Angebot Bariatrie Claraspital Teaser","mediaType":"Image","url":"/media/bj5nhuxx/medizinisches-angebot_bariatrie_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":556718,"properties":{}}],"teaserTitle":"Metabole und gastroenterologische Forschung","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"6755e1e2-2911-4006-8695-c4fbfd8ea988","properties":{"title":"Metabole und gastroenterologische Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung"}},{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"02b93292-12fd-4b10-9469-eaae67457117","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Um Behandlungskonzepte zu verbessern und neuartige Therapien zu entwickeln, ist Forschung unabdingbar. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"a629a076-ae6b-4d08-980f-af0ff3c76ca7","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Klinische Studien werden direkt am und mit dem Patienten durchgeführt. Diese kann sehr unterschiedlich sein. Beispielsweise, indem die Wirkung oder die Dosierung eines Medikaments getestet wird oder indem unterschiedliche Behandlungsmethoden für eine Indikation miteinander verglichen werden. Ziel der klinischen Forschung ist immer, Krankheiten besser zu verstehen und neue Therapieformen zu entwickeln oder bestehende zu verbessern. Zahlreiche Studien werden aktuell in der St. Clara Forschung AG durchgeführt:","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"6061c448-95d0-461b-8def-33e126368f75","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchdecke/Leiste","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":"Aktuelle Studien","items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"cd427adb-c784-4aa8-9e3b-4bf42e80faaa","properties":{"title":"Perioperative Outcome (Pain, Complications, Duration of Hops) in MIS for ventral hernie repair over 2 years. Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"c7db4eca-862e-4c73-80a3-323e0622ce20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Extraperitoneal plasty vs. intraperitoneal onlay mesh in ventral hernia repair - the randomized controlled ALPINE trial","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"BASEC 2023-02357","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie werden zwei verschiedene Techniken zur Operation eines Bauchwandbruches (=Hernie) miteinander verglichen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/249587/studie/68943","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2d595df9-22c3-4173-b0e7-532ec8cb8b63","properties":{"title":"Robotic versus conventional minimal-invasive inguinal hernia repair – a prospective, randomized and blinded clinical trial (ROGER-RCT)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"14690720-f017-4921-8789-c89c5262dc2a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-01655","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"In dieser Studie soll untersucht werden, ob eine robotergestützte Leistenhernienreparatur die postoperativen Schmerzen reduzieren und die Genesung im Vergleich zum konventionellen laparoskopischen Ansatz verbessern kann.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"960fef41-ae29-4d76-90e6-aadaad60acc9","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Bauchspeicheldrüse (Pankreas)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"13b037b7-b8ca-4c95-bce3-eb17be9c3106","properties":{"title":"Distal Pancreatectomy – A randomised controlled trial to compare minimal-invasive distal pancreatectomy to open resection (DISPACT-2 Trial)BASEC 2023-00705","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"d5d67ef3-6432-4c58-9718-937e0167d0f3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00705","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Teilentfernung der Bauchspeicheldrüse – Vergleich von Schlüssellochtechnikverfahren und offener Operation.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223849/studie/41792","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"e3257fd4-e10d-48b8-8c2d-a2736de17626","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Brust (Mamma)","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"4e77c1bd-d1e6-47c2-8d10-2019a0e82886","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"487ea7fb-26fe-47f3-bbb1-ea4cd5d843a2","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"82d0d5be-fd4b-4ccc-91f1-f3d8c14c8646","properties":{"title":"A prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (EUBREAST 03 (R) AXSANA)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"508db622-8ccb-4749-bab2-f22414e9f9b7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-02830","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Studie an mehreren Kliniken, untersucht verschiedene OP-Methoden, um die Achselhöhlen bei Brustkrebspatientinnen mit befallenen Lymphknoten zu überprüfen. Diese Patientinnen erhalten vor der Operation eine Chemotherapie. Ziel der Studie ist es, die besten chirurgischen Verfahren zu vergleichen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/axsana/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"13125a74-5577-471f-a70c-7d07cb66adf2","properties":{"title":"Methods for Localization of Different types of breast lesions (EUBREAST 04 (R) MELODY)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"48ed91fa-7e6d-42fb-807c-a22d12d019dc","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00646","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"tag":"br","attributes":{},"elements":[]},{"text":"Eine Beobachtungsstudie ohne Eingriff, die an mehreren Standorten durchgeführt wird, um verschiedene bildgebende Verfahren zur genauen Erkennung von bösartigen Brusttumoren zu bewerten.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.eubreast.org/melody/"},"elements":[{"text":"Mehr Infomationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"fba61881-b69e-4546-b129-66acf8e965f8","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"112cc61a-9fe4-4528-9742-5e58843926bb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ee5f2596-91ae-4e4b-90d7-e95d68f0d540","properties":{"title":"Intelligent Vacuum assisted biopsy Immediately before Surgery as an Intra- or pre-Operative surrogate for patient response to Neoadjuvant chemotherapy for breast cancer (VISION I) A multicenter prospective feasibility trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e3bf6ee7-83d3-40c1-84a0-3d69bf25e969","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00450","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Studie untersucht, ob eine intelligente, vakuumgestützte Biopsie direkt vor der Operation bei Brustkrebs genutzt werden kann, um schon vor oder während der Operation zu erkennen, wie gut die Patientinnen auf die vorherige Chemotherapie angesprochen haben.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/172850/studie/50248"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"502abcc8-2213-4d51-8495-2479b30b90cc","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Darm","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"b082020c-6fcb-4c92-af44-7af1c0f48a41","properties":{"title":"Cholecalciferol Comedication in patients with Chronic inflammatory bowel diseases (Crohn's disease or ulcerative Colitis) – the 5C-study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"99b902c7-464f-41b3-b98c-4e39d44b091a","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00899","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Cholecalciferol-Co-Medikation bei Patient/innen mit chronisch entzündlichen Darmerkrankungen (Morbus Crohn oder Colitis ulcerosa)","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223851/studie/62115","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c14bba1c-04c7-440b-accc-45173f02bcec","properties":{"title":"Ergebnisqualität bei Darmkrebs: Identifikation von Unterschieden und Maßnahmen zur flächendeckenden Qualitätsentwicklung (EDIUM)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"67744ab5-42e6-4389-bea6-d88b4da53380","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-03069","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Vergleich und Messung der gesundheitsbezogenen Lebensqualität von Patientinnen und Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.edium-studie.de/studyInfo"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"0924559e-5ca3-434f-8a48-d0b8d9a20853","properties":{"title":"Snap Shot Audit Early Onset Colorectal Cancer (EOCC) - Are we doing enough or can we do more?","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"00b85655-bd27-4ef1-adc5-3b0c1506026f","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02297","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Snapshot Audit on Early onset Colorectal Cancer - are we doing enough, can we do more?","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223884/studie/64169"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"c0ddbcc3-8eb3-47f6-ba49-8534dc70152f","properties":{"title":"Image-based ex-vivo  drug screening and genomics/transcriptomics for patients colorectal cancer stage II, III, IV (IBDS-CRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b5261ea6-4051-4ffc-8d08-4f502e744bf3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01441","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die klinische Bedeutung von Merkmalen der Tumorzellen bei Darmkrebs weiter zu erforschen. Dies geschieht über die Etablierung einer Plattform für die Analyse des genetischen Profils und der Wirkung von Krebsmedikamenten bei Patienten mit Darmkrebs.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.ksbl.ch/kliniken/darmkrebszentrum-baselland/studien"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"ce14c88f-3b6a-45ab-b413-390ad7d67565","properties":{"title":"Encorafenib and cetuximab in patients with metastatic, BRAFV600E-mutated, colorectal carcinoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland. (BERING CRC: BRAF inhibitor Encorafenib and Cetuximab Real life Investigation of Next Generation CRC treatment)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3a9bfa33-9127-43d2-9f83-76ac821e3aa7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00647","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird die Wirksamkeit der Kombination bestehend aus Braftovi-Kapseln (Wirkstoff Encorafenib) und Erbitux bzw. einem gleichwertigen Arzneistoff (Biosimilar) (Wirkstoff Cetuximab) bei metastasierten Darmkrebs untersucht. Die in dieser Studie gewonnenen Daten sollen dazu beitragen, Erfahrungen mit diesen zugelassenen Medikamenten unter Routinebedingungen zu sammeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"f89bd827-a273-4246-a9e8-7bd6a6ae6fe1","properties":{"title":"Patient Reported Outcomes and Markers of Inflammation in Anal Cancer – a Longitudinal Observational Study (PROSAIC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b4c19a64-c048-459c-a9a6-5a6508ee9ee7","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-02161","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine Beobachtungsstudie zur Lebensqualität beim neu diagnostizierten Analkarzinom","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"2df1ee27-e288-40d6-9cf0-9a1a53aa2ee6","properties":{"title":"Biomarker identification to guide surgical intervention after neo-adjuvant chemoradiotherapy in rectal cancer (BSIRC)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"92d91535-85d1-4576-8109-d0aad3237b20","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01199","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Identifikation von Biomarkern um das Ansprechen auf die Vorbehandlung beim Rektumkarzinom vorherzusagen","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"70895d41-749f-4143-a090-9597b0f1882c","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Eierstöcke","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2373ea90-1912-4bf7-9990-566862480908","properties":{"title":"MAintenance Therapie/ Erhaltungstherapie mit Aromatasehemmer für Patientinnen mit epithelialem Ovarialkarzinom: eine randomisierte doppelblinde Placebo-kontrollierte multizentrische Phase III Studie. (ENGOT-ov54/Swiss-GO-2/MATAO)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ba8d8b45-6fe0-4b78-9f4d-9e0f4b3e41bf","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2020-00148","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Erhaltungstherapie mit einem Aromatase-Inhibitor bei epithelialem Ovarialkarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176034/studie/52935","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"efc2c2ad-b3c6-4f30-8e0f-cae4e441d4ce","properties":{"title":"SAKK_OvCaR: A retrospective and prospective registry of patients with ovarian cancer","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"b11d6529-da0d-403d-9cd3-93593ee93bfe","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-01335","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Register Daten und Behandlung Ovarialcarcinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/ein-pro-und-retrospektives-register-von-patientinnen-mit-ovarialkarzinom"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"67cec99e-6f14-4c6d-8bcb-8e2094419ee4","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ernährung/Übergewicht","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"db4b4417-ff27-4d82-aaa5-c43d8c8f7f4f","properties":{"title":"Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM trial)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8560e58a-ef64-47a5-b2b8-71beef5f5e3d","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02392","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"SLIM Studie - Wirkung unterschiedlicher Schenkellängen beim Magenbypass","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176438/studie/52643","target":"_blank"},"elements":[{"text":"KOFAM Link","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"58fdf882-9191-4df1-9b72-4c9da32b6613","properties":{"title":"Understanding gut-brain interactions and the effect of a lowcarb dietary intervention in obese and depressive patients with and without glucose intolerance or diabetes: a pilot trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"6cbf87c1-ac9a-4786-95de-8a7934d2b6b5","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Bedeutung der Darm-Hirn-Achse und der Effekt einer kohlenhydratarmen Diät bei Übergewicht und Depression","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176258/studie/48748"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"7173dff6-7695-4eba-bf59-f71b0dd97462","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Hoden","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"d8bc2afb-28c1-4975-bf81-e2889b9aa83d","properties":{"title":"Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"19c8f679-740c-4862-97ae-9500f10b1b36","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKOS 13/083, PB_2016-00235","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Prospektive Datenerhebung bei Patienten mit Hodenkrebs","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.sag-tccs.com","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"debb5fb5-44cf-494a-ba78-c326374b15e7","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Lunge","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"2ae1ea32-2b5a-423f-abd6-d3a197091d6f","properties":{"title":"Prospective Clinical Evaluation of 4D Lifetests™ Parameters to Develop a Universal Early Cancer Diagnosis Test","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"ff0bb2d7-9965-4af5-a105-228e548e46c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01493","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In dieser Studie wird untersucht, ob bestimmte biologische Marker oder Parameter, die der 4D Lifetest™ misst, dazu verwendet werden können, Krebs frühzeitig zu erkennen, bevor Symptome auftreten. Ziel ist es, einen zuverlässigen und breiten Test zu schaffen, der für verschiedene Krebsarten angewendet werden kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://4dlifetec.com/cancer-detect-test/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"26239e17-c1a5-4ae9-b94c-632d048c523c","properties":{"title":"SAKK_LuCa_2: Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"caaed598-39ef-444b-b37e-63b3778e0aae","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00398","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es handelt sich um eine Datenbank, in der Informationen über Patienten mit einer bestimmten Art von Lungenkrebs (metastasierter nicht-kleinzelliger Lungenkrebs, NSCLC) gesammelt werden. Ziel ist es, besser zu verstehen, wie sich diese Genveränderungen auf den Krankheitsverlauf und die Behandlungsergebnisse auswirken.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.sakk.ch/de/studie/register-und-studie-zum-egfr-mutierten-nsclc"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"11b78385-b1bd-4b97-a8c2-b63c3052f70c","properties":{"title":"SAKK 16/18: Immune-modulatory radiotherapy to enhance the effects of neoadjuvant PD-L1 blockade after neoadjuvant chemotherapy in patients with resectable stage III(N2) non-small cell lung cancer (NSCLC). A multicenter phase II trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"56fa4d89-2908-4864-9256-01425d662108","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02378,  EKOS 19/185","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der Studie SAKK 16/18 wird untersucht, ob eine zusätzliche präoperative Immuntherapie mit dem anti-PD-L1 Antikörper Durvalumab in Kombination mit Radiotherapie die Prognose lokal fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) verbessern kann.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176046/studie/49836"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"3a627627-6294-44d7-ba3e-8ef2b6a1b0f8","properties":{"title":"Procalcitonin and Lung UltraSonography based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: a pragmatic stepped-wedge cluster-randomized trial - The PLUS-IS-LESS study","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"28dbdba9-d809-4ed7-ad3e-af1cb680b866","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2022-00738","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Neue Instrumente zur Verbesserung der Behandlung von Patienten mit Verdacht auf Pneumonie","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/221174/studie/61941"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"c9a139db-2e90-45cb-be2c-b250ae5824d3","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Blut- und Lymphatisches System","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"943c4c40-c866-4fbf-9133-379d51f9e704","properties":{"title":"Multicentre Observational Study of MDS Patients in Switzerland – Swiss MDS Registry","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"8ac1fcd9-2d85-4b0e-a54a-37c47617da11","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE: 339/2014; PB_2016-01917","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Daten- und Probensammlung zur Erkenntnis neuer biologischer Zusammenhänge bei myeloplastisches Syndrom, die auch eine Beschreibung des aktuellen Stands und der zukünftigen Entwicklungen in Diagnostik und Therapie erlauben. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.mds-switzerland.ch/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2a677604-1103-4bf9-a963-419377b23af5","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Magen- und Speiseröhre","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"279eb75b-392b-482b-9cac-f788b921c7f3","properties":{"title":" Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"26f6ecd6-ddb0-4f56-a2f5-4c4bc50bb87b","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"30134c7e-2494-4b1c-a92c-b4ebfd9866f0","properties":{"title":"CARDIA Trail: Surgery for Adenocarcinoma of the Gastroesophageal Junction (GEJ) Type II: Transthoracic Esophagectomy vs. Transhiatal Extended Gastrectomy","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"3dc06a31-3fa9-45df-b723-d1fef99d649c","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2023-00126","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der Vergleich von chirurgischen Therapien für das Adenokarzinom des gastroösophagealen Übergangs (GEJ): transthorakale Ösophagektomie versus transhiatal erweiterte Gastrektomie.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/223905/studie/47421"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1572715f-6fbf-41b7-bd16-1c8eae96b55c","properties":{"title":"DANTE / FLOT8: A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial.","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"4369e292-e0b0-4459-8ff5-d2c4a9ded60e","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-01150","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die DANTE/FLOT8- Studie untersucht, ob eine Kombination aus zwei Behandlungen bei Magenkrebs und Adenokarzinom an der Übergangsstelle zwischen Speiseröhre und Magen besser wirkt als eine der Behandlungen allein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/229432/studie/44090"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"082a400a-8a89-461e-9e22-abfd406c000f","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Niere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"7d27f24a-e2fc-4fa0-b976-6819ad724083","properties":{"title":"Metastatic Renal Cell Cancer: A Multicenter Prognostic and Predictive Factors Project in the Era of Modern Therapy (The International mRCC Database Consortium (IMDC))","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"a965ad71-3c5a-44b3-81e2-78d370372c33","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2018-01473","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Ein Projekt, das an mehreren Zentren durchgeführt wird, untersucht Faktoren, die den Krankheitsverlauf vorhersagen und den Behandlungserfolg in der modernen Therapie beeinflussen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"rel":"noopener","href":"https://www.imdconline.com/","target":"_blank"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"2e597fbc-b665-43c4-960d-5a4d9d6cea58","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Prostata","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"26b23bd5-fc02-4178-928c-8a0a831ec416","properties":{"title":"Blutentnahme zur Analyse zellfreier DNA bei Patienten mit fortgeschrittenen Krebsleiden (BEDNA-Studie)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"fcefe79b-f71c-4477-8124-f93b4a3c86c3","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKNZ 2014-329","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Analyse von im Blut frei zirkulierender Erbsubstanzen von Krebszellen bei Patienten mit fortgeschrittenem Krebsleiden. Die Etablierung dieser Technik könnte in Zukunft die Therapie und Überwachung von fortgeschrittenen Krebserkrankungen ermöglichen.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"b530f6c1-0a48-4984-b3df-2a30459a118b","properties":{"title":"Entwicklung von ex vivo Modellen des Prostatakarzinoms","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"e880e044-0ee9-4eb5-834b-bb33aa5c8026","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"EKBB 37/13, PB_2018-00312","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Identifizierung spezifischer Mutationen könnte das grundlegende Verständnis der Entwicklung des Prostatakarzinoms, insbesondere des kastrationsresistenten Prostatakarzinoms verbessern und dazu beitragen, neue Marker und Strategien für dessen Behandlung zu entwickeln.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"aa52b80a-7f6c-4431-8e20-68c4ce5a64e4","properties":{"title":"Prostate Cancer Outcome - Compare and Reduce Variation in DKG-Prostatakrebszentren (PCO-CRV)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"270447e4-e676-4cfd-a593-6553c1da0db0","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2016-01172","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Internationaler Vergleich von Behandlung und Ergebnisqualität bei lokal begrenzten Prostatakarzinom","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.pco-study.com/findings"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"519b835c-1f29-4b7f-9727-9781af1b21c6","properties":{"title":"An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer (ProBio)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"df50fa44-8995-40fc-8e8d-958506d8d258","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2021-02495","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es geht darum, ob man durch das Untersuchen von Tumor-DNA bei Prostatakrebspatienten frühzeitig erkennen kann, welche Therapie besonders gut wirken wird. Damit könnten die Ärztinnen und Ärzte individuellere, wirksamere Behandlungen anbieten, die für die jeweilige Krebsart des Patienten besser passen als die üblichen Standardbehandlungen.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/247767/studie/61659"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"bf3d75d5-bdd8-4f67-8920-fd2127639e61","properties":{"title":"Protocol SAKK 96/12 Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"abeff69c-6bd8-43bc-a918-356e8a8fb7c4","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-ZH-Nr. 2014-0109","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Skelettmetastasen bei Brust-und Prostata-Cancer. Verhinderung von symptomatischen Komplikationen am Skelett mit Denosumab verabreicht alle 4 Wochen gegenüber alle 12 Wochen","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.kofam.ch/de/studienportal/nach-klinischen-versuchen-suchen/176047/studie/82"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentCollapsible","id":"5775e216-94d1-410a-a8f1-fb11a9ec171a","properties":{"title":"Aktuelle Studien","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Andere","tag":"#text"}]}],"blocks":[]},"jumpNavigationTitle":null,"items":{"items":[{"content":{"contentType":"elementCollapsibleItem","id":"c0ab1fe6-5224-4618-bfad-2de2dcbd45ea","properties":{"title":"Personalized analysis of intestinal cancer ex-vivo and in-vivo","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"037e5793-4af4-4125-87cc-a3dfd59f4ddb","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"BASEC 2019-02118","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Molekulare Untersuchungen von Bauchtumoren mit in-vivo und in-vitro Testmethoden.","tag":"#text"}]}],"blocks":[]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"elementCollapsibleItem","id":"1498c7a2-37ed-4dc5-b949-53993d18ba4f","properties":{"title":"Informationssammlung zur effektiven Erforschung neuroendokrine Tumoren (SwissNET)","items":{"items":[{"content":{"contentType":"elementCollapsibleRichtext","id":"471f352b-b77e-4b55-927b-2335b0617de1","properties":{"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"KEK-BE 395/2014","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Es werden Daten von Patienten/Innen mit NET aus der ganzen Schweiz erfasst. Basierend auf diesen Daten können Häufigkeit und Verlauf dieser seltenen Tumore in der Schweiz besser dokumentiert werden. Interessierte Spezialisten aus den verschiedenen Spezialgebieten sind in dem Trägerverein dieses Registers vereinigt, was zusätzlich zu einem regen Wissensaustausch führt.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"a","attributes":{"href":"https://www.swissnet.net/de/"},"elements":[{"text":"Mehr Informationen","tag":"#text"}]}]}],"blocks":[]}}},"settings":null}]}}},"settings":null}]}}},"settings":null},{"content":{"contentType":"componentHighlight","id":"6f1711e8-6711-4975-9ae6-7e0e6a43277e","properties":{"jumpNavigationTitle":"Probanden ge­su­cht","title":"Stu­di­en­teil­neh­mer/in­nen ge­su­cht für Low Carb Stu­die","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Mit dieser Studie wollen wir den Effekt einer «Low Carb»-Ernährung genauer untersuchen: Mittels einer App werden Sie geschult, stellen Ihre Ernährung langsam auf eine «Low Carb»-Ernährung um und halten diese mindestens 6 Monate ein. Während dieser Zeit werden verschiedene Untersuchungen vorgenommen wie: Blutuntersuchungen, Bestimmung der Körperzusammensetzung (Muskel-, Fettanteil), Messung des Leberfettanteils, Untersuchung des Gehirns, Untersuchung der Darmbakterien, Fragebögen zum Befinden.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"zur Low Carb Studie","target":"_blank","destinationId":"fadeffb7-929c-4df1-b934-0ea6f0f06655","destinationType":"claraforschungGeneric","route":{"path":"/de/aktuelle-studien/studienteilnehmerinnen-gesucht","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"01270bd3-fa72-451f-88a3-7d735d3d093a","name":"Medizinisches Angebot Onkologie Claraspital Teaser 2","mediaType":"Image","url":"/media/0ufdoals/medizinisches-angebot_onkologie_claraspital_teaser_2.jpg","extension":"jpg","width":960,"height":1200,"bytes":867878,"properties":{}}],"teaserTitle":"Aktuelle Studien","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"0bdeac0c-3fbf-47fa-af19-62cdc7ec5376","properties":{"title":"Aktuelle Studien","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/aktuelle-studien"}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"3bd5e2ca-67e6-4ee8-b03f-16664dc2ed54","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"e34ba912-2111-4af3-8cec-6ae7f37a6105","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"65d3e01b-9422-4ce4-9f0e-31720b556d2c","properties":{"jumpNavigationTitle":null,"title":"Netzwerke metabole und gastroenterologische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ein umfangreiches nationales und internationales Forschungsnetzwerk sowie ein breites klinisches Netzwerk erlaubt es uns in multizentrischen Studien und mit modernsten Untersuchungs- sowie Analysetechniken unseren Zielen nachzugehen. Unsere Forschungsprojekte werden durch öffentliche Geldgeber (Schweizerischen Nationalfonds (SNF)) und private Stiftungen (z.B. Botnar Foundation, Uniscientia) unterstützt. Die Weitergabe von Wissen und die Betreuung von jungen Wissenschaftler/innen ist uns besonders wichtig. Zahlreiche Studierende (Masterstudierende, Doktorierende, PhDs und Postdocs) der Universität Basel, ETH Zürich, Universität Hohenheim und Technischen Universität München sind daher an unseren Forschungsprojekten beteiligt. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"b66dd421-8fd4-4e1c-8260-5b21ba287e45","properties":{"jumpNavigationTitle":null,"title":" Clarunis Netzwerk – Viszeralchirurgische Forschungsgruppe","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Das Netzwerk geht weit mehr als 50 Jahre auf das Departement Chirurgie der Universität Basel unter Professor Dr. med. Martin Allgöwer, Ordinarius für Chirurgie, zurück. Im Netzwerk sind Kliniken integriert, die einen engen Bezug zur Basler Chirurgenschule hatten und haben. Bei Neubesetzungen von Chefarztstellen mit Basler Schülern (z.B. Chur, Lugano, St. Claraspital etc.) hat sich ein erster Mitarbeitenden (MA)-Austausch in die Peripherie, aber auch umgekehrt ans Universitätszentrum eingestellt. Allgöwers Nachfolger, Prof. Dr. med. Felix Harder hat diese Interaktion mit den Kliniken weiter ausgebaut und intensiviert und hat neu die Videokonferenz (VC) als Fort- und Weiterbildungs-Plattform («Schlaue Stunde») etabliert.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Basierend auf diesen gut fundierten und institutionalisierten Pfeilern (VC und MA-Austausch) mit den affiliierten Kern-Kliniken ist mit Clarunis 2019 unter Prof. Dr. med. Markus von Flüe das Bewusstsein gewachsen, dass ein weiteres, gemeinsames Feld bearbeitet werden könnte, nämlich, dass dieser Verbund ein ausserordentlich grosses Potenzial für klinische Forschung birgt, das als weiteren Grundpfeiler des Netzwerkes in der erweiterten Nordwest-Schweiz bearbeitet und genutzt werden sollte.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eine erste Netzwerk-Studie (EvaCol) wurde lanciert und unter der Leitung von PD Dr. med. Marco von Strauss durchgeführt und mit über 1100 eingeschlossenen Patienten der kolorektalen Chirurgie abgeschlossen. Unter dem neuen Ordinarius von Clarunis Prof. Dr. med. Beat Müller erfährt dieses Kern-Netzwerk eine noch grössere Dimension (graphische Darstellung des Clarunis Netzwerks) und gewinnt an Bedeutung für Clarunis und damit für die St. Clara Forschung. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"tag":"br","attributes":{},"elements":[]},{"text":"Clarunis Netzwerk","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Clarunis, Prof. Dr. med. Beat Müller","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Luzerner Kantonspital (LUKS), Prof. Dr. med. Martin Bolli","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Biel (SZB), Prof. Dr. med. Carsten Th. Viehl","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonsspital Aarau (KSA), Prof. Dr. med. Mark Hartel","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Lindenhofspital, Prof. Dr. med. Mathias Worni","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spitalzentrum Oberwallis (SZO), Dr. med. Thomas Simon","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    St. Anna Klinik Luzern, Prof. Dr. med. Markus von Flüe","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Olten, Prof. Dr. med. Uli Dietz","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Spital Limmattal Schlieren, Prof. Dr. med. Urs Zingg","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"-    Kantonspital Basel-Land (KSBL) Liestal, Prof. Dr. med. Robert Rosenberg","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentImage","id":"e78a3514-102d-4b82-a4df-2d7e935b099c","properties":{"jumpNavigationTitle":null,"image":[{"focalPoint":null,"crops":[],"id":"53bec52d-9d74-48b2-8649-d8ee045b1440","name":"Claraforschung Netzwerk Contentimage","mediaType":"Image","url":"/media/fpcl2u1u/claraforschung_netzwerk_contentimage.jpg","extension":"jpg","width":1920,"height":1080,"bytes":399695,"properties":{}}],"altText":null,"caption":null,"fullWidth":false}},"settings":null},{"content":{"contentType":"componentTeasers","id":"2954661e-279b-4363-99d0-3636da9e854d","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Krebsforschung/Allgemeine Forschung","createDate":"2024-08-29T15:49:26.407Z","updateDate":"2024-11-04T10:21:32.143Z","route":{"path":"/de/klinische-forschung/krebsforschungallgemeine-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b34f8a13-b31a-46e1-b4a3-65fbe3762e06","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"9189c92b-2db9-46e1-9e71-ccd199539d22","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Die Krebstherapie hat sich in den letzten Jahren enorm schnell entwickelt. Wirksamere aber auch schonendere Therapieformen können heute eingesetzt werden.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"6fb5422b-f674-4c3a-aaf7-c08f4de58d12","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die St. Clara Forschung erforscht schwerpunktmässig die Verbesserung in der Diagnostik und Behandlung von Krebserkrankungen des Bauches, des Blutsystems, der Brust, der Lunge, der Nieren, der Hoden und der Prostata.","tag":"#text"}]},{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die allgemeine Forschung beschäftigt sich mit Forschungsprojekten ausserhalb der erwähnten Gebiete wie beispielsweise der Anästhesie, Notfallmedizin, Intensivmedizin, Palliativmedizin, Kardiologie, Pneumologie und Psychoonkologie.   ","tag":"#text"},{"tag":"span","attributes":{"style":"mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Lucida Sans Unicode'; mso-fareast-language: DE-CH;"},"elements":[{"tag":"br","attributes":{},"elements":[]}]}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentTeasers","id":"a9eb21f8-af75-4511-acaf-1354de102ea0","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"9ad2f67a-7fc6-44aa-8d56-135373d1b29f","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG – Krebsforschung","createDate":"2024-10-18T09:59:39.393Z","updateDate":"2024-11-06T16:38:56.787Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag-krebsforschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ab57b132-cff4-44a4-b377-a2e37f6d82ed","properties":{}},{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"9cfadfb4-759c-4003-87bd-daac1e91e413","name":"Medizinisches Angebot Hernienzentrum Clarunis Teaser (1)","mediaType":"Image","url":"/media/wlppvhe2/medizinisches-angebot_hernienzentrum_clarunis_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":612763,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"04a08f65-8fc5-4df4-8a37-b73dd99aca44","properties":{"title":"Krebsforschung/Allgemeine Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}},{"contentType":"claraforschungGeneric","name":"Metabole und gastroenterologische Forschung","createDate":"2024-08-29T16:05:52.92Z","updateDate":"2024-11-05T10:11:20.223Z","route":{"path":"/de/klinische-forschung/metabole-und-gastroenterologische-forschung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e3cbdff7-c98a-47c0-97e2-d7b4843206c4","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"a2dc7025-2720-43ff-825e-e8f2dd79e95e","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Stoffwechselerkrankungen wie Übergewicht, Diabetes und damit verbundene Erkrankungen wie Bluthochdruck, Blutfettstörungen und Leberverfettung nehmen weltweit zu und sehr viele Patient/innen sind davon betroffen. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"703ddc00-11e3-4ef6-b881-5f5cd9b649c8","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Übergewicht ist eine multifaktorielle, chronische Erkrankung. Die Mechanismen, die der Entstehung von Übergewicht zugrunde liegen, sind noch immer nicht vollständig geklärt. Bei der Behandlung ist eine Kombination von therapeutischen Massnahmen erforderlich. Lebensstilanpassungen wie beispielsweise eine Ernährungsumstellung, gesteigerte körperliche Aktivität, zielgerichtete Medikamente und die Übergewichtschirurgie können einzeln oder in Kombination hilfreich sein.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Die Hauptziele unseres Forschungsbereichs sind ein tieferes Verständnis für die Appetitregulation – einschliesslich der Interaktion zwischen dem Darm und dem Gehirn – zu erlangen, den Ursachen von Übergewicht und Magendarmerkrankungen auf den Grund zu gehen und schliesslich die Wirksamkeit verschiedener Behandlungsoptionen im Detail zu untersuchen. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"In der gastroenterologischen Forschung stehen die chronisch entzündlichen Darmerkrankungen (CED) im Fokus. Bei dieser Erkrankung geht man von einer überschiessenden Aktivierung des Immunsystems der Darmschleimhaut aus. Dabei spielt eine gestörte Schleimhautbarriere eine wichtige Rolle wo eine lokale Entzündung z.B. durch eindringende Erreger ausgelöst werden kann. Wir interessieren uns daher für die Immunantwort von einer bestimmten Untergruppe von Immunzellen, die von aus der Darmmikroflora stammenden Antigene stimuliert werden. Die Analysen, die wir durchführen, können bei unterschiedlichen Mustern möglicherweise Rückschlüsse auf den individuellen klinischen Verlauf oder auf das Ansprechen einer Therapie bei einzelnen CED Patienten liefern. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Studienresultate werden regelmässig in anerkannten Fachzeitschriften publiziert sowie an nationalen und internationalen Kongressen vorgestellt. Wir halten eingeladene Fachvorträge und stehen in engem Kontakt mit den öffentlichen Medien, um Fachexperten wie auch die breite Öffentlichkeit über die Ursachen und Behandlungsoptionen von Übergewicht und Magendarmerkrankungen aufzuklären. Es ist uns hierbei ein besonderes Anliegen, das Stigma des schweren Übergewichts zu bekämpfen, indem wir neue Erkenntnisse über die biologischen Ursachen dieser Krankheit und therapeutischen Massnahmen vermitteln. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentHighlight","id":"cc2ae5a6-539b-4061-8691-b4e0c98cbebf","properties":{"jumpNavigationTitle":null,"title":"Studienbeispiele","text":{"tag":"#root","attributes":{},"elements":[{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie wird der Einfluss einer kohlenhydratreduzierten Kost auf das Gewicht, den Stoffwechsel und die psychische Gesundheit untersucht.","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"In einer vom Schweizerischen Nationalfonds (SNF) finanzierten Studie werden zwei Arten von Magenbypass-Operationen auf ihre Wirksamkeit hin untersucht. Diese grosse multizentrische Studie mit > 800 Studienteilnehmer/innen erlaubt es im Detail zu untersuchen wie diese Operationen sich auf den Stoffwechsel auswirken. ","tag":"#text"}]}]}],"blocks":[]},"link":null,"variation":{"color":"c7eae0","label":"green"}}},"settings":null},{"content":{"contentType":"componentTeasers","id":"93d4d935-e853-4ea1-a42b-f965529208e6","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"items":[{"contentType":"claraforschungGeneric","name":"Aktuelle Studien","createDate":"2024-08-27T10:22:29.24Z","updateDate":"2024-11-07T16:14:02.423Z","route":{"path":"/de/aktuelle-studien","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"6d032f54-4297-46f2-89f1-083a1efe1423","properties":{}},{"contentType":"claraforschungGeneric","name":"Wissenschaftliche Netzwerke","createDate":"2024-08-27T10:21:43.06Z","updateDate":"2024-11-05T10:15:08.07Z","route":{"path":"/de/klinische-forschung/wissenschaftliche-netzwerke","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7a61644b-5247-45dd-87cf-a3ea1d05027a","properties":{}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"fc110ac2-6df1-424b-b003-4b6f3c4bf6fb","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"d2d37e0c-9af7-4748-a5c3-6e1a6fd12f79","name":"Medizinisches Angebot Bariatrie Claraspital Teaser","mediaType":"Image","url":"/media/bj5nhuxx/medizinisches-angebot_bariatrie_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":556718,"properties":{}}],"teaserTitle":null,"teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"6755e1e2-2911-4006-8695-c4fbfd8ea988","properties":{"title":"Metabole und gastroenterologische Forschung","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]}}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"23208443-572d-4e5a-a7c4-c5ac90465831","name":"Medizinisches Angebot Forschung Claraspital Teaser","mediaType":"Image","url":"/media/iwccaizn/medizinisches-angebot_forschung_claraspital_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":304241,"properties":{}}],"teaserTitle":"Wissenschaftliche Netzwerke","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"efb5b3ca-05c1-4c37-829c-f18d80376e2f","properties":{"title":"Wissenschaftliche Netzwerke","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/wissenschaftliche-netzwerke"}},{"contentType":"claraforschungGeneric","name":"Dr. Peter Eichenberger Grant","createDate":"2024-11-06T12:09:47.487Z","updateDate":"2024-11-14T09:56:10.557Z","route":{"path":"/de/klinische-forschung/dr-peter-eichenberger-grant","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"88f79ec0-708c-4670-871d-210faa0199bf","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHubLead","id":"25e720f8-9f5a-4f39-952c-81232cadba9f","properties":{"jumpNavigationTitle":null,"lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Peter Eichenberger war der langjährige Spitaldirektor des St. Claraspitals. Dank seiner visionären Idee und dem Engagement des Teams der St. Clara Forschung konnte sich die Institution in kurzer Zeit national und international profilieren.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentRichtext","id":"0df9391a-676a-4b69-9280-e8e086480665","properties":{"jumpNavigationTitle":null,"title":null,"text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Pro Jahr stehen CHF 60'000 zur Forschungsförderung zur Verfügung. Es sollen unterstützungswürdige Forschungsprojekte mit Bezug zum Claraspital finanziell unterstützt werden. Der Förderbetrag kann vom/von der Beitragsempfänger/in im Rahmen einer akademischen Karriere als kompetitiv eingeworbene Drittmittel angerechnet werden. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Beitragsberechtigt sind Angestellte des Claraspitals, von Clarunis, der Lindenhofgruppe und der St. Clara Forschung.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Eingereicht werden müssen (siehe Reglement):","tag":"#text"}]},{"tag":"ul","attributes":{},"elements":[{"tag":"li","attributes":{},"elements":[{"text":"Begleitschreiben","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"Forschungsplan/Synopsis","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"Budget- und Zeitplan","tag":"#text"}]},{"tag":"li","attributes":{},"elements":[{"text":"CV und wichtigste Publikationen","tag":"#text"}]}]},{"tag":"p","attributes":{},"elements":[{"text":"Einreichung per Email bis 20. Januar 2025 um 23.59 Uhr an ","tag":"#text"},{"tag":"a","attributes":{"href":"mailto:forschung@claraspital.ch"},"elements":[{"text":"forschung@claraspital.ch","tag":"#text"}]},{"text":"  ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"Für Fragen steht Prof. Dr. med. Markus Zuber gerne zur Verfügung.","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentDownloads","id":"7f198f1b-2a99-4aff-ae80-b53f0e75a4bf","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"items":[{"contentType":"claraforschungGlobalDownload","name":"Antragsvorlage Dr. Pe­ter Ei­chen­ber­ger Grant 2025","createDate":"2024-11-06T17:08:40.36Z","updateDate":"2024-11-06T17:18:29.393Z","route":{"path":"/global/downloads/antragsvorlage-dr-pe-ter-ei-chen-ber-ger-grant-2025","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f1bd1f84-caf7-44ea-8a69-6a4c8888de02","properties":{"title":"Antragsvorlage Dr. Pe­ter Ei­chen­ber­ger Grant 2025","description":null,"download":[{"focalPoint":null,"crops":[],"id":"bd26273f-0b91-4009-bf43-843ad3068190","name":"Grant Template Budget Zeitplan","mediaType":"umbracoMediaArticle","url":"/media/cetdnpmr/grant_template_budget_zeitplan.docx","extension":"docx","width":null,"height":null,"bytes":821707,"properties":{}}]}},{"contentType":"claraforschungGlobalDownload","name":"Reglement Dr. Pe­ter Ei­chen­ber­ger Grant","createDate":"2024-11-06T17:20:33.483Z","updateDate":"2024-11-06T17:20:33.483Z","route":{"path":"/global/downloads/reglement-dr-pe-ter-ei-chen-ber-ger-grant","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ae9d83ef-aaed-4c6c-809e-91eb3cd5100d","properties":{"title":"Reglement Dr. Pe­ter Ei­chen­ber­ger Grant","description":null,"download":[{"focalPoint":null,"crops":[],"id":"76f7b04d-0619-41ea-9133-b89e215c9dc3","name":"Reglement Dr Peter Eichenberger Forschungsfoerderung","mediaType":"umbracoMediaArticle","url":"/media/moypo3qz/reglement_dr_peter_eichenberger_forschungsfoerderung.pdf","extension":"pdf","width":null,"height":null,"bytes":128093,"properties":{}}]}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"2fbec068-e2c0-4fbd-a494-8b2875637718","properties":{"jumpNavigationTitle":null,"title":"Noch Fragen?","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Ihr Ansprechpartner","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"ad2f629c-05e1-4263-ab11-06bdc314a720","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Zuber_Markus","createDate":"2024-09-25T17:30:42.08Z","updateDate":"2024-09-26T10:47:20.88Z","route":{"path":"/de/mitarbeitende/zuber_markus","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"26776349-2a2e-4554-aa33-17d3700ebc8e","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"22158db0-3d1d-4a34-a321-152d2615ce56","name":"Forschung Grant Claraspital Teaser","mediaType":"Image","url":"/media/w0gbkiq3/forschung_grant_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":258799,"properties":{}}],"teaserTitle":"Dr. Peter Eichenberger Grant","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"2007720b-3d00-412f-a3c9-80568eae8867","properties":{"title":"Dr. Peter Eichenberger Grant","lead":"Der  Grant ist  dem ehemaligen und langjährigen Direktor des Claraspitals, Dr. rer. pol. Peter Eichenberger (1966-2024) gewidmet und wird jährlich vom Koordinationsgremium der St. Clara Forschung AG vergeben.","image":[{"focalPoint":null,"crops":[],"id":"c4504126-8917-4315-a8a4-2d682549bdad","name":"Claraforschung Grant Hero","mediaType":"Image","url":"/media/ebafbrax/claraforschung_grant_hero.jpg","extension":"jpg","width":1920,"height":1080,"bytes":439021,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/klinische-forschung/dr-peter-eichenberger-grant"}},{"contentType":"claraforschungGeneric","name":"Team","createDate":"2024-09-17T10:35:55.977Z","updateDate":"2024-11-05T10:16:59.127Z","route":{"path":"/de/team","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"4d0f538c-4e6d-4f1e-b28e-36e69b6ef2f6","properties":{"contentComponents":{"items":[{"content":{"contentType":"claraforschungComponentEmployeeList","id":"ce92e29f-07a5-4696-a0e7-ed937eb3d412","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"In der Geschäftsleitung","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"254ec8be-1faf-48e2-b68e-cda0b9ff7d3f","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Zuber_Markus","createDate":"2024-09-25T17:30:42.08Z","updateDate":"2024-09-26T10:47:20.88Z","route":{"path":"/de/mitarbeitende/zuber_markus","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"26776349-2a2e-4554-aa33-17d3700ebc8e","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Leitung","createDate":"2024-10-01T10:06:02.273Z","updateDate":"2024-11-06T16:38:58.63Z","route":{"path":"/global/position/leitung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"69ae1db3-b85c-4f67-9036-954ae3d68820","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"6feb2640-8959-47d4-8cd3-5715a5eb7051","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Templeton Arnoud","createDate":"2024-09-25T14:28:55.307Z","updateDate":"2024-09-26T10:23:24.577Z","route":{"path":"/de/mitarbeitende/templeton-arnoud","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"460a7bde-474d-4eaf-b18a-f410385fd143","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Stv. Leitung","createDate":"2024-10-01T10:06:49.027Z","updateDate":"2024-11-06T16:38:59.113Z","route":{"path":"/global/position/stv-leitung","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c5e31cb0-f856-40f8-a881-ac383393d158","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"a29db87e-de01-4641-a1c4-6505699e3ef5","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Meyer-Gerspach Anne Christin","createDate":"2024-09-25T09:36:10.713Z","updateDate":"2024-10-01T12:58:52.11Z","route":{"path":"/de/mitarbeitende/meyer-gerspach-anne-christin","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f1a90997-340e-4302-b575-33a1793f59c8","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"a121f6c7-ede5-41ef-969c-9c67f80b1ed1","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Woelnerhanssen Bettina","createDate":"2024-09-25T17:07:29.957Z","updateDate":"2024-10-24T10:24:27.907Z","route":{"path":"/de/mitarbeitende/woelnerhanssen-bettina","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"0837f013-c9cb-4f8f-b1d6-3f333ac198b3","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"f1f96e44-a911-4078-9cc7-658e69d4fd17","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"von Strauss Marco","createDate":"2024-09-25T16:30:01.517Z","updateDate":"2024-09-26T10:23:31.877Z","route":{"path":"/de/mitarbeitende/von-strauss-marco","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"3f757c45-5f65-43c0-917c-bdda064e7d57","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"4df0b6af-7e92-445e-b4b9-b6964db68cc6","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Studienkoordination und Sekretariat","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"72f25aa5-354a-49c0-b144-4c32795d2488","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Allmendinger Birgit","createDate":"2024-09-17T10:43:48.577Z","updateDate":"2024-09-17T10:44:46.19Z","route":{"path":"/global/mitarbeitende-ohne-seite/allmendinger-birgit","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c2553e67-b2a5-46f7-8709-ee1970119541","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"7b3d9f23-7c99-4e7b-ab61-db12441c8ce3","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Diana Bakker de Jong","createDate":"2024-09-17T10:45:10.133Z","updateDate":"2024-09-17T10:45:44.42Z","route":{"path":"/global/mitarbeitende-ohne-seite/diana-bakker-de-jong","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"e9161bda-166e-4764-92f7-d61f0d3352f1","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"dd34dde2-8b74-4205-95cc-261511ffad4d","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Distler Jana","createDate":"2024-09-17T10:46:06.293Z","updateDate":"2024-09-17T10:46:40.613Z","route":{"path":"/global/mitarbeitende-ohne-seite/distler-jana","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c89943ef-c3bf-491f-b291-4050910969a6","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"278b0399-2842-493b-b4aa-8001e146bce8","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Kammer Barbara","createDate":"2024-09-17T10:47:59.553Z","updateDate":"2024-09-17T10:48:41.757Z","route":{"path":"/global/mitarbeitende-ohne-seite/kammer-barbara","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"da16e846-2e92-45f0-87ed-47a639a2d7fb","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"a3eb90f7-2c72-43c0-a5f7-b8e648e0e725","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Pflimlin-Fritschy Véronique","createDate":"2024-09-17T10:49:08.393Z","updateDate":"2024-09-17T10:49:51.227Z","route":{"path":"/global/mitarbeitende-ohne-seite/pflimlin-fritschy-veronique","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"2916d5c2-81b3-49ac-b67d-c0e44b29a53d","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"5ac20dca-3bbc-4bff-86a1-fe0c2716a4ca","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Punsola Catherine","createDate":"2024-09-17T10:50:14.82Z","updateDate":"2024-09-17T10:50:58.293Z","route":{"path":"/global/mitarbeitende-ohne-seite/punsola-catherine","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"32bddcb7-a57e-4364-afec-f96f335ae5b8","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"e4589715-f8bd-4520-b789-ff67ce58167b","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Ruscher Uta","createDate":"2024-09-17T10:52:06.99Z","updateDate":"2024-09-17T10:53:10.147Z","route":{"path":"/global/mitarbeitende-ohne-seite/ruscher-uta","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"899c187e-dc20-49a8-b62f-62c03a34018b","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"6f5dc835-41b7-4b2e-bccb-a26ab6803fe4","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Nathell Benkert Therese","createDate":"2024-09-17T10:56:43.433Z","updateDate":"2024-09-17T11:02:55.383Z","route":{"path":"/global/mitarbeitende-ohne-seite/nathell-benkert-therese","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"a4a25820-1b51-4484-825e-b828b12c782c","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"b475a808-0eef-40e3-8df1-a6839843a12f","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"(Post-)Doktorand/innen","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"35b4e3aa-4dae-4a21-bd41-482a0115b7dc","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Altstädt Anita","createDate":"2024-09-17T11:07:13.57Z","updateDate":"2024-09-17T11:08:31.897Z","route":{"path":"/global/mitarbeitende-ohne-seite/altstaedt-anita","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"1dcbfe2d-b64f-4c99-a144-86843290d110","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"ac9117e6-44ee-41be-bddf-915fb36b98dc","properties":{"employee":[{"contentType":"claraforschungGlobalEmployee","name":"Flad Emilie","createDate":"2024-09-17T11:03:21.87Z","updateDate":"2024-09-17T11:04:40.893Z","route":{"path":"/global/mitarbeitende-ohne-seite/flad-emilie","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"c55116cd-5304-441c-b564-15f80cd676c1","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"2cb689c9-436f-49e2-9d21-7632e5b4f30d","name":"Claraspital Partnerschaften Teaser","mediaType":"Image","url":"/media/z4elmldp/claraspital_partnerschaften_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":435552,"properties":{}}],"teaserTitle":"Team","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"e9d302de-f0dd-4522-90c5-bc5b58fd9125","properties":{"title":"Team","lead":null,"image":[{"focalPoint":{"left":0.5288220551378446,"top":0.5133667502088555},"crops":[],"id":"569f4c4c-e84b-4422-896b-c8ed64e01f75","name":"Home Claraforschung2","mediaType":"Image","url":"/media/jjgj4vsl/home_claraforschung2.jpg","extension":"jpg","width":1920,"height":1080,"bytes":1340275,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/team"}},{"contentType":"claraforschungGeneric","name":"Medien & Publikationen","createDate":"2024-08-27T09:03:48.353Z","updateDate":"2024-11-05T11:29:12.847Z","route":{"path":"/de/medien-publikationen","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"87805e88-c17b-477e-a319-5bbe7bd5dbd9","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentRichtext","id":"8c04a69e-9d5d-4ab1-a0aa-0b9b62df5a79","properties":{"jumpNavigationTitle":null,"title":"Breite Reichweite und öffentliche Wahrnehmung ","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{"style":"line-height: normal;","class":"MsoNormal"},"elements":[{"text":"Die Clara Forschung legt grossen Wert auf den öffentlichen Dialog über ihre Arbeit und die Ergebnisse der Wissenschaft. Neben erfolgreichen Veröffentlichungen in Fachzeitschriften nehmen die Forschenden aktiv an nationalen und internationalen Kongressen sowie Fachveranstaltungen teil. ","tag":"#text"}]}],"blocks":[]},"link":null}},"settings":null},{"content":{"contentType":"componentTeasersAuto","id":"4f1fb319-ec13-4a7b-8b8d-194b7499a814","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"slider":false,"Information":null}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"f731bd2c-422e-4806-9f6d-e3f44bed596d","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"St. Clara Forschung AG","createDate":"2024-08-29T15:53:08.467Z","updateDate":"2024-11-06T16:38:54.703Z","route":{"path":"/global/contact-addresses/st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"7566ad60-49ed-47dc-8a7f-f0f77e046166","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Kontakt","title":"St. Clara Forschung AG","lead":null,"contactPhone":"+41 61 685 85 85","eMailAdress":"forschung@claraspital.ch","contactAddress":[{"url":"https://maps.app.goo.gl/ZN3PiCegNQH2Sjkt5","queryString":null,"title":"Kleinriehenstr. 43 4058 Basel","target":null,"destinationId":null,"destinationType":null,"route":null,"linkType":"External"}],"contactLinks":null}},{"contentType":"claraforschungGlobalContactAddress","name":"Klinische Forschung unterstützen","createDate":"2024-09-18T09:33:34.53Z","updateDate":"2024-11-18T07:54:30.76Z","route":{"path":"/global/contact-addresses/klinische-forschung-unterstuetzen","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ee921ab0-8e98-4632-bf44-609be7d37fff","properties":{"color":{"color":"eee4ef","label":"violet"},"label":"Klinische Forschung unterstützen","title":"Klinische Forschung unterstützen","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Spendenkonto Basler Kantonalbank, Basel   ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"CH10 0077 0252 7146 7200 1","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":" ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Bitte Zahlungszweck erwähnen:","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"• Krebsforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung Chirurgie","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Übergewichts-, Diabetes- und Stoffwechselforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung allgemein","tag":"#text"}]}],"blocks":[]},"contactPhone":null,"eMailAdress":null,"contactAddress":null,"contactLinks":null}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentEmployeeList","id":"892fad92-4da2-4792-bcd5-ec9ee6f6ca05","properties":{"jumpNavigationTitle":null,"title":"Ihre Ansprechpersonen ","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"In der St. Clara Forschung","tag":"#text"}]}],"blocks":[]},"items":{"items":[{"content":{"contentType":"claraforschungEmployeeElement","id":"6537d5a3-e8ab-4546-ae8f-cbb07a3a9192","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Zuber_Markus","createDate":"2024-09-25T17:30:42.08Z","updateDate":"2024-09-26T10:47:20.88Z","route":{"path":"/de/mitarbeitende/zuber_markus","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"26776349-2a2e-4554-aa33-17d3700ebc8e","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Leitung St. Clara Forschung AG","createDate":"2024-09-25T17:19:29.953Z","updateDate":"2024-11-06T16:38:58.13Z","route":{"path":"/global/position/leitung-st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"9e02025a-7027-41f2-8a3f-297571c02943","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"dc86d883-102a-46f9-a80c-3ca461cc0810","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Templeton Arnoud","createDate":"2024-09-25T14:28:55.307Z","updateDate":"2024-09-26T10:23:24.577Z","route":{"path":"/de/mitarbeitende/templeton-arnoud","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"460a7bde-474d-4eaf-b18a-f410385fd143","properties":{}}],"positionTitles":[{"contentType":"claraforschungGlobalPositionTitle","name":"Stv. Leitung St. Clara Forschung AG","createDate":"2024-10-01T10:04:52.593Z","updateDate":"2024-11-06T16:38:58.307Z","route":{"path":"/global/position/stv-leitung-st-clara-forschung-ag","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f34ec0a6-9d15-40cc-a932-c0339c560da9","properties":{}}],"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"7fc11125-214d-4a08-95ce-e0f0b8a15173","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Woelnerhanssen Bettina","createDate":"2024-09-25T17:07:29.957Z","updateDate":"2024-10-24T10:24:27.907Z","route":{"path":"/de/mitarbeitende/woelnerhanssen-bettina","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"0837f013-c9cb-4f8f-b1d6-3f333ac198b3","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"53ad345e-bcf6-4947-b7f1-9d86dd708549","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"Meyer-Gerspach Anne Christin","createDate":"2024-09-25T09:36:10.713Z","updateDate":"2024-10-01T12:58:52.11Z","route":{"path":"/de/mitarbeitende/meyer-gerspach-anne-christin","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"f1a90997-340e-4302-b575-33a1793f59c8","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null},{"content":{"contentType":"claraforschungEmployeeElement","id":"aa908c42-beac-427c-a7f4-f7898fe9c57f","properties":{"employee":[{"contentType":"claraforschungEmployee","name":"von Strauss Marco","createDate":"2024-09-25T16:30:01.517Z","updateDate":"2024-09-26T10:23:31.877Z","route":{"path":"/de/mitarbeitende/von-strauss-marco","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"3f757c45-5f65-43c0-917c-bdda064e7d57","properties":{}}],"positionTitles":null,"specialistTitles":null}},"settings":null}]}}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"5b24e095-f0dd-4ba0-a9f7-1b8bdf23fe18","name":"Claraspital Publikationen Teaser","mediaType":"Image","url":"/media/spqciw43/claraspital_publikationen_teaser.jpg","extension":"jpg","width":800,"height":1080,"bytes":585662,"properties":{}}],"teaserTitle":"Medien & Publikationen","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"89f3c99c-f224-4cb1-bb24-90270f21aa06","properties":{"title":"Medien & Publikationen","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/medien-publikationen"}},{"contentType":"claraforschungGeneric","name":"Spender/in werden","createDate":"2024-08-27T10:21:10.47Z","updateDate":"2024-11-05T11:29:42.043Z","route":{"path":"/de/spenderin-werden","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"b5299480-9779-4c8f-8845-1a0cf2e0c836","properties":{"contentComponents":{"items":[{"content":{"contentType":"componentHighlight","id":"14cfd0e1-cbbb-4db9-a361-2f884fc3fd40","properties":{"jumpNavigationTitle":null,"title":"Klinische Forschung","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Der medizinische Fortschritt hat die Lebensqualität und die Heilungschancen der Patient/innen wesentlich verbessert. Doch wollen wir nicht stillstehen, sondern weiter forschen. Denn die klinische Forschung hilft uns, die Behandlung künftiger Patient/innen weiter zu verbessern.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Dank grosszügigen Spenden ist es möglich, aktiv an klinischen Forschungsprogrammen teilzunehmen oder zu initiieren. Gleichzeitig können wir so die wissenschaftliche Weiterbildung und Weiterentwicklung unserer Mitarbeitenden fördern. ","tag":"#text"}]}],"blocks":[]},"link":null,"variation":{"color":"c7eae0","label":"green"}}},"settings":null},{"content":{"contentType":"componentDownloads","id":"e7b18a68-5f5a-493b-be29-ff8ccc2c5a3f","properties":{"jumpNavigationTitle":null,"title":null,"lead":null,"items":[{"contentType":"globalDownload","name":"Flyer Spenden","createDate":"2024-09-05T10:49:24.247Z","updateDate":"2024-09-18T08:04:13.327Z","route":{"path":"/global/downloads/flyer-spenden","startItem":{"id":"0fc8e525-6845-48e3-8880-bbef2831f719","path":"claraspital"}},"id":"847fa18e-084d-4445-8e1f-131d0246a4a3","properties":{"title":"Flyer Spenden","description":null,"download":[{"focalPoint":null,"crops":[],"id":"04430548-dbc9-404e-9f84-02152550b849","name":"Flyer Spenden","mediaType":"umbracoMediaArticle","url":"/media/mycfgbgj/gzd-flyer-spenden-lowres_geschwaerzt.pdf","extension":"pdf","width":null,"height":null,"bytes":2689956,"properties":{}}]}}]}},"settings":null},{"content":{"contentType":"claraforschungComponentContactAddresses","id":"41d80564-71b2-4165-b084-4e1729fc59a7","properties":{"title":null,"lead":null,"jumpNavigationTitle":null,"items":[{"contentType":"claraforschungGlobalContactAddress","name":"Klinische Forschung unterstützen","createDate":"2024-09-18T09:33:34.53Z","updateDate":"2024-11-18T07:54:30.76Z","route":{"path":"/global/contact-addresses/klinische-forschung-unterstuetzen","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"ee921ab0-8e98-4632-bf44-609be7d37fff","properties":{"color":{"color":"eee4ef","label":"violet"},"label":"Klinische Forschung unterstützen","title":"Klinische Forschung unterstützen","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Spendenkonto Basler Kantonalbank, Basel   ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"CH10 0077 0252 7146 7200 1","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":" ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Bitte Zahlungszweck erwähnen:","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"• Krebsforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung Chirurgie","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Übergewichts-, Diabetes- und Stoffwechselforschung ","tag":"#text"},{"tag":"br","attributes":{},"elements":[]},{"text":"• Forschung allgemein","tag":"#text"}]}],"blocks":[]},"contactPhone":null,"eMailAdress":null,"contactAddress":null,"contactLinks":null}},{"contentType":"claraforschungGlobalContactAddress","name":"Spenden Patientenfonds","createDate":"2024-09-23T13:04:45.143Z","updateDate":"2024-11-06T16:38:55.747Z","route":{"path":"/global/contact-addresses/spenden-patientenfonds","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"id":"1f55c287-04fe-4cfd-81f4-51f033fbfb54","properties":{"color":{"color":"f0f4f9","label":"blue"},"label":"Spenden Patientenfonds","title":"Spenden Patientenfonds","lead":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Spendenkonto Basler Kantonalbank, Basel   ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"CH54 0077 0016 0501 2088 4","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":" ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Bitte Zahlungszweck erwähnen:","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"• Fonds für Patient/innen","tag":"#text"}]}],"blocks":[]},"contactPhone":null,"eMailAdress":null,"contactAddress":null,"contactLinks":null}}]}},"settings":null}]},"metaTitle":null,"metaDescription":null,"noIndex":false,"shortUrl":null,"ogImage":null,"publishDate":null,"navigationName":null,"navigationDescription":null,"navigationOverviewLinkText":null,"navigationHideInNavigation":false,"navigationHideSubnavigation":false,"navigationHideHubNode":false,"teaserImage":[{"focalPoint":null,"crops":[],"id":"45a3b0b5-b81d-4059-a388-1a3ecbeb8bce","name":"Medizinisches Angebot Kunsttherapie Claraspital Teaser","mediaType":"Image","url":"/media/woykgri3/medizinisches-angebot_kunsttherapie_claraspital_teaser.jpg","extension":"jpg","width":960,"height":1200,"bytes":731169,"properties":{}}],"teaserTitle":"Spender/in werden","teaserLead":null,"headerComponent":{"items":[{"content":{"contentType":"defaultHeader","id":"7902a1dd-034d-47bc-88f4-de3bbee5e7c6","properties":{"title":"Spender/in werden","lead":null,"image":[{"focalPoint":null,"crops":[],"id":"653cd65c-c00d-48da-8abc-2ebead88f355","name":"Home Claraforschung","mediaType":"Image","url":"/media/llldyzin/home_claraforschung.jpg","extension":"jpg","width":1920,"height":1080,"bytes":815822,"properties":{}}]}},"settings":null}]},"teaserLinkUrl":"/de/spenderin-werden"}}]}},"settings":null,"viewContext":{"isInsideContainer":false}},{"content":{"contentType":"componentHighlight","id":"9fb21a2e-f3c8-47fe-b816-58fd00d65cbb","properties":{"jumpNavigationTitle":"Dr. Peter Eichenberger Grant","title":"Dr. Peter Eichenberger Grant am Claraspital Basel","text":{"tag":"#root","attributes":{},"elements":[{"tag":"p","attributes":{},"elements":[{"text":"Pro Jahr stehen CHF 60'000 zur Forschungsförderung zur Verfügung. Es sollen unterstützungswürdige Forschungsprojekte mit Bezug zum Claraspital finanziell unterstützt werden. Der Förderbetrag kann vom/von der Beitragsempfänger/in im Rahmen einer akademischen Karriere als kompetitiv eingeworbene Drittmittel angerechnet werden. ","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Beitragsberechtigt sind Angestellte des Claraspitals, von Clarunis, der Lindenhofgruppe und der St. Clara Forschung.","tag":"#text"}]},{"tag":"p","attributes":{},"elements":[{"text":"Der  Grant ist  dem ehemaligen und langjährigen Direktor des Claraspitals, Dr. rer. pol. Peter Eichenberger (1966-2024) gewidmet und wird jährlich vom Koordinationsgremium der St. Clara Forschung AG vergeben. Peter Eichenberger war der langjährige Spitaldirektor des St. Claraspitals. Dank seiner visionären Idee und dem Engagement des Teams der St. Clara Forschung konnte sich die Institution in kurzer Zeit national und international profilieren.","tag":"#text"}]}],"blocks":[]},"link":[{"url":null,"queryString":null,"title":"Dr. Peter Eichenberger Grant","target":null,"destinationId":"88f79ec0-708c-4670-871d-210faa0199bf","destinationType":"claraforschungGeneric","route":{"path":"/de/klinische-forschung/dr-peter-eichenberger-grant","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"linkType":"Content"}],"variation":{"color":"c7eae0","label":"green"}}},"settings":null,"viewContext":{"isInsideContainer":false}}]}},"noIndex":false,"isHome":false},"isPreview":false,"threadId":78,"isContextSetByQueryParam":false,"startItemId":"211eadbf-34ae-41af-a2ed-3837d570fd78","tinyContext":{"key":"de-ch","appUrl":"https://www.claraforschung.ch","cmsUrl":"https://cms.claraforschung.ch","culture":{"label":"de","culture":"de-ch","locale":"ch","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}}},"page":{"id":"ce42f4ed-390c-4c21-b1c1-4210f54803c9","name":"Clara Forschung","route":{"path":"/de","startItem":{"id":"211eadbf-34ae-41af-a2ed-3837d570fd78","path":"claraforschung"}},"contentType":"claraforschungHome"},"isPreview":false,"threadId":78,"isContextSetByQueryParam":false,"startItemId":"211eadbf-34ae-41af-a2ed-3837d570fd78"}}